{"trajectories": [{"actions": ["Southern blot", "Enzyme assay", "High-resolution melt analysis (HRM)", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Let's start by performing a **Southern blot** to check for the presence of an expanded fragment in the HTT gene. This will help us rule out HTT gene expansion if the fragment is normal-sized. If an expanded fragment is detected, we will need to consider other assays to further narrow down the possibilities.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot result showed a normal-sized fragment, we can rule out HTT gene expansion. Now, let's perform an **Enzyme assay** to check for G6PD enzyme activity. This will help us rule out G6PD deficiency mutation if the activity is between 75-100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 82.0459461099926 falls within the range of 75-100, which rules out G6PD deficiency mutation. \n\nNow, we are left with MTHFR mutation and DMD mutation. Let's perform a **High-resolution melt analysis (HRM)** to check for MTHFR mutation. If no abnormalities are detected, we can rule out MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) showed no melting curve abnormalities, which rules out MTHFR mutation. \n\nWe are now left with only one possibility: DMD mutation. To confirm this, let's perform a **Western blot** to check for the presence of dystrophin protein. If the protein is absent or truncated, it will support the presence of a DMD mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the dystrophin protein is absent or truncated, which strongly indicates a DMD mutation. Given that all other mutations have been ruled out, we can confidently predict that the genetic mutation is DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 7896, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 82.0459461099926}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "High-resolution melt analysis (HRM)", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, let's use the Southern blot to check for the HTT gene expansion. This will help us rule out or confirm the presence of excessive CAG repeats associated with Huntington's disease.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which rules out the HTT gene expansion. We can now focus on the remaining genetic mutations: G6PD deficiency mutation, MTHFR mutation, and DMD mutation.\n\nNext, let's perform an enzyme assay to check for G6PD activity.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result shows an activity level of 82.0459461099926, which is between 75-100. This rules out the G6PD deficiency mutation. We are now left with MTHFR mutation and DMD mutation.\n\nNext, let's perform a High-Resolution Melt Analysis (HRM) to check for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) result shows no melting curve abnormalities, which rules out the MTHFR mutation. We are now left with only the DMD mutation.\n\nTo confirm, let's perform a Western blot to check for dystrophin protein.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the dystrophin protein is absent or truncated, which confirms the presence of the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 7658, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 82.0459461099926}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "High-resolution melt analysis (HRM)", "Protein truncation test", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game, the first step is to narrow down the list of potential genetic mutations using an assay that can provide clear and distinct results. The **Southern blot** is a good starting point because it can detect the presence of an expanded CAG repeat in the HTT gene, which is a characteristic of HTT gene expansion. If the Southern blot shows a normal-sized fragment, we can rule out HTT gene expansion immediately.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result of a normal-sized fragment rules out HTT gene expansion. Therefore, we can now focus on the remaining mutations: G6PD deficiency mutation, MTHFR mutation, and DMD mutation.\n\nNext, I will use the **Enzyme assay** to check for G6PD enzyme activity. If the activity is between 75-100%, we can rule out G6PD deficiency mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 82.0459461099926% falls within the range of 75-100%, which rules out the G6PD deficiency mutation. This leaves us with MTHFR mutation and DMD mutation.\n\nNext, I will use **High-resolution melt analysis (HRM)** to check for MTHFR mutation. If no melting curve abnormalities are detected, we can rule out MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) result of no melting curve abnormalities rules out the MTHFR mutation. This leaves us with only one remaining mutation: DMD mutation.\n\nTo confirm, I will use the **Protein truncation test** to check for truncated dystrophin proteins. If no truncated proteins are detected, we can rule out DMD mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein truncation test detected truncated proteins, which is consistent with a DMD mutation. Given that all other mutations have been ruled out, the remaining mutation is DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 8110, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 82.0459461099926}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "High-resolution melt analysis (HRM)", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state, the best starting point is to perform an assay that can help us narrow down the possibilities effectively. The **Southern blot** is a good choice because it can directly detect expanded CAG repeats in the HTT gene, which would immediately rule out the HTT gene expansion mutation if the result is normal.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which rules out the HTT gene expansion. This leaves us with three possible mutations: G6PD deficiency mutation, MTHFR mutation, and DMD mutation.\n\nNext, we can perform an **Enzyme assay** to check for G6PD deficiency. If the enzyme activity is between 75-100, we can rule out G6PD deficiency mutation. If the activity is between 0-25, we will need further tests.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result shows an activity of 82.0459461099926, which falls within the normal range (75-100). This rules out the G6PD deficiency mutation. \n\nNow, we are left with two possible mutations: MTHFR mutation and DMD mutation.\n\nThe next logical step is to perform **High-resolution melt analysis (HRM)**. This assay can help us identify if there are any abnormalities in the DNA melting curve, which would suggest a potential MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) result shows no melting curve abnormalities, which rules out the MTHFR mutation.\n\nThis leaves us with only one remaining possibility: the DMD mutation.\n\nTo confirm, we can perform a **Western blot** to detect the presence or absence of the dystrophin protein. If the protein of expected size is detected, we can rule out the DMD mutation. However, if the protein is absent or truncated, it would confirm the DMD mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the dystrophin protein is absent or truncated, which confirms the DMD mutation.\n\nSince we have exhausted all other possibilities and the Western blot result is consistent with the DMD mutation, we can confidently predict that the genetic mutation responsible for the trait is the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 8170, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 82.0459461099926}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "High-resolution melt analysis (HRM)", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game, the best first action is to perform a Southern blot. This assay can help us determine if there is an expanded fragment in the HTT gene, which would be indicative of HTT gene expansion. If no expanded fragment is found, we can rule out HTT gene expansion and narrow down the possibilities.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result of a normal-sized fragment rules out HTT gene expansion. We are left with the following genetic mutations: G6PD deficiency mutation, MTHFR mutation, and DMD mutation.\n\nNext, I will perform an enzyme assay to check for G6PD enzyme activity. If the activity is between 75-100, we can rule out G6PD deficiency mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 82.0459461099926 falls within the range of 75-100, which rules out G6PD deficiency mutation. We are now left with MTHFR mutation and DMD mutation.\n\nNext, I will perform a high-resolution melt analysis (HRM) to check for MTHFR mutation. If no melting curve abnormalities are detected, we can rule out MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The high-resolution melt analysis (HRM) result of no melting curve abnormalities rules out MTHFR mutation. We are now left with only one possible mutation: DMD mutation.\n\nTo confirm this, I will perform a Western blot to check for the presence and size of the dystrophin protein. If the protein of expected size is detected, it will rule out DMD mutation. However, if the protein is absent or truncated, it will confirm the DMD mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result of a protein being absent or truncated confirms that the mutation is likely a DMD mutation, as this is indicative of issues with dystrophin production.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 8001, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 82.0459461099926}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}], "seed": 0, "average_actions": 6.0, "average_tokens": 7967.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 6.0, "average_successful_tokens": 7967.0}
{"trajectories": [{"actions": ["Western blot", "Protein truncation test", "High-resolution melt analysis (HRM)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Let's start by performing a **Western Blot**. This assay will help us determine if the protein of expected size is detected, which can rule out the DMD and COL1A1 mutations.\n\n<ANSWER> Western blot </ANSWER>", "Based on the Western Blot result, the protein of expected size was detected, which rules out the DMD and COL1A1 mutations. Now, we need to further narrow down between the APC gene mutation and the CFTR mutation.\n\nNext, let's perform a **Protein Truncation Test** to see if there are any truncated proteins, which would rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the Protein Truncation Test result, no truncated proteins were detected, which rules out the APC gene mutation. Now, we are left with the CFTR mutation.\n\nTo confirm, let's perform a **High-Resolution Melt Analysis (HRM)** to check for any melting curve abnormalities, which would rule out the CFTR mutation if none are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the High-Resolution Melt Analysis (HRM) result, abnormal melting curves were detected, which indicates a variation in the DNA sequence. This is consistent with the CFTR mutation.\n\nGiven that all other mutations have been ruled out, the remaining plausible mutation is the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 4784, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "Abnormal melting curves detected"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "Protein truncation test", "High-resolution melt analysis (HRM)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Let's start by using the **Western Blot** assay. This will help us identify if the protein of the expected size is detected, which can rule out the DMD mutation and COL1A1 mutation if the protein is detected as expected.\n\n<ANSWER> Western blot </ANSWER>", "The Western Blot results show that the protein of the expected size is detected. This rules out the DMD mutation and COL1A1 mutation. The remaining possible mutations are APC gene mutation and CFTR mutation.\n\nNext, let's use the **Protein Truncation Test** to see if there are any truncated proteins, which can help us rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test results show that no truncated proteins are detected. This rules out the APC gene mutation. The only remaining possible mutation is the CFTR mutation.\n\nLet's confirm this by using the **High-Resolution Melt Analysis (HRM)** to check for any melting curve abnormalities, which can help rule out the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) results show abnormal melting curves, which indicates the presence of a CFTR mutation. Given that this is the only remaining mutation and the HRM results confirm it, we can confidently identify the mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 4794, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "Abnormal melting curves detected"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "Protein truncation test", "High-resolution melt analysis (HRM)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Given the initial state, let's start by using an assay that can help us narrow down the list of possible genetic mutations effectively. The **Western Blot** assay can detect specific proteins and their sizes, which can help rule out some of the mutations right away.\n\n<ANSWER> Western blot </ANSWER>", "The Western Blot assay has detected a protein of the expected size, ruling out the DMD mutation and COL1A1 mutation. This leaves us with the APC gene mutation and CFTR mutation as the remaining possibilities.\n\nNext, let's use the **Protein Truncation Test** to further narrow down the list. This test will help us identify if any truncated proteins are present, which can rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test did not detect any truncated proteins, ruling out the APC gene mutation. This leaves us with the CFTR mutation as the only remaining possibility.\n\nLet's confirm this by using the **High-Resolution Melt Analysis (HRM)**. This assay can help us identify any abnormalities in the DNA sequence that might be associated with the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) detected abnormal melting curves, which confirms the presence of a mutation in the CFTR gene. Given that this is the only remaining mutation, we can confidently predict that the genetic mutation is the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 4848, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "Abnormal melting curves detected"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "Protein truncation test", "High-resolution melt analysis (HRM)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Let's start by performing a **Western Blot** to detect specific proteins and evaluate their size. This will help us rule out mutations that do not produce proteins of the expected size.\n\n<ANSWER> Western blot </ANSWER>", "Since the Western Blot detected a protein of the expected size, we can rule out the **DMD mutation** and **COL1A1 mutation**. The remaining possible mutations are **APC gene mutation** and **CFTR mutation**.\n\nNext, let's perform a **Protein Truncation Test** to see if there are any truncated proteins, which would help us further narrow down the possibilities.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, we can rule out the **APC gene mutation**. The only remaining possible mutation is the **CFTR mutation**.\n\nTo confirm this, let's perform a **High-Resolution Melt Analysis (HRM)** to check for any melting curve abnormalities that would indicate a CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The abnormal melting curves detected by the High-Resolution Melt Analysis (HRM) confirm the presence of a CFTR mutation. Since this is the only remaining mutation and the HRM results support it, we can confidently identify the mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 4750, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "Abnormal melting curves detected"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "Protein truncation test", "High-resolution melt analysis (HRM)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["To start, I'll choose an assay that can help me rule out multiple mutations at once. The **Western Blot** is a good choice because it can detect the presence of specific proteins and their sizes, which can immediately rule out several mutations.\n\n<ANSWER> Western blot </ANSWER>", "The Western Blot result showed that a protein of the expected size was detected. This rules out the DMD mutation and the COL1A1 mutation, as both of these mutations are associated with the absence or truncation of the expected protein.\n\nRemaining mutations: ['APC gene mutation', 'CFTR mutation']\n\nNext, I'll perform the **Protein Truncation Test** to further narrow down the possibilities. This test will help me identify if there are any truncated proteins, which would rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test result showed that no truncated proteins were detected. This rules out the APC gene mutation, as truncated proteins are often a hallmark of this mutation.\n\nRemaining mutations: ['CFTR mutation']\n\nTo confirm the CFTR mutation, I'll perform **High-Resolution Melt Analysis (HRM)**, which can detect variations in DNA sequences.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) detected abnormal melting curves, which is consistent with the presence of a CFTR mutation.\n\nGiven the results so far, I am confident that the mutation responsible for the observed trait is the **CFTR mutation**.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 4888, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "Abnormal melting curves detected"}], "successful": true, "parse_error": false}], "seed": 1, "average_actions": 5.0, "average_tokens": 4812.8, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 4812.8}
{"trajectories": [{"actions": ["Enzyme assay", "High-resolution melt analysis (HRM)", "Protein truncation test", "ELISA", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["To start, I will perform an **Enzyme assay** to check for the activity levels that can help rule out the PAH mutation, as it directly affects the enzyme activity.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 99.99, which falls within the range (75, 100). This result rules out the **PAH mutation**. \n\nNext, I will perform a **High-resolution melt analysis (HRM)** to check for abnormalities in the DNA double-helix stability, which can help rule out the **MTHFR mutation**.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The high-resolution melt analysis (HRM) showed no melting curve abnormalities, which rules out the **MTHFR mutation**.\n\nNow, I will perform a **Protein truncation test** to check for truncated proteins, which can help rule out the **APC gene mutation**.\n\n<ANSWER> Protein truncation test </ANSWER>", "The protein truncation test detected truncated proteins, which does not rule out any specific mutation but suggests a potential issue with protein function. Given that the PAH and MTHFR mutations have already been ruled out, and the protein truncation test detected truncated proteins, the most likely remaining mutation is the **APC gene mutation**.\n\nHowever, to confirm this, I will perform an **ELISA** to check for normal leptin function, which can help rule out the **LEP mutation**.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result is 15.96, which falls within the range (0, 25). This result rules out the **LEP mutation**.\n\nGiven that the PAH, MTHFR, and LEP mutations have been ruled out, the only remaining possible mutation is the **APC gene mutation**.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 7651, "observations": [null, {"action": "Enzyme assay", "observation": 99.99296989863173}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}, {"action": "ELISA", "observation": 15.961783452617343}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "High-resolution melt analysis (HRM)", "Protein truncation test", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["To start, I will perform a test that can potentially rule out a common mutation. The 'Enzyme assay' can help rule out the PAH mutation if the enzyme activity is within the normal range (75, 100).\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity result of 99.99296989863173 falls within the range (75, 100), which rules out the PAH mutation.\n\nNow, I will perform an ELISA to check for the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 15.961783452617343 falls within the range (0, 25), which rules out the LEP mutation.\n\nNow, I will perform a High-Resolution Melt Analysis (HRM) to check for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM result shows no melting curve abnormalities, which rules out the MTHFR mutation.\n\nThe only remaining mutation is the APC gene mutation. I will perform a Protein Truncation Test to confirm.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test detected truncated proteins, which is consistent with the APC gene mutation. Given that all other mutations have been ruled out, I can confidently predict the truth.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 7536, "observations": [null, {"action": "Enzyme assay", "observation": 99.99296989863173}, {"action": "ELISA", "observation": 15.961783452617343}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "High-resolution melt analysis (HRM)", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["To begin, let's perform an assay that can help us rule out one of the mutations based on its specific characteristics. The **Enzyme assay** is a good starting point because it can directly rule out the **PAH mutation** if the enzyme activity is within a specific range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The result of the Enzyme assay is 99.99296989863173, which falls within the range (75, 100). According to the guide, this result rules out the **PAH mutation**.\n\nNow, we have the following remaining genetic mutations:\n- MTHFR mutation\n- APC gene mutation\n- LEP mutation\n\nNext, let's perform the **ELISA** assay to see if we can rule out the **LEP mutation**.\n\n<ANSWER> ELISA </ANSWER>", "The result of the ELISA assay is 15.961783452617343, which falls within the range (0, 25). According to the guide, this result rules out the **LEP mutation**.\n\nNow, we have the following remaining genetic mutations:\n- MTHFR mutation\n- APC gene mutation\n\nNext, let's perform the **High-resolution melt analysis (HRM)** to see if we can rule out the **MTHFR mutation**.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The result of the High-resolution melt analysis (HRM) is \"No melting curve abnormalities,\" which rules out the **MTHFR mutation** according to the guide.\n\nNow, we have the following remaining genetic mutation:\n- APC gene mutation\n\nSince we have only one remaining mutation, we can confidently predict that the genetic mutation responsible for the trait is the **APC gene mutation**.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 6126, "observations": [null, {"action": "Enzyme assay", "observation": 99.99296989863173}, {"action": "ELISA", "observation": 15.961783452617343}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "High-resolution melt analysis (HRM)", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["Given the initial list of possible genetic mutations, I will start with the Enzyme assay. This assay can potentially rule out the PAH mutation if the enzyme activity is within the normal range (75, 100).\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 99.99296989863173 falls within the range (75, 100), which rules out the PAH mutation. The remaining possible mutations are MTHFR mutation, APC gene mutation, and LEP mutation.\n\nNext, I will perform the ELISA assay to rule out the LEP mutation if the result is within the normal range (0, 25).\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 15.961783452617343 falls within the range (0, 25), which rules out the LEP mutation. The remaining possible mutations are MTHFR mutation and APC gene mutation.\n\nNext, I will perform the High-Resolution Melt Analysis (HRM) to rule out the MTHFR mutation if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) result shows no melting curve abnormalities, which rules out the MTHFR mutation. The only remaining possible mutation is the APC gene mutation.\n\nSince we have ruled out all other mutations, I will predict that the genetic mutation is the APC gene mutation.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 5989, "observations": [null, {"action": "Enzyme assay", "observation": 99.99296989863173}, {"action": "ELISA", "observation": 15.961783452617343}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["High-resolution melt analysis (HRM)", "Protein truncation test", "ELISA", "Enzyme assay", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["Given the initial state, I will start by performing an assay that can potentially rule out multiple mutations. The 'High-resolution melt analysis (HRM)' is a good choice because it can rule out the MTHFR mutation, which is one of the more common mutations and can help narrow down the list quickly.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM assay result shows no melting curve abnormalities, the MTHFR mutation can be ruled out. This leaves us with the following possible mutations: 'APC gene mutation', 'LEP mutation', and 'PAH mutation'.\n\nNext, I will perform the 'Protein truncation test' to see if we can rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The protein truncation test detected truncated proteins, which does not rule out any mutations. This leaves us with the following possible mutations: 'APC gene mutation', 'LEP mutation', and 'PAH mutation'.\n\nNext, I will perform the 'ELISA' assay to check for the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result is 15.96, which falls within the range (0, 25). This rules out the LEP mutation.\n\nThis leaves us with 'APC gene mutation' and 'PAH mutation'.\n\nNext, I will perform the 'Enzyme assay' to check for the PAH mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result is 99.99, which falls within the range (75, 100). This rules out the PAH mutation.\n\nThis leaves us with only the 'APC gene mutation' as the remaining possibility.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 7668, "observations": [null, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}, {"action": "ELISA", "observation": 15.961783452617343}, {"action": "Enzyme assay", "observation": 99.99296989863173}], "successful": true, "parse_error": false}], "seed": 2, "average_actions": 5.6, "average_tokens": 6994.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.6, "average_successful_tokens": 6994.0}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "ELISA", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, I will choose an assay that can potentially rule out multiple mutations in a single step. The Next-Generation Sequencing (NGS) assay is a good choice because it can detect or rule out multiple mutations at once.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-Generation Sequencing (NGS) assay, no variants were detected. According to the guidebook, this rules out the *HBB mutation* and *COL1A1 mutation*.\n\nRemaining possible mutations: ['LEP mutation', 'PAH mutation']\n\nNext, I will choose an assay that can help distinguish between the remaining mutations. The ELISA assay is a good choice because it can specifically rule out the *LEP mutation* if the results fall within the 0 to 25 range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 24.89112088776157 falls within the 0 to 25 range, which rules out the *LEP mutation*.\n\nRemaining possible mutation: ['PAH mutation']\n\nSince only the *PAH mutation* remains, I will predict that this is the mutation responsible for the trait.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 3975, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "ELISA", "observation": 24.89112088776157}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "ELISA", "Enzyme assay", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Given the initial state and the available assays, I will start with **Next-generation sequencing (NGS)**. This assay can potentially rule out multiple mutations in one step if no variants are detected, which would be a significant step forward in narrowing down the possibilities.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-generation sequencing (NGS) assay, which showed no variants detected, we can rule out the *HBB mutation* and *COL1A1 mutation*. This leaves us with the *LEP mutation* and *PAH mutation* as the remaining possibilities.\n\nNext, I will perform an **ELISA** to further narrow down the potential mutations. ELISA can help rule out the *LEP mutation* if the quantitative results fall within the 0 to 25 range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 24.89112088776157 falls within the 0 to 25 range, which indicates that the *LEP mutation* can be ruled out.\n\nThis leaves us with the *PAH mutation* as the only remaining possibility. To confirm this, I will perform an **Enzyme assay** to check the activity level, which can help rule out or confirm the *PAH mutation*.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 11.756587688061199 falls within the 0 to 25 range, which does not rule out the *PAH mutation*. Since this is the only remaining mutation and the enzyme activity level is low, it strongly suggests that the *PAH mutation* is the correct mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5629, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "ELISA", "observation": 24.89112088776157}, {"action": "Enzyme assay", "observation": 11.756587688061199}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "ELISA", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, we should use an assay that can potentially rule out multiple mutations in one step. The 'Next-generation sequencing (NGS)' is a good choice because it can detect or rule out a broad range of genetic mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS results show no variants detected, the *HBB mutation* and *COL1A1 mutation* are ruled out. This leaves us with *LEP mutation* and *PAH mutation*.\n\nNext, we should use an assay that can help us distinguish between these two remaining mutations. The 'ELISA' assay can be useful here because it provides quantitative results that can rule out the *LEP mutation*.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 24.89 falls within the range of 0 to 25, which rules out the *LEP mutation*. This leaves us with the *PAH mutation* as the only remaining possibility.\n\nSince we have ruled out all other mutations, we can confidently predict that the genetic mutation is the *PAH mutation*.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 3925, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "ELISA", "observation": 24.89112088776157}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "ELISA", "Enzyme assay", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, I will choose an assay that can potentially rule out the most mutations in one step. The **Next-generation sequencing (NGS)** can rule out both the HBB mutation and COL1A1 mutation if no variants are detected, which would significantly narrow down the list.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The NGS results show no variants detected, which means the HBB mutation and COL1A1 mutation are ruled out. This leaves us with the LEP mutation and PAH mutation.\n\nNext, I will perform an **ELISA** to further narrow down the possibilities. If the ELISA results are in the range of 0 to 25, it will rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA results are 24.89112088776157, which fall within the range of 0 to 25. This rules out the LEP mutation.\n\nNow, the only remaining mutation is the PAH mutation. I will confirm this by performing an **Enzyme assay**. If the activity level is between 0 to 25, it will support the presence of the PAH mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay results show an activity level of 11.756587688061199, which falls within the range of 0 to 25. This supports the presence of the PAH mutation.\n\nSince the PAH mutation is the only remaining mutation and the Enzyme assay results are consistent with this mutation, I can confidently predict that the mutation is the PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5583, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "ELISA", "observation": 24.89112088776157}, {"action": "Enzyme assay", "observation": 11.756587688061199}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "ELISA", "Enzyme assay", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, I will use Next-generation sequencing (NGS) to get a broad overview of any potential mutations present. This assay can help rule out the HBB and COL1A1 mutations if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by Next-generation sequencing (NGS), we can rule out the HBB and COL1A1 mutations. This leaves us with LEP and PAH mutations.\n\nNext, I will perform an ELISA to check for the leptin (LEP) levels. If the quantitative results are between 0 to 25, the LEP mutation can be ruled out.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA results show a quantitative value of 24.89, which falls within the range of 0 to 25. This means the LEP mutation is ruled out.\n\nNow, we are left with the PAH mutation. To confirm, I will perform an enzyme assay to check the activity level of phenylalanine hydroxylase. If the activity level is between 75 to 100, the PAH mutation can be ruled out. If it is between 0 to 25, the PAH mutation is likely present.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay results show an activity level of 11.76, which falls within the range of 0 to 25. This suggests that the PAH mutation is likely present.\n\nSince the only remaining mutation is PAH, and the enzyme assay supports this, I will predict that the mutation is PAH.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5552, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "ELISA", "observation": 24.89112088776157}, {"action": "Enzyme assay", "observation": 11.756587688061199}], "successful": true, "parse_error": false}], "seed": 3, "average_actions": 4.6, "average_tokens": 4932.8, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.6, "average_successful_tokens": 4932.8}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Southern blot", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I'll perform Next-generation sequencing (NGS) to get a broad overview of any genetic variants present. This will help me eliminate several mutations in one step if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by NGS, we can rule out HBB mutation, CFTR mutation, and GJB2 mutation. This leaves us with HTT gene expansion. To confirm, I will perform a Southern blot to check for repeat expansions.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot detected an expanded fragment, which confirms the presence of an HTT gene expansion. This is consistent with the observation from the NGS, which did not detect any other mutations. Therefore, I can confidently predict that the genetic mutation responsible for the trait is the HTT gene expansion.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 3875, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will choose the most comprehensive assay that can provide information on a wide range of mutations, which is Next-generation sequencing (NGS). This assay can help rule out multiple genetic mutations at once.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected in the NGS, we can rule out HBB mutation, CFTR mutation, and GJB2 mutation. This leaves us with the HTT gene expansion as the only remaining possibility.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 2480, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will use Next-generation sequencing (NGS) to get a broad overview of any genetic variants that might be present. This will help me rule out multiple mutations in one step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected in the NGS, we can rule out the HBB mutation, CFTR mutation, and GJB2 mutation. This leaves us with the HTT gene expansion as the only remaining possibility.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 2475, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will use Next-generation sequencing (NGS) to get a broad overview of any potential variants present. This assay can help rule out multiple mutations in one step if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by NGS, the HBB mutation, CFTR mutation, and GJB2 mutation can be ruled out. This leaves us with the HTT gene expansion as the only remaining possibility.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 2478, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["Given the initial state of the game, it's best to start with an assay that can potentially rule out multiple genetic mutations at once. Next-generation sequencing (NGS) is a high-throughput method that can detect a wide range of variants, making it a good first choice.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by Next-generation sequencing (NGS), we can rule out the HBB mutation, CFTR mutation, and GJB2 mutation. This leaves us with the HTT gene expansion as the only remaining possibility.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 2512, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}], "seed": 4, "average_actions": 3.2, "average_tokens": 2764.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 3.2, "average_successful_tokens": 2764.0}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "Western blot", "Sanger sequencing", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["Based on the initial state, I will start by performing the **Multiplex ligation-dependent probe amplification (MLPA)** assay. This assay can help rule out the PMP22 duplication by checking for normal copy numbers.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay showed a normal copy number, which rules out the PMP22 duplication. Now, we need to further narrow down the remaining mutations: DMD mutation, PAH mutation, and BRCA2 mutation.\n\nNext, I will perform the **Enzyme assay** to check the activity range, which can help rule out the PAH mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 86.72672619455409 falls within the normal activity range (75-100), which rules out the PAH mutation. \n\nNow, we are left with two potential mutations: DMD mutation and BRCA2 mutation.\n\nNext, I will perform the **Western blot** to check for the presence of the protein of expected size, which can help rule out the DMD mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the protein of expected size is detected, which rules out the DMD mutation. \n\nNow, the only remaining mutation is the BRCA2 mutation.\n\nI will perform **Sanger sequencing** to confirm the absence of mutations in the BRCA2 gene.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing result shows that mutations are detected, confirming the presence of the BRCA2 mutation.\n\nSince we have ruled out the other mutations and confirmed the presence of the BRCA2 mutation, I will predict the truth.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7182, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 86.72672619455409}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "Western blot", "Sanger sequencing", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, let's perform an assay that can help us narrow down the possibilities by ruling out one or more mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good initial choice because it can detect copy number variations, which can help us rule out the PMP22 duplication if the results are normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA result showed a normal copy number, we can rule out the PMP22 duplication. This leaves us with the following mutations: DMD mutation, PAH mutation, and BRCA2 mutation.\n\nNext, let's perform an **Enzyme assay** to check the activity range of the phenylalanine hydroxylase enzyme. If the activity is within the normal range (75-100), we can rule out the PAH mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 86.72672619455409 falls within the normal activity range (75-100), so we can rule out the PAH mutation. This leaves us with the DMD mutation and BRCA2 mutation.\n\nNext, let's perform a **Western blot** to check for the presence of the dystrophin protein. If the protein of expected size is detected, the DMD mutation can be ruled out.\n\n<ANSWER> Western blot </ANSWER>", "Since the Western blot detected the protein of expected size, we can rule out the DMD mutation. This leaves us with the BRCA2 mutation as the only remaining possibility.\n\nTo confirm, we can perform **Sanger sequencing** to check for mutations in the BRCA2 gene. If no mutations are detected, we can rule out the BRCA2 mutation. However, if mutations are detected, we can confidently identify the BRCA2 mutation as the cause.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Since Sanger sequencing detected mutations, we can confidently identify the BRCA2 mutation as the cause.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7445, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 86.72672619455409}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "Protein truncation test", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will perform an assay that can rule out one of the mutations effectively. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can directly detect copy number variations, which would help rule out the PMP22 duplication if the result is normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result shows a normal copy number, so we can rule out the PMP22 duplication. This leaves us with the mutations: DMD mutation, PAH mutation, and BRCA2 mutation.\n\nNext, I will perform an **Enzyme assay** to check for normal enzyme activity, which can help rule out the PAH mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result is 86.72672619455409, which falls within the normal activity range (75-100). Therefore, we can rule out the PAH mutation. This leaves us with the mutations: DMD mutation and BRCA2 mutation.\n\nNext, I will perform a **Protein truncation test** to check for truncated proteins, which can help rule out the DMD mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The protein truncation test result shows no truncated proteins detected, so we can rule out the DMD mutation. This leaves us with the BRCA2 mutation as the only remaining possibility.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5560, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 86.72672619455409}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "Western blot", "Sanger sequencing", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, let's perform an assay that can help us quickly rule out one of the mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can help us identify copy number variations, which are relevant for the PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation of a normal copy number from the MLPA assay, we can rule out the PMP22 duplication. Now, we need to narrow down the remaining mutations: DMD mutation, PAH mutation, and BRCA2 mutation.\n\nNext, let's perform an **Enzyme assay** to check the activity of the phenylalanine hydroxylase enzyme. This will help us rule out the PAH mutation if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is within the normal range (75-100), which means we can rule out the PAH mutation. The remaining possibilities are DMD mutation and BRCA2 mutation.\n\nNext, let's perform a **Western blot** to check for the presence of the dystrophin protein. This will help us rule out the DMD mutation if the protein of expected size is detected.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot detected the protein of expected size, which rules out the DMD mutation. The only remaining possibility is the BRCA2 mutation.\n\nLet's confirm this by performing **Sanger sequencing** to check for any mutations in the BRCA2 gene.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Based on the Sanger sequencing results, mutations were detected in the BRCA2 gene. Therefore, the genetic mutation responsible for the trait is the BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7271, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 86.72672619455409}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "Western blot", "Sanger sequencing", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, let's use an assay that can quickly rule out one of the mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect copy number variations, which would help us rule out the PMP22 duplication if the copy number is normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the MLPA assay, which showed a normal copy number, we can rule out the PMP22 duplication. \n\nNext, let's perform an **Enzyme assay** to check for PAH mutation. If the enzyme activity is within the normal range (75-100), we can rule out the PAH mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 86.72672619455409, which falls within the normal range (75-100). Therefore, we can rule out the PAH mutation.\n\nNext, let's perform a **Western blot** to check for the DMD mutation. If the protein of expected size is detected, we can rule out the DMD mutation.\n\n<ANSWER> Western blot </ANSWER>", "Based on the results from the Western blot, the protein of expected size was detected, which rules out the DMD mutation.\n\nAt this point, the only remaining mutation is the BRCA2 mutation. Let's confirm this by performing **Sanger sequencing** to check for any mutations in the BRCA2 gene.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing detected mutations, confirming that the remaining mutation is the BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7207, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 86.72672619455409}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}], "seed": 5, "average_actions": 5.8, "average_tokens": 6933.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.8, "average_successful_tokens": 6933.0}
{"trajectories": [{"actions": ["Tandem repeat PCR", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform the **Tandem Repeat PCR** assay. This assay is particularly useful for identifying the **FMR1 gene expansion**, which is associated with a specific range of repeat sizes. By ruling out this mutation if the repeat size is between 0 and 30, we can narrow down the possibilities more effectively.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of the Tandem Repeat PCR assay shows a repeat size of approximately 63. This falls within the range of 30 to 200, which means we cannot rule out the **FMR1 gene expansion**. Therefore, we need to perform another assay to further narrow down the possibilities.\n\nNext, I will perform the **Southern Blot** assay. This assay can help us confirm or rule out the presence of an expanded fragment associated with the **FMR1 gene expansion**.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot assay detected an expanded fragment, which confirms the presence of the **FMR1 gene expansion**. This result strongly suggests that the genetic mutation responsible for the observed trait is the **FMR1 gene expansion**.\n\nSince we have strong evidence from two assays (Tandem Repeat PCR and Southern Blot) that point to the **FMR1 gene expansion**, I will predict that the mutation is the **FMR1 gene expansion**.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 3834, "observations": [null, {"action": "Tandem repeat PCR", "observation": 63.678176433371156}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Southern blot", "Western blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform a **Tandem Repeat PCR** to check for the repeat size, which can help rule out the **FMR1 gene expansion** if the repeat size is between 0 and 30.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result shows a repeat size of 63.68, which is between 30 and 200. This means we cannot rule out **FMR1 gene expansion**. The next step is to perform a **Southern Blot** to further investigate the presence of an expanded fragment.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot detected an expanded fragment, which strongly suggests **FMR1 gene expansion**. To confirm this, I will perform a **Western Blot** to check for the presence of the protein. If the protein is absent or truncated, it will further support the **FMR1 gene expansion** hypothesis.\n\n<ANSWER> Western blot </ANSWER>", "The Western Blot confirmed that the protein is absent or truncated, which strongly supports the **FMR1 gene expansion**. Based on the results from the Tandem Repeat PCR, Southern Blot, and Western Blot, I can confidently predict that the genetic mutation is **FMR1 gene expansion**.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5105, "observations": [null, {"action": "Tandem repeat PCR", "observation": 63.678176433371156}, {"action": "Southern blot", "observation": "Expanded fragment detected"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "Tandem repeat PCR", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an assay that can potentially rule out multiple mutations. The **Protein Truncation Test** is a good choice because it can help rule out both the **DMD mutation** and the **APC gene mutation** if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, we can rule out both the **DMD mutation** and the **APC gene mutation**. This leaves us with the **FMR1 gene expansion** and the **SERPINA1 mutation**.\n\nNext, I will perform a **Tandem Repeat PCR** to check for the presence of an expanded repeat in the FMR1 gene.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result shows a repeat size of approximately 63.68, which falls within the range of 30 to 200. This indicates that the **FMR1 gene expansion** is a strong candidate. To confirm, I will perform a **Southern Blot** to check for the presence of an expanded fragment.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot detected an expanded fragment, which confirms the presence of the **FMR1 gene expansion**. Based on the results of the assays performed, I can confidently identify the mutation.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5169, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Tandem repeat PCR", "observation": 63.678176433371156}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "Tandem repeat PCR", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, we should choose an assay that can potentially rule out multiple mutations. The **Protein Truncation Test** is a good choice because it can eliminate both the **DMD mutation** and the **APC gene mutation** if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected in the Protein Truncation Test, we can rule out both the **DMD mutation** and the **APC gene mutation**. This leaves us with **FMR1 gene expansion** and **SERPINA1 mutation**.\n\nNext, we should choose an assay that can help us differentiate between these two remaining mutations. The **Tandem Repeat PCR** is a good choice because it can specifically detect the expansion associated with the **FMR1 gene**.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result of 63.678176433371156 indicates that the repeat size is between 30 and 200, which is consistent with the **FMR1 gene expansion**. Therefore, we can confidently identify the mutation as **FMR1 gene expansion**.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 3759, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Tandem repeat PCR", "observation": 63.678176433371156}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", null], "generated_text": ["To start, I will perform an assay that can help me narrow down the list of possible genetic mutations. The **Tandem Repeat PCR** is a good initial choice because it specifically addresses the **FMR1 gene expansion**, which is a mutation involving a repeat size. This will help me quickly rule out or confirm one of the mutations.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of the Tandem Repeat PCR is 63.678176433371156, which falls between 30 and 200. This means we cannot rule out the **FMR1 gene expansion** based on this assay. However, this also confirms that the **FMR1 gene expansion** is a potential candidate.\n\nNext, I will perform the **Southern Blot** to further investigate the **FMR1 gene expansion**.\n\n<ANSWER> Southern Blot </ANSWER>"], "consumed_tokens": 2409, "observations": [null, {"action": "Tandem repeat PCR", "observation": 63.678176433371156}], "successful": false, "parse_error": true}], "seed": 6, "average_actions": 4.0, "average_tokens": 4055.2, "average_correct": 0.8, "average_parse_error": 0.2, "average_successful_action_num": 4.5, "average_successful_tokens": 4466.75}
{"trajectories": [{"actions": ["Southern blot", "Fluorescence in situ hybridization (FISH)", "PCR amplification", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To begin, I will choose an assay that can potentially rule out one or more mutations based on its results. A good starting point is the **Southern Blot** assay, as it can detect specific DNA sequences and help rule out the HTT gene expansion if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern Blot assay, a normal-sized fragment was detected, which rules out the **HTT gene expansion**. This leaves us with the following possible genetic mutations:\n\n- SMN1 deletion\n- COL1A1 mutation\n- MTHFR mutation\n\nNext, I will perform a **Fluorescence in situ Hybridization (FISH)** assay to check for deletions in the SMN1 gene.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Based on the observation from the Fluorescence in situ Hybridization (FISH) assay, a deletion was detected, which strongly suggests the **SMN1 deletion**. To confirm this, I will perform a **PCR amplification** assay to see if the SMN1 gene fragment is amplified.\n\n<ANSWER> PCR amplification </ANSWER>", "The observation from the PCR amplification assay shows that there was no amplification, which further supports the presence of an **SMN1 deletion**. Given the results from the FISH and PCR amplification assays, I can confidently predict that the genetic mutation is **SMN1 deletion**.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5723, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Fluorescence in situ hybridization (FISH)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform a **Southern blot** to detect specific DNA sequences. This assay can help rule out the HTT gene expansion if a normal-sized fragment is detected, which will narrow down the list of possible mutations.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot detected a normal-sized fragment, which rules out the HTT gene expansion. The remaining possible mutations are:\n\n- SMN1 deletion\n- COL1A1 mutation\n- MTHFR mutation\n\nNext, I will perform a **Fluorescence in situ hybridization (FISH)** to detect any deletions, which can help rule out the SMN1 deletion if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay detected a deletion, which strongly suggests the presence of an SMN1 deletion. Given this information, I will predict that the mutation is **SMN1 deletion**.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 4052, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Fluorescence in situ hybridization (FISH)", "PCR amplification", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform a **Southern blot** to detect specific DNA sequences. This assay can help rule out the **HTT gene expansion** if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern blot, the **HTT gene expansion** is ruled out. The remaining possible genetic mutations are:\n\n- **SMN1 deletion**\n- **COL1A1 mutation**\n- **MTHFR mutation**\n\nNext, I will perform a **Fluorescence in situ hybridization (FISH)** to detect deletions. This assay can help rule out **SMN1 deletion** if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Based on the observation from the Fluorescence in situ hybridization (FISH), a deletion was detected, which strongly suggests **SMN1 deletion**. The remaining possible genetic mutations are:\n\n- **SMN1 deletion**\n- **COL1A1 mutation**\n- **MTHFR mutation**\n\nTo confirm, I will perform a **PCR amplification**. If the fragment is not amplified, it will further support the diagnosis of **SMN1 deletion**.\n\n<ANSWER> PCR amplification </ANSWER>", "Based on the observation from the PCR amplification, no amplification was detected, which strongly supports the diagnosis of **SMN1 deletion**. The previous FISH result also detected a deletion, further confirming this.\n\nTherefore, I will predict that the genetic mutation responsible for the trait is **SMN1 deletion**.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5718, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}, {"actions": [null], "generated_text": ["To start narrowing down the possible genetic mutations, I will choose an assay that can provide clear and definitive results for at least one of the mutations. The **Southern Blot** is a good initial choice because it can directly detect deletions and expansions, which can help rule out HTT gene expansion or identify the presence of other mutations.\n\n<ANSWER> Southern Blot </ANSWER>"], "consumed_tokens": 1250, "observations": [null], "successful": false, "parse_error": true}, {"actions": ["Southern blot", "PCR amplification", "High-resolution melt analysis (HRM)", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, I will perform a **Southern Blot** to detect any specific DNA sequence deletions or expansions. This will help me rule out the HTT gene expansion if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern blot, a normal-sized fragment was detected, which rules out the HTT gene expansion. The remaining possible genetic mutations are:\n\n- SMN1 deletion\n- COL1A1 mutation\n- MTHFR mutation\n\nNext, I will perform a **PCR amplification** to check if the SMN1 gene is present and can be amplified. If no amplification is observed, this will rule out SMN1 deletion.\n\n<ANSWER> PCR amplification </ANSWER>", "Based on the observation from the PCR amplification, no amplification was detected, which strongly suggests that the SMN1 gene is deleted. This rules out the possibility of SMN1 deletion.\n\nThe remaining possible genetic mutations are:\n- COL1A1 mutation\n- MTHFR mutation\n\nNext, I will perform a **High-resolution Melt Analysis (HRM)** to check for any melting curve abnormalities, which can help rule out the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the observation from the High-resolution Melt Analysis (HRM), no melting curve abnormalities were detected, which rules out the MTHFR mutation.\n\nThe remaining possible genetic mutation is:\n- COL1A1 mutation\n\nSince we have ruled out the other mutations, the most plausible remaining mutation is the COL1A1 mutation.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 5714, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "PCR amplification", "observation": "No amplification"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": false, "parse_error": false}], "seed": 7, "average_actions": 4.0, "average_tokens": 4491.4, "average_correct": 0.6, "average_parse_error": 0.2, "average_successful_action_num": 4.666666666666667, "average_successful_tokens": 5164.333333333333}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Southern blot", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, I will use an assay that can provide broad information and potentially rule out multiple mutations. The 'Next-generation sequencing (NGS)' is a high-throughput method that can detect variants across a wide range of genes, making it a good initial choice.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by Next-generation sequencing (NGS), we can rule out the HBB mutation and COL1A1 mutation. This leaves us with PAH mutation and HTT gene expansion.\n\nThe next step is to use an assay that can specifically differentiate between these two remaining mutations. A good choice would be 'Southern blot', as it can detect the size of DNA fragments, which is relevant for identifying gene expansions like HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The observation from the Southern blot shows a normal-sized fragment, which rules out HTT gene expansion. This leaves us with the PAH mutation as the only remaining possibility.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 3998, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Southern blot", "RFLP analysis", "Next-generation sequencing (NGS)", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Given the initial state of the game and the available assays, I will start by performing a **Tandem Repeat PCR**. This assay is particularly useful for detecting expansions in the HTT gene, which is a strong candidate for a neurodegenerative disorder like Huntington's disease. If the repeat size is within the normal range (0-30), we can rule out HTT gene expansion early in the process.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result from the Tandem Repeat PCR shows a repeat size of 13.77, which is within the normal range (0-30). This rules out HTT gene expansion.\n\nGiven this, the remaining possible genetic mutations are:\n- HBB mutation\n- PAH mutation\n- COL1A1 mutation\n\nNext, I will perform a **Southern Blot** to check for the presence of specific DNA sequences and rule out any large structural changes that might be indicative of the remaining mutations.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot result shows a normal-sized fragment, which rules out any large structural changes that might be indicative of the HTT gene expansion. Since we have already ruled out HTT gene expansion, the remaining possible genetic mutations are:\n- HBB mutation\n- PAH mutation\n- COL1A1 mutation\n\nNext, I will perform **RFLP analysis** to check for specific restriction patterns that can help identify the HBB mutation. If the restriction pattern is normal, we can rule out the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis result shows a normal restriction pattern, which rules out the HBB mutation.\n\nGiven this, the remaining possible genetic mutations are:\n- PAH mutation\n- COL1A1 mutation\n\nNext, I will perform **Next-generation sequencing (NGS)** to detect any variants in the remaining genes. If no variants are detected, we can rule out HBB and COL1A1 mutations, leaving PAH mutation as the only possibility.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-generation sequencing (NGS) result shows no variants detected, which rules out HBB and COL1A1 mutations.\n\nGiven this, the remaining possible genetic mutation is:\n- PAH mutation\n\nSince we have ruled out all other mutations, the only remaining possibility is the PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 7713, "observations": [null, {"action": "Tandem repeat PCR", "observation": 13.7740128831719}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Southern blot", "RFLP analysis", "DNA sequencing", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To begin, I will choose an assay that can help me narrow down the list of possible genetic mutations. The 'Next-generation sequencing (NGS)' is a high-throughput method that can detect variants in multiple genes, making it a good starting point.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by Next-generation sequencing (NGS), I can rule out the HBB and COL1A1 mutations, as these would likely have shown up as variants. This leaves me with PAH mutation and HTT gene expansion.\n\nNext, I will use the Southern blot to see if there is an expanded fragment, which would help me rule out the HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot showed a normal-sized fragment, which rules out the HTT gene expansion. This leaves the PAH mutation as the only remaining possibility.\n\nI will now use RFLP analysis to confirm the PAH mutation. If the restriction pattern is abnormal, it will support the presence of a PAH mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis showed a normal restriction pattern, which rules out the PAH mutation. However, since the previous assays have already ruled out HBB and COL1A1 mutations, and the Southern blot ruled out the HTT gene expansion, this suggests that there might be an oversight or a need for a different approach.\n\nGiven the results, the only mutation that has not been ruled out is the PAH mutation. However, since the RFLP analysis also did not detect any abnormalities, I will perform DNA sequencing to confirm the presence or absence of the PAH mutation.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing detected mutations, which confirms that the PAH mutation is present. Since all other mutations have been ruled out by previous assays, I can confidently predict that the genetic mutation responsible for the observed trait is the PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 7299, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "RFLP analysis", "Western blot", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Let's start by performing a Southern blot to check for the presence of any expanded DNA sequences, which can help us rule out the HTT gene expansion if the fragment size is normal.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot results show a normal-sized fragment, which rules out the HTT gene expansion. The remaining possible mutations are HBB mutation, PAH mutation, and COL1A1 mutation. \n\nNext, let's perform RFLP analysis to check for the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis shows a normal restriction pattern, which rules out the HBB mutation. The remaining possible mutations are PAH mutation and COL1A1 mutation.\n\nNext, let's perform a Western blot to check for the presence of the protein produced by the COL1A1 gene.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot results show that the protein of the expected size is detected, which rules out the COL1A1 mutation. The only remaining possible mutation is the PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5369, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Western blot", "observation": "Protein of expected size detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Next-generation sequencing (NGS)", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Given the initial state, the most effective first step is to perform an assay that can potentially rule out multiple mutations. The **Tandem Repeat PCR** is particularly useful for this purpose because it can directly assess the HTT gene expansion, which is a significant cause of Huntington's disease. If the repeat size is within the normal range (0-30), we can confidently rule out the HTT gene expansion. If the repeat size is expanded (30-200), we can still proceed with further assays to narrow down the remaining possibilities.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem Repeat PCR indicates a repeat size of 13.774, which falls within the normal range (0-30). This rules out the **HTT gene expansion** as the mutation causing the observed trait.\n\nNow, we need to choose another assay to further narrow down the remaining possibilities: HBB mutation, PAH mutation, and COL1A1 mutation.\n\nThe **Next-Generation Sequencing (NGS)** is a comprehensive assay that can detect variants in multiple genes, making it a good choice for the next step. If no variants are detected, we can rule out HBB and COL1A1 mutations, leaving PAH mutation as the most likely candidate.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The observation from the Next-Generation Sequencing (NGS) indicates that no variants were detected. This rules out the **HBB mutation** and **COL1A1 mutation**, as these mutations would have been detected by NGS.\n\nGiven that the remaining mutation is **PAH mutation**, we can now confidently predict that the **PAH mutation** is the cause of the observed trait.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 4360, "observations": [null, {"action": "Tandem repeat PCR", "observation": 13.7740128831719}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}], "seed": 8, "average_actions": 5.0, "average_tokens": 5747.8, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 5747.8}
{"trajectories": [{"actions": ["Methylation-specific PCR", "Enzyme assay", "Fluorescence in situ hybridization (FISH)", "PCR amplification", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Given the initial state and the guidebook, a good starting point would be to perform an assay that can potentially rule out multiple mutations. The **Methylation-specific PCR** is a good choice because it can immediately rule out the **MECP2 mutation** if the methylation pattern is normal, which would help narrow down the list significantly.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The observation of a **Normal methylation pattern** from the Methylation-specific PCR rules out the **MECP2 mutation**. Now, we are left with three possible mutations: **PAH mutation**, **DMD mutation**, and **COL1A1 mutation**.\n\nNext, we should perform an **Enzyme assay**. If the enzyme activity is within the range of 75 to 100, it will rule out the **PAH mutation**.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity result of 18.204805884327666 is within the range of 0 to 25, which does not rule out any specific mutations. Therefore, the **PAH mutation** is still a possibility, but we need more information to rule out the others.\n\nNext, let's perform **Fluorescence in situ hybridization (FISH)** to check for deletions. If no deletions are detected, it will rule out the **DMD mutation**.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The observation of a **Deletion detected** from the Fluorescence in situ hybridization (FISH) suggests that the **DMD mutation** is highly likely, as deletions are a common feature of this mutation. Given the previous results, the **MECP2 mutation** has been ruled out, and the **PAH mutation** is still a possibility, but the deletion detected points strongly towards the **DMD mutation**.\n\nTo confirm, we can perform a **PCR amplification**. If no amplification occurs, it will further support the **DMD mutation**.\n\n<ANSWER> PCR amplification </ANSWER>", "The **PCR amplification** result of a **Fragment amplified** rules out the **DMD mutation** because DMD mutations often involve deletions that would prevent amplification.\n\nGiven the remaining mutations (PAH mutation and COL1A1 mutation), and the previous enzyme activity result which was within the range of 0 to 25, the **PAH mutation** is the most likely candidate.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 7562, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Enzyme assay", "observation": 18.204805884327666}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "PCR amplification", "observation": "Fragment amplified"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Enzyme assay", "Western blot", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["Given the initial state, the best starting point is to perform an assay that can provide clear information to rule out a significant number of mutations. The **Methylation-specific PCR** is a good choice because it can directly rule out the **MECP2 mutation** if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation pattern is normal, we can rule out the **MECP2 mutation**. This leaves us with the following possible mutations: **PAH mutation**, **DMD mutation**, and **COL1A1 mutation**.\n\nNext, we can perform an **Enzyme assay** to check for PAH enzyme activity. This will help us rule out the **PAH mutation** if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 18.204805884327666, which is within the range of 0 to 25. This suggests that the PAH enzyme activity is impaired, which is consistent with a **PAH mutation**. However, since the range of 75 to 100 would rule out the **PAH mutation**, and 18.204805884327666 is not in that range, we can confidently rule out **PAH mutation**.\n\nThis leaves us with **DMD mutation** and **COL1A1 mutation**. Next, we can perform a **Western blot** to check for protein size and expression. This will help us differentiate between the two remaining mutations.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that a protein of the expected size was detected. This rules out **DMD mutation** because dystrophin protein is typically absent or truncated in DMD mutations.\n\nThis leaves us with **COL1A1 mutation** as the only remaining possibility.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 5721, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Enzyme assay", "observation": 18.204805884327666}, {"action": "Western blot", "observation": "Protein of expected size detected"}], "successful": false, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Enzyme assay", "Western blot", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Given the initial list of possible genetic mutations and the available assays, a strategic first step is to perform an assay that can potentially rule out multiple mutations. The 'Methylation-specific PCR' is a good choice because it can directly rule out MECP2 mutations if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The observation of a normal methylation pattern rules out the MECP2 mutation. The remaining possible mutations are PAH mutation, DMD mutation, and COL1A1 mutation.\n\nNext, I will perform an 'Enzyme assay' to rule out the PAH mutation if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity result of 18.204805884327666 is significantly below the normal range (75 to 100), which suggests that the PAH mutation is present. However, to confirm this, I will perform an additional assay to rule out the remaining possibilities.\n\nNext, I will perform a 'Western blot' to check for protein of expected size, which can help rule out DMD and COL1A1 mutations if the protein is of the expected size.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result of detecting a protein of the expected size rules out the DMD and COL1A1 mutations, as these mutations typically affect protein size.\n\nGiven the enzyme activity result and the Western blot result, the remaining plausible mutation is the PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5522, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Enzyme assay", "observation": 18.204805884327666}, {"action": "Western blot", "observation": "Protein of expected size detected"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Enzyme assay", "Western blot", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To begin, let's use an assay that can help us narrow down the list of possible mutations. The **Methylation-specific PCR** is a good starting point because it can directly rule out MECP2 mutations if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Given the normal methylation pattern, we can rule out the **MECP2 mutation**. The remaining possible mutations are **PAH mutation**, **DMD mutation**, and **COL1A1 mutation**.\n\nNext, let's perform an **Enzyme assay** to check for PAH enzyme activity, which can help us rule out the **PAH mutation** if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 18.204805884327666 is within the range of 0 to 25, which does not rule out the **PAH mutation**. However, since the range 75 to 100 would rule out the **PAH mutation**, we can conclude that the **PAH mutation** is a strong candidate.\n\nTo confirm, we can perform a **Western blot** to check for the protein of the expected size. If the protein is of the expected size, we can rule out **DMD** and **COL1A1** mutations, which typically affect protein size.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the protein of the expected size is detected, which rules out **DMD** and **COL1A1** mutations. This leaves us with the **PAH mutation** as the only remaining candidate.\n\nGiven the evidence from the previous assays, we can confidently predict that the genetic mutation is the **PAH mutation**.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5624, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Enzyme assay", "observation": 18.204805884327666}, {"action": "Western blot", "observation": "Protein of expected size detected"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Enzyme assay", "Western blot", "Fluorescence in situ hybridization (FISH)", "PCR amplification", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["Given the list of possible genetic mutations and available assays, a strategic first step would be to perform an assay that can potentially rule out multiple mutations. The **Methylation-specific PCR** is a good choice because it can specifically rule out MECP2 mutations if the methylation pattern is normal. This assay can provide a clear indication early on whether MECP2 is involved.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation pattern was normal, we can rule out the MECP2 mutation. The remaining possible mutations are PAH mutation, DMD mutation, and COL1A1 mutation.\n\nNext, I will perform an **Enzyme assay** to check the activity of the PAH enzyme. This can help rule out PAH mutations if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 18.204805884327666 is not within the range of 75 to 100, which indicates that PAH activity is impaired. Therefore, we can rule out the PAH mutation.\n\nThe remaining possible mutations are DMD mutation and COL1A1 mutation. To differentiate between these two, I will perform a **Western Blot** to check for protein size and expression.\n\n<ANSWER> Western blot </ANSWER>", "The observation from the Western Blot indicates that a protein of the expected size was detected. This finding rules out the DMD mutation, as DMD mutations typically result in truncated or absent dystrophin protein.\n\nThe remaining possible mutation is the COL1A1 mutation. To confirm, I will perform **Fluorescence in situ hybridization (FISH)** to check for deletions. If no deletions are detected, this will further support the diagnosis of a COL1A1 mutation.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay detected a deletion, which is more consistent with a DMD mutation rather than a COL1A1 mutation. Since we previously ruled out MECP2 and PAH mutations, and the Western Blot indicated a protein of the expected size (which is not typical for DMD mutations), the most plausible remaining mutation is the DMD mutation.\n\nHowever, to be thorough, I will perform **PCR amplification** to confirm the deletion, as this assay can specifically show failed amplification due to deletions in the DMD gene.\n\n<ANSWER> PCR amplification </ANSWER>", "The PCR amplification showed a fragment was amplified, which rules out a DMD mutation, as DMD mutations often involve deletions that prevent successful amplification.\n\nGiven the remaining mutations (COL1A1 mutation) and the observations so far, the most plausible mutation is the COL1A1 mutation. The normal methylation pattern, impaired PAH enzyme activity, and the detection of a protein of the expected size all support this conclusion.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 9384, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Enzyme assay", "observation": 18.204805884327666}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "PCR amplification", "observation": "Fragment amplified"}], "successful": false, "parse_error": false}], "seed": 9, "average_actions": 5.6, "average_tokens": 6762.6, "average_correct": 0.6, "average_parse_error": 0.0, "average_successful_action_num": 5.333333333333333, "average_successful_tokens": 6236.0}
{"trajectories": [{"actions": ["Enzyme assay", "High-resolution melt analysis (HRM)", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["Given the initial state, the best first step is to perform an assay that can potentially rule out multiple genetic mutations. The **Enzyme assay** is a good choice because it can exclude both the SERPINA1 mutation and the G6PD deficiency mutation based on the enzyme activity range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 76.9022336695337 falls within the range of 75-100. According to the guidebook, this range excludes the SERPINA1 mutation and the G6PD deficiency mutation. Therefore, the remaining possible genetic mutations are:\n\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, I will perform a **High-resolution melt analysis (HRM)** to see if there are any melting curve abnormalities, which can help rule out the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The high-resolution melt analysis (HRM) result shows no melting curve abnormalities, which excludes the MTHFR mutation. Therefore, the only remaining possible genetic mutation is:\n\n- FMR1 gene expansion\n\nI will now predict the truth based on the remaining mutation.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 4208, "observations": [null, {"action": "Enzyme assay", "observation": 76.9022336695337}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "RNA sequencing", "Tandem repeat PCR", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an **Enzyme Assay**. This assay can help rule out mutations related to enzyme deficiencies, such as the SERPINA1 mutation and G6PD deficiency mutation, which can be identified by their specific enzyme activity levels.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 76.9022336695337 falls within the range of 75-100. According to the guidebook, this range excludes the SERPINA1 mutation and the G6PD deficiency mutation. \n\nThe remaining possible mutations are:\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, I will perform **RNA sequencing** to check for normal transcript levels, which can help rule out the FMR1 gene expansion.\n\n<ANSWER> RNA sequencing </ANSWER>", "The RNA sequencing result shows abnormal transcript levels, which does not exclude the FMR1 gene expansion. Therefore, the FMR1 gene expansion remains a possibility.\n\nNext, I will perform **Tandem Repeat PCR** to measure the repeat size, which can help confirm or rule out the FMR1 gene expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result shows a repeat size of 191.90786929412837, which falls within the range of 30-200. This confirms the presence of an FMR1 gene expansion.\n\nTherefore, the mutation responsible for the observed trait is the FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5817, "observations": [null, {"action": "Enzyme assay", "observation": 76.9022336695337}, {"action": "RNA sequencing", "observation": "Abnormal transcript levels"}, {"action": "Tandem repeat PCR", "observation": 191.90786929412837}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "RNA sequencing", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an assay that can help me narrow down the list of possible mutations. The 'Tandem repeat PCR' assay is particularly useful for ruling out the FMR1 gene expansion, which is a significant mutation to consider due to its characteristic repeat expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result from the Tandem repeat PCR assay indicates a repeat size of approximately 192, which falls into the range of 30-200 repeats. This suggests the presence of an FMR1 gene expansion. However, to confirm this and rule out other possibilities, I will perform an RNA sequencing assay next to check for normal transcript levels.\n\n<ANSWER> RNA sequencing </ANSWER>", "The RNA sequencing results show abnormal transcript levels, which supports the presence of the FMR1 gene expansion mutation. Given the results from both the Tandem repeat PCR and RNA sequencing, I am confident that the genetic mutation is the FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 4106, "observations": [null, {"action": "Tandem repeat PCR", "observation": 191.90786929412837}, {"action": "RNA sequencing", "observation": "Abnormal transcript levels"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "RNA sequencing", "Tandem repeat PCR", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["Let's start by performing an assay that can help us narrow down the list of possible genetic mutations. The 'Enzyme assay' can exclude multiple mutations if the enzyme activity levels fall within a certain range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 76.9022336695337 falls within the range of 75-100. Based on the genetic analysis guidebook, this range excludes the SERPINA1 mutation and the G6PD deficiency mutation. \n\nNow we are left with:\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, let's perform an assay that can help us distinguish between these two remaining mutations. The 'RNA sequencing' assay can help us identify if there are any abnormal transcript levels, which would exclude the FMR1 gene expansion if the transcript levels are normal.\n\n<ANSWER> RNA sequencing </ANSWER>", "The observation of 'Abnormal transcript levels' from the RNA sequencing assay indicates that the FMR1 gene expansion is still a plausible mutation, as normal transcript levels would have excluded it.\n\nWe are now left with:\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, let's perform a 'Tandem repeat PCR' assay to check for the presence of trinucleotide repeats, which would help us identify the FMR1 gene expansion if the repeat size is between 30-200.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation of a repeat size of 191.90786929412837 from the Tandem repeat PCR assay falls within the range of 30-200, which is indicative of the FMR1 gene expansion. This confirms that the FMR1 gene expansion is the responsible mutation.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5934, "observations": [null, {"action": "Enzyme assay", "observation": 76.9022336695337}, {"action": "RNA sequencing", "observation": "Abnormal transcript levels"}, {"action": "Tandem repeat PCR", "observation": 191.90786929412837}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "High-resolution melt analysis (HRM)", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I'll perform an `Enzyme assay` to quickly rule out any mutations that are associated with enzyme activity levels outside the range of 0-25. This will help narrow down the possibilities.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 76.90, which falls within the range of 75-100. According to the guidebook, this excludes the SERPINA1 mutation and the G6PD deficiency mutation. \n\nThe remaining possible mutations are:\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, I will perform a `High-resolution melt analysis (HRM)` to see if there are any melting curve abnormalities that can help rule out the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The observation from the High-resolution melt analysis (HRM) shows no melting curve abnormalities, which excludes the MTHFR mutation.\n\nThe only remaining possible mutation is:\n- FMR1 gene expansion\n\nI will now predict the truth.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 4131, "observations": [null, {"action": "Enzyme assay", "observation": 76.9022336695337}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}], "seed": 10, "average_actions": 4.4, "average_tokens": 4839.2, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.4, "average_successful_tokens": 4839.2}
{"trajectories": [{"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "Methylation-specific PCR", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, I will perform the Southern blot assay. This assay can help rule out FMR1 gene expansion, which is a significant genetic mutation associated with Fragile X syndrome. By detecting the size of the DNA fragment, we can determine if this mutation is present or not.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot assay revealed a normal-sized fragment, which rules out FMR1 gene expansion. This leaves us with three possible genetic mutations: MECP2 mutation, LEP mutation, and PMP22 duplication.\n\nNext, I will perform the Multiplex ligation-dependent probe amplification (MLPA) assay to check for copy number variations, which can help rule out PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The Multiplex ligation-dependent probe amplification (MLPA) assay revealed a normal copy number, which rules out PMP22 duplication. This leaves us with two possible genetic mutations: MECP2 mutation and LEP mutation.\n\nNext, I will perform the Methylation-specific PCR assay to check for methylation patterns, which can help rule out MECP2 mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The Methylation-specific PCR assay revealed a normal methylation pattern, which rules out MECP2 mutation. This leaves us with only one possible genetic mutation: LEP mutation.\n\nSince all other mutations have been ruled out, the remaining mutation is the LEP mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 5285, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "MECP2 mutation", {"predicted_truth": "MECP2 mutation"}], "generated_text": ["To start, I will perform an assay that can help rule out a common and easily identifiable mutation. The Southern blot is a good initial test as it can quickly rule out the FMR1 gene expansion, which is a significant mutation associated with Fragile X syndrome.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which rules out the FMR1 gene expansion. \n\nThe remaining possible genetic mutations are:\n- MECP2 mutation\n- LEP mutation\n- PMP22 duplication\n\nNext, I will perform an assay to rule out PMP22 duplication, as it is a common mutation that can be detected with several assays. The Multiplex Ligation-dependent Probe Amplification (MLPA) is a good choice for this purpose.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result shows a normal copy number, which rules out PMP22 duplication.\n\nThe remaining possible genetic mutations are:\n- MECP2 mutation\n- LEP mutation\n\nTo differentiate between these two, I will perform an ELISA assay to measure the level of leptin, which can help rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a leptin level of 82.585, which is outside the normal range (0-25). This high leptin level rules out the LEP mutation, as it indicates atypical hormonal regulation.\n\nThe only remaining possible genetic mutation is the MECP2 mutation.\n\n<ANSWER> MECP2 mutation </ANSWER>"], "consumed_tokens": 5324, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "ELISA", "observation": 82.58503156561314}], "successful": false, "parse_error": false}, {"actions": ["Southern blot", "Methylation-specific PCR", "ELISA", "PMP22 duplication", {"predicted_truth": "PMP22 duplication"}], "generated_text": ["To begin, I will perform a Southern blot to check for FMR1 gene expansion, as this assay can quickly rule out one of the genetic mutations.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot showed a normal-sized fragment, we can rule out the FMR1 gene expansion. Now, we need to choose another assay to further narrow down the possible mutations. I will perform a Methylation-specific PCR to check for MECP2 mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the Methylation-specific PCR showed a normal methylation pattern, we can rule out the MECP2 mutation. Now, we are left with two possible genetic mutations: LEP mutation and PMP22 duplication. To further narrow this down, I will perform an ELISA to check for leptin levels.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a leptin level of 82.58503156561314, which is well above the normal range (0-25). This rules out the LEP mutation, as it indicates that there is no issue with leptin production.\n\nGiven the remaining options, the only possible mutation left is the PMP22 duplication. I will predict that the mutation is PMP22 duplication.\n\n<ANSWER> PMP22 duplication </ANSWER>"], "consumed_tokens": 5092, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "ELISA", "observation": 82.58503156561314}], "successful": false, "parse_error": false}, {"actions": ["Southern blot", "Methylation-specific PCR", "ELISA", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, I'll perform a Southern blot to check for FMR1 gene expansion, as this assay can quickly rule out this specific mutation if the results show a normal-sized fragment.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot showed a normal-sized fragment, we can rule out the FMR1 gene expansion. Now, I'll perform a Methylation-specific PCR to check for MECP2 mutation, as this assay can help rule out this mutation if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation pattern is normal, we can rule out the MECP2 mutation. Now, I'll perform an ELISA to check for LEP mutation by measuring leptin levels.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a leptin level of 82.58503156561314, which is outside the normal range (0-25). This suggests that the LEP mutation is present. \n\nSince we have ruled out FMR1 gene expansion, MECP2 mutation, and the leptin level is abnormally high, the remaining plausible mutation is the LEP mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 5067, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "ELISA", "observation": 82.58503156561314}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Methylation-specific PCR", "ELISA", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["Let's start by ruling out the FMR1 gene expansion, as this can be detected using a Southern blot. This will help us narrow down the possibilities.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which means we can rule out the FMR1 gene expansion. The remaining possible genetic mutations are:\n\n- MECP2 mutation\n- LEP mutation\n- PMP22 duplication\n\nNext, let's use the Methylation-specific PCR to check for the MECP2 mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The Methylation-specific PCR result shows a normal methylation pattern, which means we can rule out the MECP2 mutation. The remaining possible genetic mutations are:\n\n- LEP mutation\n- PMP22 duplication\n\nNext, let's use the ELISA assay to check for the LEP mutation by measuring leptin levels.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a leptin level of 82.585, which is outside the normal range (0-25). This indicates that the LEP mutation is present. Therefore, we can confidently identify the genetic mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 5098, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "ELISA", "observation": 82.58503156561314}], "successful": true, "parse_error": false}], "seed": 11, "average_actions": 5.0, "average_tokens": 5173.2, "average_correct": 0.6, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 5150.0}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state and the genetic analysis guidebook, the most strategic first step is to perform an assay that can potentially rule out multiple mutations. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** is a good choice because it can detect copy number variations, which can help rule out the **PMP22 duplication**.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay result shows a normal copy number, which rules out the **PMP22 duplication**. Now, we have three remaining mutations to consider: **SERPINA1 mutation**, **DMD mutation**, and **PAH mutation**.\n\nNext, we can perform an **Enzyme Assay** to further narrow down the possibilities. The enzyme assay can help us rule out **SERPINA1 mutation** and **PAH mutation** if the enzyme activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 91.53302714680002 suggests that the enzyme activity is between 75 and 100. According to the guidebook, this rules out the **SERPINA1 mutation** and **PAH mutation**.\n\nNow, we are left with only one possible mutation: **DMD mutation**.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4363, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 91.53302714680002}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, let's choose an assay that can potentially rule out multiple mutations in one step. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** is a good choice because it can detect copy number variations, which can help us rule out the **PMP22 duplication** and potentially other mutations if there are no copy number variations detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation that the MLPA assay showed a normal copy number, we can rule out the **PMP22 duplication**. This leaves us with the following possible mutations: **SERPINA1 mutation**, **DMD mutation**, and **PAH mutation**.\n\nNext, we should perform an **enzyme assay**. This assay can help us differentiate between the remaining mutations by checking the enzyme activity levels.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result shows an activity level of 91.533, which falls between 75 and 100. According to the guidebook, this result rules out the **SERPINA1 mutation** and **PAH mutation**.\n\nThis leaves us with only the **DMD mutation** as the remaining possible mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4315, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 91.53302714680002}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, let's perform an assay that can potentially rule out multiple mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect copy number variations, which are relevant to the PMP22 duplication. If we find a normal copy number, we can rule out PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the MLPA assay, we can rule out PMP22 duplication because the copy number was normal. Now, we have three remaining mutations to consider: SERPINA1 mutation, DMD mutation, and PAH mutation.\n\nNext, let's perform an **Enzyme assay** to further narrow down the possibilities. This assay can help us rule out SERPINA1 mutation and PAH mutation if the enzyme activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 91.53302714680002 is between 75 and 100, which rules out both the SERPINA1 mutation and the PAH mutation. This leaves us with only one remaining mutation: DMD mutation.\n\nSince we have ruled out the other mutations, we can confidently predict that the genetic mutation responsible for the trait is the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4359, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 91.53302714680002}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state, the most informative assay to start with would be the **Multiplex Ligation-Dependent Probe Amplification (MLPA)**. This assay can help us determine if there are any copy number variations, which would be particularly useful in ruling out the **PMP22 duplication**.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA results showed a normal copy number, we can rule out the **PMP22 duplication**. The remaining possible mutations are **SERPINA1 mutation**, **DMD mutation**, and **PAH mutation**.\n\nNext, I will perform an **Enzyme assay** to further narrow down the possibilities. The enzyme assay can help us rule out **SERPINA1 mutation** and **PAH mutation** if the activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 91.53 indicates that the enzyme activity is between 75 and 100. According to the guidebook, this result rules out both the **SERPINA1 mutation** and the **PAH mutation**.\n\nThis leaves us with only one remaining possible mutation: **DMD mutation**.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4314, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 91.53302714680002}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Let's start by performing an assay that can help us rule out multiple mutations at once. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect copy number variations, which can help us rule out PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA result showed a normal copy number, we can rule out PMP22 duplication. Now, we have three remaining possible mutations: SERPINA1 mutation, DMD mutation, and PAH mutation.\n\nNext, let's perform an **Enzyme assay** to further narrow down the possibilities. The enzyme assay can help us rule out SERPINA1 and PAH mutations if the activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 91.533 indicates that the enzyme activity is between 75 and 100. This rules out both the SERPINA1 mutation and the PAH mutation.\n\nNow, we are left with only the DMD mutation as a possible candidate.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4270, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 91.53302714680002}], "successful": true, "parse_error": false}], "seed": 12, "average_actions": 4.0, "average_tokens": 4324.2, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.0, "average_successful_tokens": 4324.2}
{"trajectories": [{"actions": ["DNA sequencing", "Methylation-specific PCR", "PCR amplification", "RFLP analysis", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will choose an assay that can potentially rule out multiple genetic mutations based on a single result. The 'DNA sequencing' assay is a comprehensive method that can detect mutations in the genetic sequence, which can help rule out HBB and GJB2 mutations if no mutations are detected.\n\n<ANSWER> DNA sequencing </ANSWER>", "Since 'DNA sequencing' detected mutations, we cannot rule out any specific mutations based on that result. We need to proceed with another assay to further narrow down the possibilities.\n\nNext, I will choose 'Methylation-specific PCR' to check for the methylation pattern, which can help rule out the UBE3A mutation if a normal methylation pattern is observed.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the 'Methylation-specific PCR' showed a normal methylation pattern, we can rule out the UBE3A mutation. This leaves us with 'DMD mutation', 'GJB2 mutation', and 'HBB mutation' as possibilities.\n\nNext, I will choose 'PCR amplification' to check for the presence of a fragment, which can help rule out the DMD mutation if a fragment is amplified.\n\n<ANSWER> PCR amplification </ANSWER>", "Since 'PCR amplification' showed a fragment amplified, we can rule out the DMD mutation. This leaves us with 'GJB2 mutation' and 'HBB mutation' as possibilities.\n\nNext, I will choose 'RFLP analysis' to check for the restriction pattern, which can help rule out the HBB mutation if a normal restriction pattern is observed.\n\n<ANSWER> RFLP analysis </ANSWER>", "Since 'RFLP analysis' showed a normal restriction pattern, we can rule out the HBB mutation. This leaves us with the 'GJB2 mutation' as the only remaining possibility.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6890, "observations": [null, {"action": "DNA sequencing", "observation": "Mutations detected"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}], "successful": true, "parse_error": false}, {"actions": ["DNA sequencing", "Methylation-specific PCR", "PCR amplification", "RFLP analysis", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Based on the initial state, I will start by performing an assay that can potentially rule out multiple mutations. The 'DNA sequencing' assay is a good initial choice because it can directly identify or rule out mutations in specific genes.\n\n<ANSWER> DNA sequencing </ANSWER>", "Given that mutations were detected by DNA sequencing, we can't rule out any specific mutations yet. The next step is to perform an assay that can help narrow down the possibilities. The 'Methylation-specific PCR' assay is useful for identifying issues with the UBE3A gene, which is associated with Angelman syndrome.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation-specific PCR showed a normal methylation pattern, we can rule out the UBE3A mutation. This leaves us with DMD mutation, GJB2 mutation, and HBB mutation.\n\nNext, I will perform a PCR amplification to check for the integrity of the DMD gene.\n\n<ANSWER> PCR amplification </ANSWER>", "Since the PCR amplification showed a fragment amplified, we can rule out the DMD mutation. This leaves us with GJB2 mutation and HBB mutation.\n\nNext, I will perform RFLP analysis to check for the integrity of the HBB gene.\n\n<ANSWER> RFLP analysis </ANSWER>", "Since the RFLP analysis showed a normal restriction pattern, we can rule out the HBB mutation. This leaves us with the GJB2 mutation as the only remaining possibility.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6668, "observations": [null, {"action": "DNA sequencing", "observation": "Mutations detected"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}], "successful": true, "parse_error": false}, {"actions": ["PCR amplification", "RFLP analysis", "Methylation-specific PCR", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Let's start by performing an assay that can potentially rule out one of the genetic mutations. A good initial choice is **PCR amplification** because it can directly indicate if the DMD gene is intact, which would help us narrow down the list of possible mutations.\n\n<ANSWER> PCR amplification </ANSWER>", "The observation that a fragment is amplified suggests that the DMD gene is likely intact, allowing us to rule out the DMD mutation. \n\nNext, let's perform **RFLP analysis** to see if we can rule out the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The normal restriction pattern observed in the RFLP analysis suggests that the HBB gene is likely normal, allowing us to rule out the HBB mutation.\n\nNow, we are left with the **GJB2 mutation** and the **UBE3A mutation**. To further narrow it down, let's perform **Methylation-specific PCR** to check for abnormalities in methylation patterns that might indicate a UBE3A mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The normal methylation pattern observed in the Methylation-specific PCR suggests that the UBE3A gene's regulation is likely unaffected, allowing us to rule out the UBE3A mutation.\n\nGiven the remaining possibilities, the only mutation left is the **GJB2 mutation**. Therefore, we can confidently predict that the genetic mutation responsible for the trait is the GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 5218, "observations": [null, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "PCR amplification", "RFLP analysis", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will use an assay that can help narrow down the list of possible mutations. The Methylation-specific PCR is a good choice because it can quickly rule out the UBE3A mutation if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The normal methylation pattern rules out the UBE3A mutation. Now we have the following possible mutations left: DMD mutation, GJB2 mutation, and HBB mutation.\n\nNext, I will perform PCR amplification to see if the DMD gene is intact.\n\n<ANSWER> PCR amplification </ANSWER>", "The fragment amplification in the PCR suggests that the DMD gene is likely intact, ruling out the DMD mutation. Now we are left with GJB2 mutation and HBB mutation.\n\nNext, I will perform RFLP analysis to check for the normal restriction pattern, which can rule out the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The normal restriction pattern in the RFLP analysis rules out the HBB mutation. Now we are left with only the GJB2 mutation.\n\nSince we have narrowed it down to a single mutation, I will predict the GJB2 mutation as the answer.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 5146, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}], "successful": true, "parse_error": false}, {"actions": ["DNA sequencing", "RFLP analysis", "PCR amplification", "Methylation-specific PCR", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, let's use an assay that can potentially rule out multiple mutations in one step. The 'DNA sequencing' assay can help us identify if there are any mutations in the HBB and GJB2 genes, which are known for specific mutations that can be detected by sequencing.\n\n<ANSWER> DNA sequencing </ANSWER>", "Given that mutations were detected by DNA sequencing, we can no longer rule out HBB and GJB2 mutations. However, we need to narrow down the possibilities further. Let's use the 'RFLP analysis' to check for the presence of an HBB mutation, which would help us rule it out if the restriction pattern is normal.\n\n<ANSWER> RFLP analysis </ANSWER>", "Since the RFLP analysis showed a normal restriction pattern, we can rule out the HBB mutation. This leaves us with DMD mutation, GJB2 mutation, and UBE3A mutation.\n\nNext, let's use the 'PCR amplification' assay to check for the integrity of the DMD gene. If the fragment is amplified, we can rule out the DMD mutation.\n\n<ANSWER> PCR amplification </ANSWER>", "Since the PCR amplification showed that the DMD gene fragment was amplified, we can rule out the DMD mutation. This leaves us with GJB2 mutation and UBE3A mutation.\n\nTo further narrow it down, let's use the 'Methylation-specific PCR' to check for the methylation pattern, which can help us rule out the UBE3A mutation if the pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the Methylation-specific PCR showed a normal methylation pattern, we can rule out the UBE3A mutation. This leaves us with the GJB2 mutation as the only remaining possibility.\n\nTherefore, the mutation responsible for the observed trait is:\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6865, "observations": [null, {"action": "DNA sequencing", "observation": "Mutations detected"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}], "successful": true, "parse_error": false}], "seed": 13, "average_actions": 5.6, "average_tokens": 6157.4, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.6, "average_successful_tokens": 6157.4}
{"trajectories": [{"actions": ["Karyotyping", "High-resolution melt analysis (HRM)", "PCR amplification", "HBB mutation", {"predicted_truth": "HBB mutation"}], "generated_text": ["To start, I will perform an assay that can help me rule out one of the mutations based on its broad impact. Karyotyping is a good choice because it can immediately rule out large chromosomal duplications, which are associated with PMP22 duplication.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, we can rule out PMP22 duplication. Next, I will perform High-resolution melt analysis (HRM) to check for CFTR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM analysis showed no melting curve abnormalities, so we can rule out CFTR mutations. This leaves us with HBB mutation and DMD mutation. Next, I will perform PCR amplification to check for DMD mutations.\n\n<ANSWER> PCR amplification </ANSWER>", "The PCR amplification successfully amplified a fragment, which suggests that DMD mutations are unlikely. This leaves us with HBB mutation as the only remaining possibility.\n\n<ANSWER> HBB mutation </ANSWER>"], "consumed_tokens": 4666, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "PCR amplification", "observation": "Fragment amplified"}], "successful": true, "parse_error": false}, {"actions": ["PCR amplification", "Karyotyping", "High-resolution melt analysis (HRM)", "HBB mutation", {"predicted_truth": "HBB mutation"}], "generated_text": ["Given the initial state, the most efficient first step is to perform an assay that can potentially rule out multiple genetic mutations based on a single result. Let's consider the available assays:\n\n1. **PCR Amplification**: This assay can rule out *DMD mutations* if a fragment is successfully amplified. This is a good starting point because it directly tests for the presence of a large deletion or duplication that might affect the DMD gene.\n2. **Karyotyping**: This can rule out *PMP22 duplication* if the karyotype is normal. This is also a strong candidate because it can detect large chromosomal changes.\n3. **High-resolution Melt Analysis (HRM)**: This can rule out *CFTR mutations* if no melting curve abnormalities are observed. This is a more specific test and might be less useful initially.\n4. **DNA Sequencing**: This can rule out *CFTR* and *HBB mutations* if no mutations are detected. This is a comprehensive test but might be more time-consuming and expensive.\n5. **Protein Truncation Test**: This can rule out *DMD mutations* if no truncated proteins are detected. This is another specific test that might be less useful initially.\n6. **Splice-site Analysis**: This can rule out *CFTR mutations* if no splicing abnormalities are detected. This is also a specific test and might be less useful initially.\n\nConsidering the efficiency and the potential to rule out multiple mutations, **PCR Amplification** is the best first step. If a fragment is successfully amplified, we can rule out *DMD mutations* and narrow down the list of possible mutations.\n\n<ANSWER> PCR amplification </ANSWER>", "Since the PCR amplification result was \"Fragment amplified,\" we can rule out the *DMD mutation*. This leaves us with the following possible genetic mutations: 'CFTR mutation', 'PMP22 duplication', and 'HBB mutation'.\n\nNext, we should perform an assay that can help us narrow down the remaining possibilities. **Karyotyping** is a good choice because it can rule out *PMP22 duplication* if the karyotype is normal. This will help us further narrow down the list of potential mutations.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, we can rule out the *PMP22 duplication*. This leaves us with the following possible genetic mutations: 'CFTR mutation' and 'HBB mutation'.\n\nTo further narrow down the possibilities, we can use **High-resolution Melt Analysis (HRM)**. This assay can help rule out *CFTR mutations* if no melting curve abnormalities are observed. This will help us determine whether the remaining mutation is *CFTR* or *HBB*.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the high-resolution melt analysis (HRM) result was \"No melting curve abnormalities,\" we can rule out the *CFTR mutation*. This leaves us with only one possible genetic mutation: 'HBB mutation'.\n\nTherefore, we can confidently predict that the genetic mutation responsible for the trait is the *HBB mutation*.\n\n<ANSWER> HBB mutation </ANSWER>"], "consumed_tokens": 6139, "observations": [null, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Karyotyping", "High-resolution melt analysis (HRM)", "PCR amplification", "DNA sequencing", "HBB mutation", {"predicted_truth": "HBB mutation"}], "generated_text": ["To start, I will perform an assay that can help narrow down the potential mutations quickly. Karyotyping is a good initial test because it can rule out large chromosomal duplications, such as PMP22 duplication, which is a significant cause of Charcot-Marie-Tooth disease type 1A.\n\n<ANSWER> Karyotyping </ANSWER>", "Given the normal karyotype, we can rule out the PMP22 duplication. Next, I will perform a high-resolution melt analysis (HRM) to check for any melting curve abnormalities, which can help rule out CFTR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the high-resolution melt analysis (HRM) showed no melting curve abnormalities, we can rule out CFTR mutations. Now, we have narrowed it down to HBB mutation and DMD mutation. \n\nNext, I will perform a PCR amplification to check for the presence of a fragment, which can help rule out DMD mutations.\n\n<ANSWER> PCR amplification </ANSWER>", "The PCR amplification showed that a fragment was successfully amplified, which suggests that DMD mutations are unlikely. This leaves us with HBB mutations as the remaining possibility.\n\nTo confirm, I will perform DNA sequencing to check for any mutations in the HBB gene.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing detected mutations, confirming that the HBB gene is affected. Based on the results, the genetic mutation responsible for the observed trait is the HBB mutation.\n\n<ANSWER> HBB mutation </ANSWER>"], "consumed_tokens": 6233, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Karyotyping", "PCR amplification", "High-resolution melt analysis (HRM)", "HBB mutation", {"predicted_truth": "HBB mutation"}], "generated_text": ["To start, let's perform an assay that can potentially rule out one of the mutations. Karyotyping is a good initial test because it can quickly identify large chromosomal abnormalities, which would help us rule out PMP22 duplication.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype was normal, we can rule out PMP22 duplication. The remaining mutations are CFTR mutation, HBB mutation, and DMD mutation.\n\nNext, let's perform a PCR amplification to see if we can rule out DMD mutation.\n\n<ANSWER> PCR amplification </ANSWER>", "Since the PCR amplification showed that a fragment was successfully amplified, we can rule out DMD mutation. The remaining mutations are CFTR mutation and HBB mutation.\n\nNext, let's perform a high-resolution melt analysis (HRM) to check for CFTR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the high-resolution melt analysis (HRM) showed no melting curve abnormalities, we can rule out CFTR mutation. The only remaining mutation is HBB mutation.\n\n<ANSWER> HBB mutation </ANSWER>"], "consumed_tokens": 4704, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Karyotyping", "PCR amplification", "High-resolution melt analysis (HRM)", "HBB mutation", {"predicted_truth": "HBB mutation"}], "generated_text": ["To start, I will perform an assay that can potentially rule out a significant number of mutations in one step. Karyotyping is a good choice because it can immediately exclude PMP22 duplication if the karyotype is normal.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, we can exclude PMP22 duplication. This leaves us with CFTR mutation, HBB mutation, and DMD mutation.\n\nNext, I will perform a PCR amplification to see if we can rule out DMD mutation. If a fragment is successfully amplified, DMD mutations are unlikely.\n\n<ANSWER> PCR amplification </ANSWER>", "Since the PCR amplification resulted in a fragment being amplified, we can exclude DMD mutation. This leaves us with CFTR mutation and HBB mutation.\n\nNext, I will perform a High-resolution Melt Analysis (HRM) to see if we can rule out CFTR mutation. If no melting curve abnormalities are detected, CFTR mutations are unlikely.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the High-resolution Melt Analysis (HRM) showed no melting curve abnormalities, we can exclude CFTR mutation. This leaves us with HBB mutation as the only remaining possibility.\n\nTherefore, I will predict that the genetic mutation is HBB mutation.\n\n<ANSWER> HBB mutation </ANSWER>"], "consumed_tokens": 4788, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "PCR amplification", "observation": "Fragment amplified"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}], "seed": 14, "average_actions": 5.2, "average_tokens": 5306.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.2, "average_successful_tokens": 5306.0}
{"trajectories": [{"actions": ["Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "TaqMan assay", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will use an assay that can potentially rule out multiple mutations in a single step. The **Fluorescence in situ hybridization (FISH)** assay can detect the presence or absence of specific DNA sequences on chromosomes, which is particularly useful for identifying large-scale changes like PMP22 duplication.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since no deletions were detected by the FISH assay, we can rule out the PMP22 duplication. This leaves us with three possible mutations: BRCA1 mutation, BRCA2 mutation, and MTHFR mutation.\n\nNext, I will use the **High-resolution melt analysis (HRM)** to check for sequence variations that can help rule out the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since no melting curve abnormalities were detected by the HRM assay, we can rule out the MTHFR mutation. This leaves us with two possible mutations: BRCA1 mutation and BRCA2 mutation.\n\nNext, I will use the **TaqMan assay** to check for the presence of the BRCA1 mutation.\n\n<ANSWER> TaqMan assay </ANSWER>", "Since there was no amplification with the mutant probe in the TaqMan assay, we can rule out the BRCA1 mutation. This leaves us with the BRCA2 mutation as the only remaining possibility.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5603, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "TaqMan assay", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will use an assay that can help me rule out a significant number of mutations. The **Fluorescence in situ hybridization (FISH)** assay can detect chromosomal abnormalities, which will help me rule out the PMP22 duplication if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since no deletions were detected with the FISH assay, we can rule out the PMP22 duplication. Now, we are left with the following possible mutations: **BRCA1 mutation**, **BRCA2 mutation**, and **MTHFR mutation**.\n\nNext, I will use the **High-resolution melt analysis (HRM)** to see if there are any abnormalities in the DNA sequences, which can help rule out the MTHFR mutation if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since no melting curve abnormalities were detected with the HRM assay, we can rule out the MTHFR mutation. Now, we are left with the following possible mutations: **BRCA1 mutation** and **BRCA2 mutation**.\n\nNext, I will use the **TaqMan assay** to detect the presence of specific genetic variations, which can help rule out the BRCA1 mutation if no amplification with the mutant probe is detected.\n\n<ANSWER> TaqMan assay </ANSWER>", "Since there was no amplification with the mutant probe in the TaqMan assay, we can rule out the BRCA1 mutation. Now, we are left with only one possible mutation: **BRCA2 mutation**.\n\nGiven the results of the previous assays, the remaining mutation is the BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5721, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "TaqMan assay", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will use the **Fluorescence in situ hybridization (FISH)** assay. This assay is particularly useful for detecting large-scale chromosomal abnormalities, such as duplications or deletions, which can help rule out the PMP22 duplication.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since no deletions were detected by the FISH assay, we can rule out the **PMP22 duplication**. Next, I will use the **High-resolution melt analysis (HRM)** to check for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since no melting curve abnormalities were detected by the HRM assay, we can rule out the **MTHFR mutation**. Now, we are left with two possible mutations: **BRCA1 mutation** and **BRCA2 mutation**. To distinguish between these, I will use the **TaqMan assay**.\n\n<ANSWER> TaqMan assay </ANSWER>", "Since there was no amplification with the mutant probe in the TaqMan assay, we can rule out the **BRCA1 mutation**. This leaves us with the **BRCA2 mutation** as the only remaining possibility. I will now predict the **BRCA2 mutation** as the answer.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5499, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "TaqMan assay", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["Given the list of genetic mutations and the available assays, the most strategic first step is to perform an assay that can potentially rule out a significant number of mutations. The **Fluorescence in situ hybridization (FISH)** assay can detect and localize the presence or absence of specific DNA sequences on chromosomes, which can help rule out the PMP22 duplication if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since the FISH assay did not detect any deletions, we can rule out the PMP22 duplication. The remaining possible mutations are BRCA1 mutation, BRCA2 mutation, and MTHFR mutation.\n\nNext, we can perform a **High-resolution melt analysis (HRM)** to check for variations in DNA sequences, which can help rule out the MTHFR mutation if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM assay did not detect any melting curve abnormalities, we can rule out the MTHFR mutation. The remaining possible mutations are BRCA1 mutation and BRCA2 mutation.\n\nTo further narrow down, we can perform a **TaqMan assay** to detect genetic variations. If no amplification with the mutant probe is observed, we can rule out the BRCA1 mutation.\n\n<ANSWER> TaqMan assay </ANSWER>", "Since the TaqMan assay did not show amplification with the mutant probe, we can rule out the BRCA1 mutation. The only remaining possible mutation is the BRCA2 mutation.\n\nGiven the results from the previous assays, we can confidently predict that the mutation is the BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5734, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "TaqMan assay", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will perform an assay that can help me narrow down the list of possible genetic mutations. Fluorescence in situ hybridization (FISH) is a good choice because it can detect deletions or duplications, which would help rule out the PMP22 duplication if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Based on the observation that no deletions were detected by FISH, we can rule out the PMP22 duplication. The remaining possible mutations are BRCA1 mutation, BRCA2 mutation, and MTHFR mutation.\n\nNext, I will perform High-resolution melt analysis (HRM) to check for variations in DNA sequences, which could help rule out the MTHFR mutation if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the observation that no melting curve abnormalities were detected by HRM, we can rule out the MTHFR mutation. The remaining possible mutations are BRCA1 mutation and BRCA2 mutation.\n\nNext, I will perform a TaqMan assay to check for the presence of the BRCA1 mutation. If no amplification with the mutant probe is detected, we can rule out the BRCA1 mutation.\n\n<ANSWER> TaqMan assay </ANSWER>", "Based on the observation that no amplification with the mutant probe was detected by the TaqMan assay, we can rule out the BRCA1 mutation. The only remaining possible mutation is the BRCA2 mutation.\n\nSince we have narrowed it down to one mutation, I will predict the truth.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5671, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}], "successful": true, "parse_error": false}], "seed": 15, "average_actions": 5.0, "average_tokens": 5645.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 5645.6}
{"trajectories": [{"actions": ["Enzyme assay", "ELISA", "Allele-specific oligonucleotide hybridization", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To begin, I will perform an enzyme assay to check the activity level of specific enzymes. This will help me rule out PAH and SERPINA1 mutations if the activity level is within the 75-100 range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 82.41, which falls within the 75-100 range. Based on this, we can rule out the PAH mutation and SERPINA1 mutation. \n\nNow, the remaining possible mutations are LEP mutation and GJB2 mutation. Next, I will perform an ELISA to measure the signal intensity, which will help rule out the LEP mutation if the signal intensity is low.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA signal intensity is 20.37, which falls within the 0-25 range. Based on this, we can rule out the LEP mutation.\n\nNow, the only remaining possible mutation is the GJB2 mutation. To confirm this, I will perform an allele-specific oligonucleotide hybridization to check for the presence of the mutant probe.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The allele-specific oligonucleotide hybridization shows hybridization with the mutant probe, which confirms the presence of a GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 5853, "observations": [null, {"action": "Enzyme assay", "observation": 82.41493409537593}, {"action": "ELISA", "observation": 20.372778984729823}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "Hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Given the initial state, the best strategy is to use an assay that can help eliminate the most potential mutations in a single step. The 'Enzyme assay' can rule out both PAH mutation and SERPINA1 mutation if the activity level is between 75 and 100. This is a strong choice because it can significantly narrow down the possibilities.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 82.41, which is between 75 and 100. According to the genetic analysis guidebook, this result allows us to rule out both the PAH mutation and the SERPINA1 mutation. This leaves us with two possible mutations: LEP mutation and GJB2 mutation.\n\nNext, we should perform an assay that can help us differentiate between these two remaining mutations. The ELISA assay can rule out the LEP mutation if the signal intensity is low (0-25).\n\n<ANSWER> ELISA </ANSWER>", "The ELISA signal intensity is 20.37, which is between 0 and 25. According to the guidebook, this result allows us to rule out the LEP mutation. This leaves us with only one possible mutation: GJB2 mutation.\n\nSince only the GJB2 mutation remains, we can confidently predict that this is the responsible mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 4333, "observations": [null, {"action": "Enzyme assay", "observation": 82.41493409537593}, {"action": "ELISA", "observation": 20.372778984729823}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to check the activity level of enzymes. This assay can help rule out PAH and SERPINA1 mutations if the activity level is between 75 and 100. If the activity level is very low (0-25), it will not rule out any mutations, but it will provide useful information for subsequent steps.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 82.41, which falls between 75 and 100. According to the guidebook, this result allows us to rule out the PAH mutation and the SERPINA1 mutation. \n\nThis leaves us with two possible mutations: LEP mutation and GJB2 mutation.\n\nNext, I will perform an **ELISA** to check the signal intensity. This assay can help rule out the LEP mutation if the signal intensity is low (0-25).\n\n<ANSWER> ELISA </ANSWER>", "The ELISA signal intensity is 20.37, which falls between 0 and 25. According to the guidebook, this result allows us to rule out the LEP mutation.\n\nThis leaves us with only one possible mutation: GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 4324, "observations": [null, {"action": "Enzyme assay", "observation": 82.41493409537593}, {"action": "ELISA", "observation": 20.372778984729823}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I'll perform an enzyme assay to check the activity levels of specific enzymes, which can help rule out PAH and SERPINA1 mutations if the activity level is high.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay observation is 82.41, which is in the range of 75-100. According to the guidebook, this rules out PAH mutation and SERPINA1 mutation.\n\nNow, the remaining possible mutations are:\n- LEP mutation\n- GJB2 mutation\n\nNext, I will perform an ELISA to check the signal intensity, which can help rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA observation is 20.37, which is in the range of 0-25. According to the guidebook, this rules out the LEP mutation.\n\nNow, the only remaining possible mutation is:\n- GJB2 mutation\n\nSince we have ruled out all other mutations, the most likely mutation is the GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 4176, "observations": [null, {"action": "Enzyme assay", "observation": 82.41493409537593}, {"action": "ELISA", "observation": 20.372778984729823}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, let's use the **Enzyme Assay** to get a broad understanding of the enzyme activity levels, which can help us rule out some of the mutations based on the activity levels.\n\n<ANSWER> Enzyme assay </ANSWER>", "Based on the enzyme activity level of 82.41493409537593, we can rule out the PAH mutation and SERPINA1 mutation, as the activity level is between 75 and 100. This leaves us with the LEP mutation and GJB2 mutation.\n\nNext, let's perform an **ELISA** to check for the presence of leptin, which can help us rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "Based on the ELISA signal intensity of 20.372778984729823, we can rule out the LEP mutation, as the signal intensity is low (0-25).\n\nThis leaves us with the GJB2 mutation as the only remaining possibility.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 4200, "observations": [null, {"action": "Enzyme assay", "observation": 82.41493409537593}, {"action": "ELISA", "observation": 20.372778984729823}], "successful": true, "parse_error": false}], "seed": 16, "average_actions": 4.2, "average_tokens": 4577.2, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.2, "average_successful_tokens": 4577.2}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To efficiently narrow down the list of possible genetic mutations, I will start with an assay that can potentially rule out multiple mutations. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** is a good choice because it can detect copy number variations, which are relevant to the PMP22 duplication. If the assay shows a normal copy number, we can rule out the PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out the PMP22 duplication. The remaining possible mutations are G6PD deficiency mutation, GJB2 mutation, and PAH mutation.\n\nNext, I will perform an **Enzyme assay**. This assay can help rule out PAH mutation and G6PD deficiency mutation if the enzyme activity is within the normal range (75-100%).\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay resulted in 96.49% activity, which falls within the normal range (75-100%). This allows us to rule out both the PAH mutation and the G6PD deficiency mutation.\n\nThe remaining possible mutation is the GJB2 mutation.\n\nTo confirm this, I will perform **DNA sequencing**. If no mutations are detected, we can rule out the GJB2 mutation. If mutations are detected, it will confirm the GJB2 mutation.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing assay detected mutations, which confirms the presence of a GJB2 mutation. Given that this is the only remaining mutation and the assay results are consistent with it, I can confidently predict the genetic mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6240, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 96.49262195482899}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Given the initial list of genetic mutations and the available assays, a strategic first step is to choose an assay that can potentially rule out multiple mutations or at least provide a clear direction. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect copy number variations, which would be particularly useful for ruling out the **PMP22 duplication** if no abnormal copy number changes are detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, the **PMP22 duplication** has been ruled out. This leaves us with three possible mutations: **G6PD deficiency mutation**, **GJB2 mutation**, and **PAH mutation**.\n\nNext, we can use the **Enzyme assay** to check for enzyme activity. This assay can help us rule out **PAH mutation** and **G6PD deficiency mutation** if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity result of 96.49% is within the normal range (75-100% activity). This means that the **PAH mutation** and **G6PD deficiency mutation** can both be ruled out, as the enzyme activity is normal.\n\nThis leaves us with the **GJB2 mutation** as the only remaining possibility.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 4510, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 96.49262195482899}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will use an assay that can help me narrow down the possibilities by ruling out one or more mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect copy number variations, which would rule out the PMP22 duplication if no abnormal copy number changes are detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the MLPA assay was 'Normal copy number,' which means the PMP22 duplication is ruled out. Now, I have the following possible mutations left:\n\n- G6PD deficiency mutation\n- GJB2 mutation\n- PAH mutation\n\nNext, I will use the **Enzyme assay** to further narrow down the possibilities. The Enzyme assay can rule out the PAH mutation and G6PD deficiency mutation if the enzyme activity is within the normal range (75-100%).\n\n<ANSWER> Enzyme assay </ANSWER>", "The observation from the Enzyme assay was 96.49262195482899, which falls within the normal range (75-100% activity). This means the PAH mutation and G6PD deficiency mutation are ruled out.\n\nNow, I have only one possible mutation left:\n\n- GJB2 mutation\n\nTo confirm this, I will use **DNA sequencing** to check if any mutations are detected in the GJB2 gene.\n\n<ANSWER> DNA sequencing </ANSWER>", "The observation from the DNA sequencing assay indicates that mutations are detected in the GJB2 gene. This confirms that the GJB2 mutation is the responsible genetic mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6229, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 96.49262195482899}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will choose the 'Multiplex ligation-dependent probe amplification (MLPA)' assay. This assay can help detect copy number variations, which is particularly relevant for the PMP22 duplication mutation associated with Charcot-Marie-Tooth Disease Type 1A (CMT1A).\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out the PMP22 duplication. The remaining possible mutations are G6PD deficiency mutation, GJB2 mutation, and PAH mutation.\n\nNext, I will perform an enzyme assay to check for enzyme activity, which can help rule out the PAH mutation and G6PD deficiency mutation if the activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result shows an activity of 96.49%, which is within the normal range (75-100% activity). Based on this, we can rule out the PAH mutation and G6PD deficiency mutation.\n\nThe remaining possible mutation is the GJB2 mutation.\n\nTo confirm, I will perform a DNA sequencing assay to check for mutations in the GJB2 gene.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing assay detected mutations, confirming that the GJB2 mutation is present.\n\nSince we have ruled out all other mutations and the DNA sequencing results confirm the presence of a GJB2 mutation, I can confidently predict the truth.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6099, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 96.49262195482899}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Given the initial state of the game, the best starting point would be to use an assay that can rule out the most mutations in a single step. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** assay is a good choice because it can detect copy number variations, which would immediately rule out the **PMP22 duplication** if no such variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay result showed a normal copy number, the **PMP22 duplication** can be ruled out. The remaining possible genetic mutations are:\n\n- **G6PD deficiency mutation**\n- **GJB2 mutation**\n- **PAH mutation**\n\nThe next logical step is to use an **Enzyme Assay** to rule out **PAH mutation** and **G6PD deficiency mutation**. If the enzyme activity is within the normal range (75-100%), these mutations can be ruled out.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 96.49% activity is within the normal range (75-100%), which means that the **PAH mutation** and **G6PD deficiency mutation** can be ruled out. \n\nThe only remaining possible genetic mutation is:\n\n- **GJB2 mutation**\n\nTo confirm this, we can use **DNA sequencing** to check for mutations in the GJB2 gene.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing result indicates that mutations are detected in the GJB2 gene, confirming the presence of a **GJB2 mutation**.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 6240, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 96.49262195482899}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}], "seed": 17, "average_actions": 4.8, "average_tokens": 5863.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.8, "average_successful_tokens": 5863.6}
{"trajectories": [{"actions": ["Methylation-specific PCR", "Multiplex ligation-dependent probe amplification (MLPA)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["To start, I will use an assay that can potentially rule out multiple mutations in one step. The 'Methylation-specific PCR' can rule out both UBE3A mutation and MECP2 mutation if the methylation pattern is normal, which would significantly narrow down the list of possible mutations.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Based on the observation of a normal methylation pattern, we can rule out both the UBE3A mutation and the MECP2 mutation. This leaves us with the CFTR mutation and the SMN1 deletion.\n\nNext, I will perform an assay that can help distinguish between these two remaining mutations. The 'Multiplex ligation-dependent probe amplification (MLPA)' can rule out the SMN1 deletion if a normal copy number is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation of a normal copy number from the MLPA, we can rule out the SMN1 deletion. This leaves us with only the CFTR mutation as the remaining possible mutation.\n\nTherefore, I will predict the mutation as the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 3982, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Fluorescence in situ hybridization (FISH)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["To start, I will choose an assay that can potentially rule out multiple genetic mutations. The **Methylation-specific PCR** is a good choice because it can rule out both the UBE3A mutation and the MECP2 mutation if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation pattern is normal, we can rule out both the UBE3A mutation and the MECP2 mutation. This leaves us with the CFTR mutation and the SMN1 deletion.\n\nNext, I will use the **Fluorescence in situ hybridization (FISH)** to check for deletions. If no deletions are detected, we can rule out the SMN1 deletion, leaving the CFTR mutation as the only remaining possibility.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since no deletions were detected by FISH, we can rule out the SMN1 deletion. This leaves the CFTR mutation as the only remaining possibility.\n\nGiven the remaining options, I will predict the mutation as the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 3968, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Splice-site analysis", "Methylation-specific PCR", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["To start, I will choose an assay that can potentially rule out multiple genetic mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect copy number variations and directly rule out both the UBE3A mutation and the SMN1 deletion if the copy number is normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA test showed a normal copy number, we can rule out the UBE3A mutation and the SMN1 deletion. The remaining possible mutations are CFTR mutation and MECP2 mutation.\n\nNext, I will perform a **Splice-site analysis** to check for splicing abnormalities, which can help rule out the CFTR mutation.\n\n<ANSWER> Splice-site analysis </ANSWER>", "Since splicing abnormalities were detected, the CFTR mutation cannot be ruled out. This leaves us with two possible mutations: CFTR mutation and MECP2 mutation.\n\nTo further narrow it down, I will perform a **Methylation-specific PCR** to check the methylation pattern. This assay can help rule out the MECP2 mutation and UBE3A mutation if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation pattern is normal, we can rule out the MECP2 mutation and the UBE3A mutation. The only remaining mutation is the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 5546, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Splice-site analysis", "observation": "Splicing abnormalities detected"}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Fluorescence in situ hybridization (FISH)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Let's start by using an assay that can potentially rule out multiple mutations. The **Methylation-specific PCR** can rule out both the UBE3A mutation and the MECP2 mutation if the methylation pattern is normal. This will help us narrow down the list of possible mutations more effectively.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Given the observation of a normal methylation pattern, we can rule out the UBE3A mutation and the MECP2 mutation. This leaves us with the CFTR mutation and the SMN1 deletion as the remaining possibilities.\n\nNext, we can use the **Fluorescence in situ hybridization (FISH)** assay to check for deletions. If no deletions are detected, we can rule out the SMN1 deletion, leaving the CFTR mutation as the only possibility.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Given that no deletions were detected by FISH, we can rule out the SMN1 deletion. This leaves us with the CFTR mutation as the only remaining possibility.\n\nTo confirm, we can perform a **Splice-site analysis** to check for splicing abnormalities, which would rule out the CFTR mutation if no abnormalities are detected. However, since we have only one mutation left, we can confidently predict the mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 4034, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "Fluorescence in situ hybridization (FISH)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["To start, I will perform an assay that can potentially rule out multiple genetic mutations. The Methylation-specific PCR is a good choice because it can rule out both UBE3A mutation and MECP2 mutation if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The observation from the Methylation-specific PCR shows a normal methylation pattern, which means we can rule out both UBE3A mutation and MECP2 mutation. This leaves us with CFTR mutation and SMN1 deletion.\n\nNext, I will perform an assay that can help us distinguish between these two remaining mutations. The Fluorescence in situ hybridization (FISH) is a good choice because it can detect deletions, which would help us rule out SMN1 deletion if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The observation from the Fluorescence in situ hybridization (FISH) shows no deletions detected, which rules out SMN1 deletion. This leaves us with CFTR mutation as the only remaining possibility.\n\nSince we have ruled out all other mutations, the remaining mutation is the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 3985, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}], "successful": true, "parse_error": false}], "seed": 18, "average_actions": 4.2, "average_tokens": 4303.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.2, "average_successful_tokens": 4303.0}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "DNA sequencing", "BRCA1 mutation", {"predicted_truth": "BRCA1 mutation"}], "generated_text": ["To start, I will use an assay that can potentially rule out a significant number of genetic mutations. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** is a good choice because it can detect copy number variations, which are indicative of the PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the MLPA assay, the PMP22 duplication has been ruled out. The remaining possible genetic mutations are:\n\n- MTHFR mutation\n- CFTR mutation\n- BRCA1 mutation\n\nThe next logical step is to use the **High-Resolution Melt Analysis (HRM)**, which can rule out MTHFR and CFTR mutations if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the observation from the HRM assay, no melting curve abnormalities were detected, which rules out both MTHFR and CFTR mutations. The remaining possible genetic mutation is:\n\n- BRCA1 mutation\n\nTo confirm this, I will use **DNA sequencing**, which can rule out BRCA1 mutations if no mutations are detected.\n\n<ANSWER> DNA sequencing </ANSWER>", "Based on the DNA sequencing results, mutations were detected, which confirms the presence of a BRCA1 mutation. Since this is the only remaining mutation, I can confidently identify it as the mutation responsible for the trait.\n\n<ANSWER> BRCA1 mutation </ANSWER>"], "consumed_tokens": 5926, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["High-resolution melt analysis (HRM)", "Multiplex ligation-dependent probe amplification (MLPA)", "BRCA1 mutation", {"predicted_truth": "BRCA1 mutation"}], "generated_text": ["To systematically rule out genetic mutations, I will start with an assay that can potentially eliminate multiple options. The **High-Resolution Melt Analysis (HRM)** can rule out both CFTR and MTHFR mutations if no melting curve abnormalities are detected. This is a good starting point.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the High-Resolution Melt Analysis (HRM) did not detect any melting curve abnormalities, we can rule out both **CFTR mutation** and **MTHFR mutation**.\n\nThe remaining possible genetic mutations are:\n- **PMP22 duplication**\n- **BRCA1 mutation**\n\nNext, I will use the **Multiplex Ligation-Dependent Probe Amplification (MLPA)** to check for copy number variations, which can help rule out the **PMP22 duplication** if no copy number variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the Multiplex Ligation-Dependent Probe Amplification (MLPA) showed a normal copy number, we can rule out the **PMP22 duplication**.\n\nThe only remaining possible genetic mutation is:\n- **BRCA1 mutation**\n\nI will now predict the truth based on the remaining options.\n\n<ANSWER> BRCA1 mutation </ANSWER>"], "consumed_tokens": 4324, "observations": [null, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "BRCA1 mutation", {"predicted_truth": "BRCA1 mutation"}], "generated_text": ["To start, I will use the Multiplex Ligation-Dependent Probe Amplification (MLPA) assay. This assay is particularly useful for detecting copy number variations, which can help rule out the PMP22 duplication mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay showed a normal copy number, which rules out the PMP22 duplication. This leaves us with the following possible genetic mutations: MTHFR mutation, CFTR mutation, and BRCA1 mutation.\n\nNext, I will perform High-Resolution Melt Analysis (HRM) to rule out the presence of CFTR and MTHFR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM assay showed no melting curve abnormalities, which rules out the presence of CFTR and MTHFR mutations. This leaves us with only one possible genetic mutation: BRCA1 mutation.\n\n<ANSWER> BRCA1 mutation </ANSWER>"], "consumed_tokens": 4205, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "BRCA1 mutation", {"predicted_truth": "BRCA1 mutation"}], "generated_text": ["To start, let's use the **Multiplex Ligation-Dependent Probe Amplification (MLPA)** assay. This assay can detect copy number variations, which will help us rule out the PMP22 duplication if no copy number variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out the PMP22 duplication. Now, we need to further narrow down the remaining possibilities: MTHFR mutation, CFTR mutation, and BRCA1 mutation.\n\nNext, let's use the **High-Resolution Melt Analysis (HRM)** assay. This assay can detect melting curve abnormalities that are associated with CFTR and MTHFR mutations. If no abnormalities are detected, we can rule out both CFTR and MTHFR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM assay showed no melting curve abnormalities, we can rule out both the MTHFR mutation and the CFTR mutation. This leaves us with the BRCA1 mutation as the only remaining possibility.\n\nGiven the results from the previous assays, we can confidently predict the genetic mutation.\n\n<ANSWER> BRCA1 mutation </ANSWER>"], "consumed_tokens": 4303, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "BRCA1 mutation", {"predicted_truth": "BRCA1 mutation"}], "generated_text": ["To start, let's use an assay that can help us rule out a significant number of mutations with a single test. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** is a good choice because it can detect copy number variations, which would help us rule out the PMP22 duplication if no copy number variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA test showed a normal copy number, we can rule out PMP22 duplication. This leaves us with the following possible mutations: MTHFR mutation, CFTR mutation, and BRCA1 mutation.\n\nNext, let's use **High-Resolution Melt Analysis (HRM)** to further narrow down the possibilities. HRM can help us rule out MTHFR and CFTR mutations if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM test showed no melting curve abnormalities, we can rule out both MTHFR and CFTR mutations. This leaves us with only one possible mutation: BRCA1 mutation.\n\nGiven that we have ruled out all other mutations, we can confidently predict that the genetic mutation is BRCA1 mutation.\n\n<ANSWER> BRCA1 mutation </ANSWER>"], "consumed_tokens": 4335, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}], "seed": 19, "average_actions": 4.2, "average_tokens": 4618.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.2, "average_successful_tokens": 4618.6}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Next-generation sequencing (NGS)", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial list of possible genetic mutations and the available assays, a logical first step is to use an assay that can potentially rule out multiple mutations efficiently. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** assay is a good choice because it can detect copy number variations, which can help rule out the SMN1 deletion mutation and potentially provide insights into the other mutations.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay showed a normal copy number, which rules out the SMN1 deletion. This leaves us with the following possible mutations: COL1A1 mutation, DMD mutation, and CFTR mutation.\n\nThe next logical step is to use an assay that can detect specific sequence variants. **Next-Generation Sequencing (NGS)** is a comprehensive and efficient method for this purpose, as it can detect a wide range of genetic variants and help us rule out or confirm the presence of specific mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS assay showed no variants detected, this rules out both the COL1A1 mutation and the CFTR mutation. This leaves us with the DMD mutation as the only possible remaining mutation.\n\nTo confirm the DMD mutation, we can use **Fluorescence In Situ Hybridization (FISH)**, which is effective in detecting deletions and other structural variations in the DMD gene.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay detected a deletion, which confirms the presence of a DMD mutation. Given the results from the previous assays, we can confidently identify the genetic mutation responsible for the observed trait.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6251, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Next-generation sequencing (NGS)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state, the best first step is to use an assay that can potentially rule out multiple mutations with a single test. The 'Multiplex ligation-dependent probe amplification (MLPA)' is a good choice because it can detect copy number variations, which are relevant to the SMN1 deletion and DMD mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA results showed a normal copy number, we can rule out the SMN1 deletion. This leaves us with the following possible mutations: COL1A1 mutation, DMD mutation, and CFTR mutation.\n\nNext, we should use an assay that can provide more specific information about these remaining mutations. The 'Next-generation sequencing (NGS)' is a comprehensive assay that can detect a wide range of genetic variants, making it a good choice for this step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS results showed no variants detected, we can rule out the COL1A1 mutation and the CFTR mutation. This leaves us with the DMD mutation as the only remaining possibility.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4405, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Next-generation sequencing (NGS)", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial list of genetic mutations and the available assays, a good starting point is to use an assay that can provide broad and initial insights. The Multiplex Ligation-Dependent Probe Amplification (MLPA) is suitable for this purpose because it can detect copy number variations, which can help rule out the SMN1 deletion quickly.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Given the observation from the MLPA assay, which indicates a normal copy number, we can rule out the SMN1 deletion. This leaves us with three potential genetic mutations: COL1A1 mutation, DMD mutation, and CFTR mutation. \n\nNext, we should use an assay that can provide information to further narrow down the possibilities. The Next-Generation Sequencing (NGS) is a comprehensive assay that can detect a wide range of genetic variants, making it a good choice for the next step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Given the observation from the NGS assay, which indicates no variants detected, we can rule out the COL1A1 mutation and the CFTR mutation. This leaves us with the DMD mutation as the only remaining possibility.\n\nTo confirm this, we can use the Fluorescence In Situ Hybridization (FISH) assay, which is particularly effective in detecting deletions and can help confirm the presence or absence of a DMD mutation.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Given the observation from the FISH assay, which indicates a deletion detected, we can confidently identify the DMD mutation as the responsible genetic mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6212, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Next-generation sequencing (NGS)", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game, I will start by using an assay that can provide broad information to help narrow down the list of possible genetic mutations. The **Multiplex Ligation-Dependent Probe Amplification (MLPA)** is a good choice for this purpose because it can detect copy number variations, which are particularly relevant for identifying the presence of an SMN1 deletion.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the Multiplex Ligation-Dependent Probe Amplification (MLPA) assay, which showed a normal copy number, we can rule out the **SMN1 deletion**. This leaves us with the following possible genetic mutations: **COL1A1 mutation**, **DMD mutation**, and **CFTR mutation**.\n\nNext, I will use the **Next-Generation Sequencing (NGS)** assay, which can provide comprehensive profiling of genetic variants and help us further narrow down the list of possible mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Given that the Next-Generation Sequencing (NGS) assay did not detect any variants, we can rule out **COL1A1 mutation** and **CFTR mutation**. This leaves us with the **DMD mutation** as the only remaining possible genetic mutation.\n\nTo confirm this, I will use the **Fluorescence In Situ Hybridization (FISH)** assay, which can detect deletions and is particularly useful for identifying DMD mutations.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The Fluorescence In Situ Hybridization (FISH) assay detected a deletion, which confirms the presence of a **DMD mutation**. Since this is the only remaining possible genetic mutation and the FISH result is consistent with a DMD mutation, I am confident in identifying the mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6300, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Next-generation sequencing (NGS)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game, the most efficient first step is to perform an assay that can quickly eliminate a significant number of possibilities. The Multiplex Ligation-Dependent Probe Amplification (MLPA) is a good choice because it can detect copy number variations, which would help rule out the SMN1 deletion if no variations are detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result indicates a normal copy number, which rules out the SMN1 deletion. The remaining possible mutations are COL1A1 mutation, DMD mutation, and CFTR mutation. \n\nNext, I will perform Next-Generation Sequencing (NGS) to detect any variants in the remaining genes.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The NGS result indicates no variants detected, which rules out both the COL1A1 mutation and the CFTR mutation. The only remaining possible mutation is the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4352, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}], "seed": 20, "average_actions": 4.6, "average_tokens": 5504.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.6, "average_successful_tokens": 5504.0}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "ELISA", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will use the **Multiplex ligation-dependent probe amplification (MLPA)** assay because it can help determine if there are copy number variations, which would be indicative of the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result shows a normal copy number, which excludes the UBE3A mutation. Now, I will perform an **Enzyme assay** to check for G6PD activity levels.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result shows an activity level of 84.27616729080269, which is within the normal range (75-100). This excludes the G6PD deficiency mutation.\n\nNext, I will perform an **ELISA** to check for leptin concentration levels.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a concentration level of 14.634062429553104, which is in the range of 0-25. This excludes the LEP mutation.\n\nGiven that we have excluded UBE3A mutation, G6PD deficiency mutation, and LEP mutation, the only remaining mutation is GJB2 mutation. To confirm, I will perform **DNA sequencing**.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing result shows that mutations were detected, which confirms the presence of a GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7265, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 84.27616729080269}, {"action": "ELISA", "observation": 14.634062429553104}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "ELISA", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Based on the initial state, I will start by performing the **Multiplex ligation-dependent probe amplification (MLPA)** assay. This assay can help determine if there are any copy number variations that might exclude the **UBE3A mutation**.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the MLPA assay shows a normal copy number, which excludes the **UBE3A mutation**. The remaining possible mutations are **G6PD deficiency mutation**, **LEP mutation**, and **GJB2 mutation**.\n\nNext, I will perform the **Enzyme assay** to check for enzyme activity levels, which can help exclude the **G6PD deficiency mutation**.\n\n<ANSWER> Enzyme assay </ANSWER>", "The observation from the Enzyme assay shows an activity level of 84.27616729080269, which is within the normal range (75-100). This excludes the **G6PD deficiency mutation**. The remaining possible mutations are **LEP mutation** and **GJB2 mutation**.\n\nNext, I will perform the **ELISA** assay to check for leptin concentration levels, which can help exclude the **LEP mutation**.\n\n<ANSWER> ELISA </ANSWER>", "The observation from the ELISA assay shows a concentration level of 14.634062429553104, which is below the normal range (0-25). This excludes the **LEP mutation**. The remaining possible mutation is **GJB2 mutation**.\n\nTo confirm, I will perform **DNA sequencing** to check for specific nucleotide alterations.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing assay detected mutations, which is consistent with the **GJB2 mutation**. Given that this is the only remaining possible mutation, I can confidently predict that the genetic mutation responsible for the observed trait is the **GJB2 mutation**.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7572, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 84.27616729080269}, {"action": "ELISA", "observation": 14.634062429553104}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "ELISA", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, we should use an assay that can potentially eliminate the most mutations in one step. The Multiplex Ligation-Dependent Probe Amplification (MLPA) is a good choice because it can detect copy number variations, which are often associated with the UBE3A mutation. This will help us rule out the UBE3A mutation if the result is normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA result shows a normal copy number, we can exclude the UBE3A mutation. This leaves us with G6PD deficiency mutation, LEP mutation, and GJB2 mutation.\n\nNext, we should use the Enzyme assay to check for G6PD enzyme activity. If the activity level is normal (75-100), we can exclude the G6PD deficiency mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 84.27616729080269 falls within the normal range (75-100), so we can exclude the G6PD deficiency mutation. This leaves us with LEP mutation and GJB2 mutation.\n\nNext, we should use the ELISA assay to check for leptin concentration. If the concentration level is normal (75-100), we can exclude the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 14.634062429553104 falls within the range that excludes the LEP mutation (0-25). This leaves us with the GJB2 mutation as the only remaining possibility.\n\nTo confirm, we can use DNA sequencing to check for mutations in the GJB2 gene. If no mutations are detected, we can rule out the GJB2 mutation. However, if mutations are detected, we can confidently identify the GJB2 mutation as the correct one.\n\n<ANSWER> DNA sequencing </ANSWER>", "Since DNA sequencing detected mutations, we can confidently identify the GJB2 mutation as the correct one.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7728, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 84.27616729080269}, {"action": "ELISA", "observation": 14.634062429553104}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "ELISA", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Let's start by using the **Multiplex Ligation-Dependent Probe Amplification (MLPA)** assay. This assay can help us determine if there is a copy number variation, which is a key indicator for the UBE3A mutation. If the MLPA results show a normal copy number, we can rule out the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA results show a normal copy number, which allows us to rule out the UBE3A mutation. The remaining possible mutations are G6PD deficiency mutation, LEP mutation, and GJB2 mutation.\n\nNext, let's perform an **Enzyme assay** to check for the activity level of the G6PD enzyme. If the activity level is within the normal range (75-100), we can rule out the G6PD deficiency mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay results show an activity level of 84.27616729080269, which is within the normal range (75-100). This allows us to rule out the G6PD deficiency mutation.\n\nThe remaining possible mutations are LEP mutation and GJB2 mutation.\n\nNext, let's perform an **ELISA** to check the concentration level of leptin. If the concentration level is within the normal range (75-100), we can rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA results show a concentration level of 14.634062429553104, which is in the range of 0-25. This allows us to rule out the LEP mutation.\n\nThe only remaining possible mutation is the GJB2 mutation.\n\nTo confirm, let's perform a **DNA sequencing** assay. If no mutations are detected, we can rule out the GJB2 mutation. However, if mutations are detected, we can confidently identify the GJB2 mutation.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing results show that mutations are detected. Given that the only remaining possible mutation is the GJB2 mutation, we can confidently identify it as the responsible mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7814, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 84.27616729080269}, {"action": "ELISA", "observation": 14.634062429553104}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Enzyme assay", "ELISA", "DNA sequencing", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["Given the initial state and the available options, I will start by performing the **Multiplex ligation-dependent probe amplification (MLPA)** assay. This assay can help me quickly determine if there is a copy number variation, which is particularly relevant for the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay has shown a normal copy number, which excludes the UBE3A mutation. Therefore, the remaining possible mutations are G6PD deficiency mutation, LEP mutation, and GJB2 mutation.\n\nNext, I will perform an **Enzyme assay** to check for G6PD enzyme activity, which will help me rule out the G6PD deficiency mutation if the activity level is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 84.27616729080269 indicates a normal G6PD enzyme activity level (75-100), which excludes the G6PD deficiency mutation. Therefore, the remaining possible mutations are LEP mutation and GJB2 mutation.\n\nNext, I will perform an **ELISA** to check for leptin concentration, which will help me rule out the LEP mutation if the concentration level is within the normal range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 14.634062429553104 indicates a concentration level (0-25), which excludes the LEP mutation. Therefore, the remaining possible mutation is the GJB2 mutation.\n\nTo confirm this, I will perform **DNA sequencing** to check for specific mutations in the GJB2 gene.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing result confirms that mutations are detected in the GJB2 gene. Therefore, the genetic mutation responsible for the trait is the GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7585, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Enzyme assay", "observation": 84.27616729080269}, {"action": "ELISA", "observation": 14.634062429553104}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}], "seed": 21, "average_actions": 6.0, "average_tokens": 7592.8, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 6.0, "average_successful_tokens": 7592.8}
{"trajectories": [{"actions": ["Enzyme assay", "Protein truncation test", "Next-generation sequencing (NGS)", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["To start, I will perform an enzyme assay to check for the activity levels of specific enzymes, which can help rule out the PAH mutation if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 82.77%, which is within the normal range (75-100%). Based on this result, we can rule out the PAH mutation.\n\nRemaining genetic mutations: ['CFTR mutation', 'APC gene mutation', 'HBB mutation']\n\nNext, I will perform a protein truncation test to check for truncated proteins, which can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "The protein truncation test detected truncated proteins, which suggests that the APC gene mutation is a strong candidate. However, this test does not completely rule out other mutations, so I will perform next-generation sequencing (NGS) to further narrow down the possibilities.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The next-generation sequencing (NGS) did not detect any variants, which means we can rule out CFTR and HBB mutations. \n\nRemaining genetic mutations: ['APC gene mutation']\n\nGiven the previous observations, the only remaining mutation is the APC gene mutation. Therefore, I will predict that the genetic mutation responsible for the trait is the APC gene mutation.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 5569, "observations": [null, {"action": "Enzyme assay", "observation": 82.76703011645351}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Protein truncation test", "High-resolution melt analysis (HRM)", "Next-generation sequencing (NGS)", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["Given the initial state, the best strategy is to perform an assay that can potentially rule out multiple genetic mutations at once. The **Enzyme assay** is a good choice because it can specifically rule out the PAH mutation if the enzyme activity is normal (75-100% activity). This will help narrow down the list of possible mutations.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 82.77%, which is within the 75-100% range. According to the guidebook, this means the PAH mutation can be ruled out.\n\nThe remaining possible genetic mutations are:\n- CFTR mutation\n- APC gene mutation\n- HBB mutation\n\nNext, I will perform the **Protein truncation test** to see if the APC gene mutation can be ruled out.\n\n<ANSWER> Protein truncation test </ANSWER>", "The protein truncation test detected truncated proteins, which means the APC gene mutation is still a possibility and cannot be ruled out. \n\nSince the APC gene mutation is still a viable candidate and we need to narrow down further, the next best step is to perform **High-resolution melt analysis (HRM)** to see if the CFTR mutation can be ruled out.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The high-resolution melt analysis (HRM) detected abnormal melting curves, which means the CFTR mutation is still a possibility and cannot be ruled out. \n\nGiven that both the APC gene mutation and CFTR mutation are still possible, the next best step is to perform **Next-generation sequencing (NGS)** to see if we can rule out the CFTR mutation or the HBB mutation.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The next-generation sequencing (NGS) did not detect any variants, which means the CFTR and HBB mutations can be ruled out.\n\nThe remaining possible genetic mutation is:\n- APC gene mutation\n\nSince we have ruled out all other mutations, the only plausible mutation left is the APC gene mutation.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 7499, "observations": [null, {"action": "Enzyme assay", "observation": 82.76703011645351}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "Abnormal melting curves detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Next-generation sequencing (NGS)", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to check the activity levels of the enzyme, which can help rule out the PAH mutation if the activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 82.77%, which is within the range of 75-100% activity. This means the PAH mutation is ruled out.\n\nNow, I will perform a **Next-Generation Sequencing (NGS)** to check for variants in the remaining possible mutations: CFTR, APC, and HBB.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by the Next-Generation Sequencing (NGS), the CFTR and HBB mutations are ruled out. This leaves us with the **APC gene mutation** as the only remaining possibility.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 3954, "observations": [null, {"action": "Enzyme assay", "observation": 82.76703011645351}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", null], "generated_text": ["To start, I will use the Enzyme assay to check for PAH mutations, as it is a specific test that can rule out this mutation if the enzyme activity is within normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 82.77%, which is within the range of 75-100% activity. According to the guidebook, this result rules out the PAH mutation.\n\nRemaining possible genetic mutations: ['CFTR mutation', 'APC gene mutation', 'HBB mutation']\n\nNext, I will use the Protein Truncation Test to check for the APC gene mutation.\n\n<ANSWER> Protein Truncation Test </ANSWER>"], "consumed_tokens": 2541, "observations": [null, {"action": "Enzyme assay", "observation": 82.76703011645351}], "successful": false, "parse_error": true}, {"actions": ["Enzyme assay", "Next-generation sequencing (NGS)", "Protein truncation test", "APC gene mutation", {"predicted_truth": "APC gene mutation"}], "generated_text": ["Given the initial state of the game, the most efficient first step would be to perform an assay that can potentially rule out multiple genetic mutations. The **Enzyme assay** is a good choice because it can directly rule out PAH mutations if the enzyme activity is within the normal range (75-100%).\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 82.767% falls within the normal range (75-100%), which means the PAH mutation can be ruled out. \n\nGiven this information, we now have the following possible genetic mutations:\n- CFTR mutation\n- APC gene mutation\n- HBB mutation\n\nNext, we should perform an assay that can help us further narrow down the possibilities. The **Next-generation sequencing (NGS)** assay is a good choice because it can rule out CFTR and HBB mutations if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The observation from the Next-generation sequencing (NGS) assay shows that no variants were detected. This means we can rule out CFTR and HBB mutations.\n\nThe remaining possible genetic mutation is:\n- APC gene mutation\n\nTo confirm the APC gene mutation, we can perform the **Protein truncation test**. This assay is specifically useful for identifying truncated proteins, which would indicate a mutation in the APC gene.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein truncation test detected truncated proteins, which confirms the presence of an APC gene mutation.\n\nGiven the results of the assays, we can confidently identify the genetic mutation.\n\n<ANSWER> APC gene mutation </ANSWER>"], "consumed_tokens": 5772, "observations": [null, {"action": "Enzyme assay", "observation": 82.76703011645351}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}], "successful": true, "parse_error": false}], "seed": 22, "average_actions": 4.4, "average_tokens": 5067.0, "average_correct": 0.8, "average_parse_error": 0.2, "average_successful_action_num": 5.0, "average_successful_tokens": 5698.5}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Protein truncation test", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will use the Next-Generation Sequencing (NGS) assay because it can provide comprehensive information about multiple genes at once, helping to rule out several potential mutations efficiently.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-Generation Sequencing (NGS) assay results indicate that no variants were detected. According to the guidebook, this rules out the BRCA2 mutation and GJB2 mutation.\n\nNow, the remaining possible mutations are:\n- APC gene mutation\n- FMR1 gene expansion\n\nNext, I will use the Protein Truncation Test to further narrow down the possibilities.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test results indicate that no truncated proteins were detected. According to the guidebook, this rules out the APC gene mutation.\n\nNow, the only remaining possible mutation is:\n- FMR1 gene expansion\n\nTo confirm this, I will use the Southern Blot assay to detect the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot assay has confirmed the presence of an expanded fragment, which indicates the FMR1 gene expansion.\n\nSince this is the only remaining possible mutation and it has been confirmed by the assay, I will predict the truth.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5232, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Protein truncation test", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will use **Next-generation sequencing (NGS)** to rule out multiple mutations in one step. This assay can help me eliminate **BRCA2 mutation** and **GJB2 mutation** if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS assay showed no variants detected, we can rule out **BRCA2 mutation** and **GJB2 mutation**. This leaves us with **APC gene mutation** and **FMR1 gene expansion**.\n\nNext, I will use the **Protein truncation test** to further narrow down the possibilities. If no truncated proteins are detected, it will rule out **APC gene mutation**.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since the Protein truncation test showed no truncated proteins detected, we can rule out **APC gene mutation**. This leaves us with **FMR1 gene expansion**.\n\nTo confirm, I will use the **Southern blot** assay. If a normal-sized fragment is detected, it will rule out **FMR1 gene expansion**. Otherwise, it will confirm the presence of the mutation.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot assay detected an expanded fragment, confirming the presence of an **FMR1 gene expansion**. This mutation is associated with Fragile X syndrome.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5308, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Protein truncation test", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I'll choose an assay that can potentially rule out multiple genetic mutations at once. The **Next-Generation Sequencing (NGS)** is a comprehensive assay that can help narrow down the list efficiently.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-Generation Sequencing (NGS) assay, \"No variants detected,\" we can rule out the BRCA2 mutation and GJB2 mutation. \n\nThe remaining possible genetic mutations are:\n- APC gene mutation\n- FMR1 gene expansion\n\nTo further narrow it down, I'll perform a **Protein Truncation Test** next, as it can specifically rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the observation from the Protein Truncation Test, \"No truncated proteins detected,\" we can rule out the APC gene mutation.\n\nThe remaining possible genetic mutation is:\n- FMR1 gene expansion\n\nTo confirm this, I'll perform a **Southern Blot** to detect the presence of a normal-sized fragment or an expansion.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern Blot, an \"Expanded fragment detected\" confirms the presence of an FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5286, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Protein truncation test", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform the most comprehensive test available to gather a broad range of information. The Next-Generation Sequencing (NGS) can help rule out multiple mutations in a single step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-Generation Sequencing (NGS) test, the following mutations have been ruled out:\n- **BRCA2 mutation**\n- **GJB2 mutation**\n\nThis leaves us with two possible mutations:\n- **APC gene mutation**\n- **FMR1 gene expansion**\n\nTo further narrow down the options, I will perform the Protein Truncation Test next.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test result of \"No truncated proteins detected\" rules out the **APC gene mutation**.\n\nThis leaves us with only one possible mutation:\n- **FMR1 gene expansion**\n\nTo confirm, I will perform a Southern Blot to check for the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot detected an expanded fragment, confirming the presence of the **FMR1 gene expansion**.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5215, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Protein truncation test", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will use a broad-spectrum assay to rule out multiple mutations at once. The Next-Generation Sequencing (NGS) is a comprehensive method that can detect multiple genetic mutations simultaneously.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-Generation Sequencing (NGS) assay, \"No variants detected,\" we can rule out the BRCA2 mutation and GJB2 mutation. This leaves us with the APC gene mutation and FMR1 gene expansion as the remaining possible mutations.\n\nNext, I will perform the Protein Truncation Test to further narrow down the possibilities.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the observation from the Protein Truncation Test, \"No truncated proteins detected,\" we can rule out the APC gene mutation. This leaves us with the FMR1 gene expansion as the remaining possible mutation.\n\nTo confirm this, I will perform a Southern Blot to check for the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern Blot, \"Expanded fragment detected,\" we can confirm that the genetic mutation responsible is the FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5219, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}], "seed": 23, "average_actions": 5.0, "average_tokens": 5252.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 5252.0}
{"trajectories": [{"actions": ["Southern blot", "ELISA", "Sanger sequencing", "Western blot", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, I will use the Southern blot assay to check for the presence of an expanded HTT gene, which is a key indicator of Huntington's disease. This will help me rule out the HTT gene expansion if the fragment is normal-sized.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot assay revealed a normal-sized fragment, ruling out the HTT gene expansion. Now, I will use the ELISA assay to check the protein concentration, which can help rule out the LEP mutation if the concentration is within the normal range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA assay showed a protein concentration of 11.034, which is within the range of 0-25 units. This rules out the LEP mutation.\n\nNext, I will use the Sanger sequencing assay to check for mutations in the BRCA1 gene. This will help me determine if the BRCA1 mutation can be excluded.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing assay showed no mutations detected, ruling out the BRCA1 mutation.\n\nAt this point, the only remaining genetic mutation is the UBE3A mutation. I will use the Western blot assay to check for the presence of the UBE3A protein, which can help confirm or rule out the UBE3A mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot assay detected a protein of the expected size, which does not rule out the UBE3A mutation but does not provide conclusive evidence. Since the only remaining mutation is UBE3A, I will predict that the genetic mutation is the UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 8252, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 11.034443875357564}, {"action": "Sanger sequencing", "observation": "No mutations detected"}, {"action": "Western blot", "observation": "Protein of expected size detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "ELISA", "Sanger sequencing", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the list of possible genetic mutations, the first step is to rule out the most distinctive mutation. The HTT gene expansion can be easily identified or ruled out using the Southern blot assay due to its unique characteristic of an expanded fragment.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot assay revealed a normal-sized fragment, we can rule out the HTT gene expansion. This leaves us with three possible mutations: UBE3A mutation, BRCA1 mutation, and LEP mutation. \n\nNext, we can use the ELISA assay to measure protein concentration, which can help us rule out the LEP mutation if the protein concentration is within a normal range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA assay result shows a protein concentration of 11.034443875357564 units, which falls between 0-25 units. This range allows us to rule out the LEP mutation, as it indicates normal leptin production.\n\nWe are now left with two possible mutations: UBE3A mutation and BRCA1 mutation. To further narrow it down, we can use Sanger sequencing to check for specific mutations in the BRCA1 gene.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Since Sanger sequencing did not detect any mutations in the BRCA1 gene, we can rule out the BRCA1 mutation. This leaves us with only one possible mutation: UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 6493, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 11.034443875357564}, {"action": "Sanger sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "ELISA", "Sanger sequencing", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, I will perform a Southern blot to check for the HTT gene expansion. This will help me rule out the HTT gene expansion if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot detected a normal-sized fragment, we can rule out the HTT gene expansion. The remaining possible mutations are UBE3A mutation, BRCA1 mutation, and LEP mutation.\n\nNext, I will perform an ELISA to check the protein concentration, which can help rule out the LEP mutation if the concentration is between 0-25 units.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a protein concentration of 11.034443875357564 units, which falls between 0-25 units. This allows us to rule out the LEP mutation, as it suggests normal leptin production.\n\nThe remaining possible mutations are UBE3A mutation and BRCA1 mutation.\n\nNext, I will perform a Sanger sequencing to check for mutations in the BRCA1 gene. If no mutations are detected, we can rule out the BRCA1 mutation.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Since no mutations were detected in the Sanger sequencing, we can rule out the BRCA1 mutation. The remaining possible mutation is the UBE3A mutation.\n\nGiven that all other mutations have been ruled out, I will predict that the genetic mutation is the UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 6470, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 11.034443875357564}, {"action": "Sanger sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "ELISA", "Sanger sequencing", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the initial state, the most informative assay to start with is the **Southern blot**. This is because it can directly detect the presence or absence of an expanded fragment in the HTT gene, which would allow us to quickly rule out the HTT gene expansion if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot assay showed a normal-sized fragment, which rules out the HTT gene expansion. This leaves us with three possible mutations: UBE3A mutation, BRCA1 mutation, and LEP mutation.\n\nNext, I will perform the **ELISA** assay to measure protein concentrations, which can help rule out the LEP mutation if the protein concentration is within the normal range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA assay result of 11.034443875357564 units is within the 0-25 units range, which rules out the LEP mutation. This leaves us with two possible mutations: UBE3A mutation and BRCA1 mutation.\n\nNext, I will perform **Sanger sequencing** to determine if there are any detectable mutations in the BRCA1 gene.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing assay did not detect any mutations in the BRCA1 gene, which rules out the BRCA1 mutation. This leaves us with only one possible mutation: UBE3A mutation.\n\nGiven the results from the previous assays, the remaining plausible mutation is the UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 6533, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 11.034443875357564}, {"action": "Sanger sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "ELISA", "Sanger sequencing", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, I will use the Southern blot to check for the HTT gene expansion, as this assay can specifically rule out the presence of an expanded fragment in the HTT gene.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot observed a normal-sized fragment, we can rule out the HTT gene expansion. Now, I will perform an ELISA to check for the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 11.034443875357564 units is within the range of 0-25 units, which rules out the LEP mutation. Now, I will perform Sanger sequencing to check for the BRCA1 mutation.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Since Sanger sequencing detected no mutations, we can rule out the BRCA1 mutation. This leaves us with the UBE3A mutation as the only remaining possibility.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 6228, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 11.034443875357564}, {"action": "Sanger sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}], "seed": 24, "average_actions": 5.2, "average_tokens": 6795.2, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.2, "average_successful_tokens": 6795.2}
{"trajectories": [{"actions": ["Tandem repeat PCR", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["Given the initial state, the most informative assay to start with would be **Tandem Repeat PCR**. This assay is specifically designed to detect CAG repeat expansions, which are characteristic of the HTT gene expansion mutation. If the result shows a normal number of repeats, we can rule out the HTT gene expansion mutation. If it shows an expanded range, we can further investigate.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result of 127.90264171909645 repeats indicates an expansion, which is characteristic of the HTT gene expansion mutation. This strongly suggests that the genetic mutation responsible for the observed trait is the HTT gene expansion. Given this clear result, we can confidently predict the truth.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 2527, "observations": [null, {"action": "Tandem repeat PCR", "observation": 127.90264171909645}], "successful": false, "parse_error": false}, {"actions": ["Southern blot", "Tandem repeat PCR", "Sanger sequencing", "Next-generation sequencing (NGS)", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, let's use an assay that can help us narrow down the list of possible genetic mutations. The `Southern blot` assay can detect the HTT gene expansion, which is a unique mutation characterized by an expansion of CAG repeats. This will allow us to rule out the HTT gene expansion if the result is normal.\n\n<ANSWER> Southern blot </ANSWER>", "The `Southern blot` assay result shows a normal-sized fragment, which rules out the HTT gene expansion. This leaves us with the following possible genetic mutations: 'BRCA2 mutation', 'BRCA1 mutation', and 'GJB2 mutation'.\n\nNext, let's use the `Tandem repeat PCR` assay to further narrow down the possibilities. This assay is specifically designed to detect expansions in repeat sequences, and since we have already ruled out HTT gene expansion, this assay can help us confirm that the remaining mutations do not involve repeat expansions.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The `Tandem repeat PCR` assay result shows a repeat count of 127.90264171909645, which is well above the normal range of (0, 30) repeats. This indicates that there is an expansion of repeats, but since we have already ruled out the HTT gene expansion with the `Southern blot` assay, this result is not consistent with the remaining mutations in our list.\n\nGiven this result, it seems there might be an error or an unexpected finding. However, based on the available assays and the current list of mutations, the most logical next step is to use `Sanger sequencing` to directly sequence the DNA and look for mutations in the remaining genes: BRCA2, BRCA1, and GJB2.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The `Sanger sequencing` assay result shows no mutations detected, which rules out BRCA1 and BRCA2 mutations. This leaves us with the `GJB2 mutation` as the only remaining possibility.\n\nTo confirm this, we can use the `Next-generation sequencing (NGS)` assay, which can detect variants in multiple genes, including GJB2.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The `Next-generation sequencing (NGS)` assay detected variants, which confirms that there is a mutation in one of the tested genes. Since the only remaining possibility is the `GJB2 mutation`, we can confidently predict that the genetic mutation responsible for the trait is the `GJB2 mutation`.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7562, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Tandem repeat PCR", "observation": 127.90264171909645}, {"action": "Sanger sequencing", "observation": "No mutations detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Southern blot", "Sanger sequencing", "Next-generation sequencing (NGS)", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To begin, I will perform a **Tandem Repeat PCR** assay. This assay is particularly useful for detecting the number of CAG repeats in the HTT gene, which is a key indicator of Huntington's disease. If the number of repeats is within the normal range, we can rule out the HTT gene expansion mutation.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR assay detected 127.90264171909645 CAG repeats, which is significantly above the normal range (30 repeats). This strongly suggests that the mutation is the **HTT gene expansion**. \n\nTo confirm this, I will perform a **Southern Blot** assay, which can detect the expanded fragment of the HTT gene.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot assay detected a normal-sized fragment, which rules out the HTT gene expansion. This means the mutation is not the HTT gene expansion.\n\nNext, I will perform a **Sanger sequencing** assay to check for mutations in the BRCA1 and BRCA2 genes.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing assay detected no mutations, which rules out BRCA1 and BRCA2 mutations. This leaves us with the **GJB2 mutation** as the only remaining possibility.\n\nTo confirm, I will perform a **Next-generation sequencing (NGS)** assay, which can detect variants in the GJB2 gene.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-generation sequencing (NGS) assay detected variants, which confirms the presence of a mutation in the GJB2 gene. Given that all other mutations have been ruled out, I can confidently predict that the genetic mutation responsible for the trait is the **GJB2 mutation**.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7144, "observations": [null, {"action": "Tandem repeat PCR", "observation": 127.90264171909645}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Sanger sequencing", "observation": "No mutations detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Southern blot", "Sanger sequencing", "Next-generation sequencing (NGS)", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will perform a **Tandem Repeat PCR** to check for the number of CAG repeats in the HTT gene. This will help me determine if the HTT gene expansion is present, which is a specific and critical mutation to rule out early.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of the Tandem Repeat PCR shows 127.90264171909645 repeats, which is within the pathogenic range (30, 200) for the HTT gene expansion. This strongly suggests that the genetic mutation is likely the HTT gene expansion.\n\nTo confirm this, I will perform a **Southern blot** to verify the presence of an expanded fragment.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which rules out the HTT gene expansion. Since the Tandem Repeat PCR indicated a high number of repeats, but the Southern blot shows a normal fragment, we need to investigate further to rule out the other mutations.\n\nNext, I will perform a **Sanger sequencing** to check for mutations in the BRCA1 and BRCA2 genes.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing result shows no mutations detected, which rules out BRCA1 and BRCA2 mutations. Since the HTT gene expansion has also been ruled out, the remaining possibility is a GJB2 mutation.\n\nTo confirm this, I will perform a **Next-generation sequencing (NGS)** to check for mutations in the GJB2 gene.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-generation sequencing (NGS) results show variants detected, which confirms the presence of a mutation in the GJB2 gene. Given that all other mutations have been ruled out, the remaining genetic mutation is the GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 7164, "observations": [null, {"action": "Tandem repeat PCR", "observation": 127.90264171909645}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Sanger sequencing", "observation": "No mutations detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Sanger sequencing", "Next-generation sequencing (NGS)", "GJB2 mutation", {"predicted_truth": "GJB2 mutation"}], "generated_text": ["To start, I will perform a **Southern blot** to check for the presence of an expanded fragment, which is a key indicator of the HTT gene expansion associated with Huntington's disease. This will help me rule out the HTT gene expansion if the fragment is normal-sized.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which rules out the HTT gene expansion. Therefore, the remaining possible genetic mutations are 'BRCA2 mutation', 'BRCA1 mutation', and 'GJB2 mutation'.\n\nNext, I will perform **Sanger sequencing** to check for mutations in the BRCA1 and BRCA2 genes. This will help me rule out these mutations if no variants are detected.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing result shows no mutations detected, which rules out BRCA1 and BRCA2 mutations. Therefore, the remaining possible genetic mutation is 'GJB2 mutation'.\n\nI will now perform **Next-generation sequencing (NGS)** to confirm the presence of variants in the GJB2 gene.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-generation sequencing (NGS) result shows variants detected, confirming the presence of a mutation in the GJB2 gene.\n\nGiven the results from the previous assays, the only remaining and confirmed mutation is the GJB2 mutation.\n\n<ANSWER> GJB2 mutation </ANSWER>"], "consumed_tokens": 5379, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Sanger sequencing", "observation": "No mutations detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}], "successful": true, "parse_error": false}], "seed": 25, "average_actions": 5.2, "average_tokens": 5955.2, "average_correct": 0.8, "average_parse_error": 0.0, "average_successful_action_num": 5.75, "average_successful_tokens": 6812.25}
{"trajectories": [{"actions": ["Enzyme assay", "DNA sequencing", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an **Enzyme assay** to quickly rule out the **G6PD deficiency mutation** if the enzyme activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 94.65761085832469 rules out the **G6PD deficiency mutation**. The remaining possible mutations are:\n\n- BRCA1 mutation\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, I will perform a **DNA sequencing** to rule out **BRCA1 mutation** and **MTHFR mutation** if no mutations are detected.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing result of \"No mutations detected\" rules out the **BRCA1 mutation** and **MTHFR mutation**. The only remaining possible mutation is **FMR1 gene expansion**.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 3728, "observations": [null, {"action": "Enzyme assay", "observation": 94.65761085832469}, {"action": "DNA sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an Enzyme Assay to check for G6PD deficiency, as this test can quickly rule out one of the possible mutations if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme Assay result shows an activity level of 94.65761085832469, which is between 75 and 100. This rules out the G6PD deficiency mutation. \n\nThe remaining possible mutations are:\n- BRCA1 mutation\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, I will perform a Southern Blot to check for the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot result shows an expanded fragment detected, which indicates the presence of the FMR1 gene expansion. \n\nGiven this result, the remaining possible mutation is:\n- FMR1 gene expansion\n\nI will predict the truth based on the current evidence.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 3759, "observations": [null, {"action": "Enzyme assay", "observation": 94.65761085832469}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an **Enzyme Assay**. This assay can quickly rule out the G6PD deficiency mutation if the enzyme activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 94.65761085832469, which is between 75 and 100. This result rules out the G6PD deficiency mutation.\n\nNow, the remaining possible genetic mutations are:\n- BRCA1 mutation\n- FMR1 gene expansion\n- MTHFR mutation\n\nNext, I will perform a **Southern Blot** to check for the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot detected an expanded fragment, which indicates the presence of the FMR1 gene expansion. This result strongly suggests that the genetic mutation is the FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 3738, "observations": [null, {"action": "Enzyme assay", "observation": 94.65761085832469}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "DNA sequencing", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an Enzyme Assay to check the enzyme activity levels. This will help me rule out the G6PD deficiency mutation if the activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 94.66, which is between 75 and 100. This rules out the G6PD deficiency mutation.\n\nNow, I will perform DNA sequencing to check for mutations in the remaining genes.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing result shows no mutations detected, which rules out the BRCA1 mutation and the MTHFR mutation. The only remaining possibility is the FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 3632, "observations": [null, {"action": "Enzyme assay", "observation": 94.65761085832469}, {"action": "DNA sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "DNA sequencing", "Southern blot", "FMR1 gene expansion", {"predicted_truth": "FMR1 gene expansion"}], "generated_text": ["To start, I will perform an **Enzyme assay** to check for the activity levels, which can help rule out the G6PD deficiency mutation if the activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 94.66, which falls between 75 and 100. This result rules out the G6PD deficiency mutation.\n\nNow, I will perform a **DNA sequencing** to further narrow down the possible mutations.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing result shows \"No mutations detected,\" which rules out both the BRCA1 mutation and the MTHFR mutation.\n\nGiven the remaining possible mutation is the FMR1 gene expansion, I will perform a **Southern blot** to confirm or rule out this mutation.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows an expanded fragment detected, which confirms the presence of the FMR1 gene expansion.\n\nGiven the results, I can confidently predict that the genetic mutation is the FMR1 gene expansion.\n\n<ANSWER> FMR1 gene expansion </ANSWER>"], "consumed_tokens": 5060, "observations": [null, {"action": "Enzyme assay", "observation": 94.65761085832469}, {"action": "DNA sequencing", "observation": "No mutations detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}], "seed": 26, "average_actions": 4.2, "average_tokens": 3983.4, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.2, "average_successful_tokens": 3983.4}
{"trajectories": [{"actions": ["Protein truncation test", "Allele-specific oligonucleotide hybridization", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["To start, let's use an assay that can potentially eliminate multiple mutations at once. The **Protein Truncation Test** is a good choice because it can rule out both the **BRCA1 mutation** and the **DMD mutation** if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, we can rule out the **BRCA1 mutation** and the **DMD mutation**. This leaves us with the **SERPINA1 mutation** and the **GJB2 mutation**.\n\nNext, let's use the **Allele-specific oligonucleotide hybridization** assay to see if we can further narrow down the possibilities.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Since no hybridization with the mutant probe was observed, we can rule out the **GJB2 mutation**. This leaves us with the **SERPINA1 mutation** as the only remaining possibility.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 3941, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "Allele-specific oligonucleotide hybridization", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["Given the initial state with all four genetic mutations as possibilities, the best first step is to perform an assay that can potentially rule out multiple mutations at once. The **Protein Truncation Test** is a good choice here because it can immediately rule out both **BRCA1 mutation** and **DMD mutation** if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the observation that no truncated proteins were detected, we can rule out both **BRCA1 mutation** and **DMD mutation**. This leaves us with **SERPINA1 mutation** and **GJB2 mutation**.\n\nNext, we should perform an assay that can help us distinguish between these two remaining mutations. The **Allele-specific oligonucleotide hybridization** is a good choice because it can rule out **GJB2 mutation** if no hybridization with the mutant probe is observed.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Since there was no hybridization with the mutant probe in the **Allele-specific oligonucleotide hybridization** assay, we can rule out the **GJB2 mutation**. This leaves us with only **SERPINA1 mutation** as the remaining possibility.\n\nWe can now confidently predict the genetic mutation.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 4061, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "Allele-specific oligonucleotide hybridization", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["Given the initial state and the available assays, I will start with the **Protein Truncation Test**. This assay can potentially rule out both the **BRCA1 mutation** and the **DMD mutation** if no truncated proteins are detected, which would significantly narrow down the list of possible mutations.\n\n<ANSWER> Protein truncation test </ANSWER>", "Given the observation that no truncated proteins were detected, we can rule out both the **BRCA1 mutation** and the **DMD mutation**. This leaves us with the **SERPINA1 mutation** and the **GJB2 mutation**.\n\nNext, I will perform **Allele-specific oligonucleotide hybridization** to further narrow down the possibilities.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Given the observation that there was no hybridization with the mutant probe, we can rule out the **GJB2 mutation**. This leaves us with the **SERPINA1 mutation** as the only remaining possibility.\n\nI will now predict the **SERPINA1 mutation** as the responsible genetic mutation.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 3973, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "DNA sequencing", "Sanger sequencing", "Allele-specific oligonucleotide hybridization", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["To start, I will perform the **Protein Truncation Test**. This test can quickly rule out **BRCA1** and **DMD** mutations if no truncated proteins are detected, which would significantly narrow down the list of possible mutations.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected in the Protein Truncation Test, we can rule out **BRCA1 mutation** and **DMD mutation**. This leaves us with **SERPINA1 mutation** and **GJB2 mutation**.\n\nNext, I will perform **DNA sequencing** to further narrow down the possibilities.\n\n<ANSWER> DNA sequencing </ANSWER>", "Since mutations were detected in the DNA sequencing, we need to determine which of the remaining mutations (**SERPINA1 mutation** or **GJB2 mutation**) is present. \n\nNext, I will perform **Sanger sequencing** to further investigate the detected mutations.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Since mutations were detected in both DNA sequencing and Sanger sequencing, we need to further differentiate between **SERPINA1 mutation** and **GJB2 mutation**. \n\nNext, I will perform **Allele-specific oligonucleotide hybridization** to see if we can rule out **GJB2 mutation**.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Since there was no hybridization with the mutant probe in the Allele-specific oligonucleotide hybridization, we can rule out **GJB2 mutation**. This leaves us with **SERPINA1 mutation** as the only remaining possibility.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 7017, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "DNA sequencing", "observation": "Mutations detected"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "Allele-specific oligonucleotide hybridization", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["Given the initial state of the game, the most informative assay to start with would be the **Protein Truncation Test**. This test can potentially rule out multiple mutations (BRCA1 and DMD) if no truncated proteins are detected, which would significantly narrow down the list of possible mutations.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the observation from the Protein Truncation Test, no truncated proteins were detected, which allows us to rule out the **BRCA1 mutation** and **DMD mutation**. This leaves us with **SERPINA1 mutation** and **GJB2 mutation**.\n\nNext, we can use **Allele-Specific Oligonucleotide Hybridization** to further narrow down the possibilities. This assay can help us rule out the **GJB2 mutation** if no hybridization with the mutant probe is observed.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The observation from the Allele-Specific Oligonucleotide Hybridization test indicates no hybridization with the mutant probe, which allows us to rule out the **GJB2 mutation**. This leaves us with only one possible mutation: **SERPINA1 mutation**.\n\nSince we have only one possible mutation remaining, we can confidently predict the truth.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 4046, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}], "seed": 27, "average_actions": 4.4, "average_tokens": 4607.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.4, "average_successful_tokens": 4607.6}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "DNA sequencing", "Multiplex ligation-dependent probe amplification (MLPA)", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, I will perform an assay that can potentially rule out multiple genetic mutations at once. Next-generation sequencing (NGS) is a comprehensive method that can detect variants across large fragments of DNA, making it a good starting point.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since next-generation sequencing (NGS) detected variants, we can conclude that the mutation is present in one of the remaining genes: CFTR, HBB, or COL1A1. To narrow it down further, I will perform a DNA sequencing assay, which can detect specific mutations in CFTR and HBB.\n\n<ANSWER> DNA sequencing </ANSWER>", "Since DNA sequencing did not detect any mutations in CFTR and HBB, the remaining possibilities are COL1A1 mutation or UBE3A mutation. To further narrow it down, I will perform a multiplex ligation-dependent probe amplification (MLPA) assay, which can help identify copy number variations that are characteristic of the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, the UBE3A mutation is ruled out. The only remaining possibility is the COL1A1 mutation.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 5449, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}, {"action": "DNA sequencing", "observation": "No mutations detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "RFLP analysis", "High-resolution melt analysis (HRM)", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, I will use the Multiplex Ligation-Dependent Probe Amplification (MLPA) to evaluate the copy number variations in the genes. This assay can help rule out the UBE3A mutation if the copy number is normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result shows a normal copy number, which rules out the UBE3A mutation. The remaining possible mutations are CFTR mutation, COL1A1 mutation, and HBB mutation.\n\nNext, I will perform RFLP analysis to check for the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis shows a normal restriction pattern, which rules out the HBB mutation. The remaining possible mutations are CFTR mutation and COL1A1 mutation.\n\nNext, I will perform High-Resolution Melt Analysis (HRM) to check for the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM analysis shows no melting curve abnormalities, which rules out the CFTR mutation. The remaining possible mutation is the COL1A1 mutation.\n\nSince only one mutation remains, I will predict the truth.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 5451, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "RFLP analysis", "Multiplex ligation-dependent probe amplification (MLPA)", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, let's use an assay that can potentially rule out multiple genetic mutations in one step. The 'Next-generation sequencing (NGS)' assay is a comprehensive method that can detect variants across large fragments of DNA, making it a good choice for the first round.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS assay detected variants, we can rule out the possibility of no mutations in the genes it tested. This means that the remaining mutations to consider are 'CFTR mutation', 'COL1A1 mutation', 'UBE3A mutation', and 'HBB mutation'.\n\nNext, let's use the 'High-resolution melt analysis (HRM)' to see if we can rule out the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM assay showed no melting curve abnormalities, we can rule out the CFTR mutation. This leaves us with 'COL1A1 mutation', 'UBE3A mutation', and 'HBB mutation'.\n\nNext, let's use the 'RFLP analysis' to see if we can rule out the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "Since the RFLP analysis showed a normal restriction pattern, we can rule out the HBB mutation. This leaves us with 'COL1A1 mutation' and 'UBE3A mutation'.\n\nNext, let's use the 'Multiplex ligation-dependent probe amplification (MLPA)' to see if we can rule out the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out the UBE3A mutation. This leaves us with only one remaining possible mutation: 'COL1A1 mutation'.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 7247, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Multiplex ligation-dependent probe amplification (MLPA)", "RFLP analysis", "High-resolution melt analysis (HRM)", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To begin, let's use an assay that can potentially rule out multiple mutations at once. The `Next-generation sequencing (NGS)` is a comprehensive test that can detect variants across large fragments of DNA, making it a good choice for the first round.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS detected variants, we know that at least one of the genes (CFTR, COL1A1, UBE3A, or HBB) has a mutation. However, NGS alone doesn't specify which one. Let's use a more targeted assay to narrow it down.\n\nGiven the results, the next logical step is to use `Multiplex ligation-dependent probe amplification (MLPA)` to check for copy number variations, which can help rule out the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA showed a normal copy number, we can rule out the UBE3A mutation. This leaves us with CFTR, COL1A1, and HBB mutations.\n\nNext, let's use `RFLP analysis` to check for the HBB mutation, as it can specifically identify normal or abnormal restriction patterns in the HBB gene.\n\n<ANSWER> RFLP analysis </ANSWER>", "Since the RFLP analysis showed a normal restriction pattern, we can rule out the HBB mutation. This leaves us with CFTR and COL1A1 mutations.\n\nNext, let's use `High-resolution melt analysis (HRM)` to check for the CFTR mutation, as it can identify melting curve abnormalities that are indicative of mutations in the CFTR gene.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM analysis showed no melting curve abnormalities, we can rule out the CFTR mutation. This leaves us with only the COL1A1 mutation.\n\nGiven the remaining options, we can confidently predict that the genetic mutation is the COL1A1 mutation.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 7366, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "RFLP analysis", "High-resolution melt analysis (HRM)", "Multiplex ligation-dependent probe amplification (MLPA)", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["Given the initial list of possible genetic mutations, I will start by performing an assay that can potentially rule out multiple mutations in one step. The 'Next-generation sequencing (NGS)' assay is a good choice because it can detect variants across large fragments of DNA, potentially excluding the CFTR, HBB, and COL1A1 mutations in a single test.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS assay detected variants, we can conclude that the mutation is likely one of the following: CFTR mutation, HBB mutation, or COL1A1 mutation. The UBE3A mutation has not been ruled out by NGS, but we need to further narrow down the possibilities.\n\nNext, I will perform a 'RFLP analysis' to rule out the HBB mutation. If the HBB mutation is present, we should see an abnormal restriction pattern. If the pattern is normal, we can rule out the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "Since the RFLP analysis showed a normal restriction pattern, we can rule out the HBB mutation. This leaves us with the CFTR mutation, COL1A1 mutation, and UBE3A mutation.\n\nNext, I will perform a 'High-resolution melt analysis (HRM)' to rule out the CFTR mutation. If the HRM shows no melting curve abnormalities, we can exclude the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM analysis showed no melting curve abnormalities, we can rule out the CFTR mutation. This leaves us with the COL1A1 mutation and UBE3A mutation.\n\nNext, I will perform a 'Multiplex ligation-dependent probe amplification (MLPA)' to rule out the UBE3A mutation. If the MLPA shows a normal copy number, we can exclude the UBE3A mutation.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA analysis showed a normal copy number, we can rule out the UBE3A mutation. This leaves us with the COL1A1 mutation as the only remaining possibility.\n\nTherefore, the genetic mutation responsible for the trait is the **COL1A1 mutation**.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 7542, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}], "successful": true, "parse_error": false}], "seed": 28, "average_actions": 5.6, "average_tokens": 6611.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.6, "average_successful_tokens": 6611.0}
{"trajectories": [{"actions": ["Enzyme assay", "ELISA", "Next-generation sequencing (NGS)", "Protein truncation test", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to check the activity level of phenylalanine hydroxylase, which will help me rule out the PAH mutation if the enzyme activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.59%, which is between 75% and 100%. According to the guidebook, this rules out the PAH mutation.\n\nRemaining possible mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I will perform an **ELISA** to check the concentration of leptin. This will help me rule out the LEP mutation if the concentration is normal.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a concentration of 86.12%, which is between 75% and 100%. According to the guidebook, this does not rule out any genetic mutations.\n\nRemaining possible mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I will perform **Next-Generation Sequencing (NGS)** to check for genetic variants. This will help me rule out the GJB2 mutation if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The NGS result shows no variants detected, which rules out the GJB2 mutation.\n\nRemaining possible mutations: ['LEP mutation', 'APC gene mutation']\n\nNext, I will perform a **Protein Truncation Test** to check for truncated proteins. This will help me rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test result shows no truncated proteins detected, which rules out the APC gene mutation.\n\nRemaining possible mutation: ['LEP mutation']\n\nSince only the LEP mutation remains, I will predict that the genetic mutation responsible for the trait is the LEP mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 7483, "observations": [null, {"action": "Enzyme assay", "observation": 77.5933172269576}, {"action": "ELISA", "observation": 86.11758214462493}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Protein truncation test", "ELISA", "Next-generation sequencing (NGS)", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, let's use the **Enzyme Assay** to measure the activity level of specific enzymes, which can help rule out the PAH mutation if the activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "Based on the observation from the Enzyme Assay, the enzyme activity is 77.59%, which is between 75% and 100%. This result rules out the PAH mutation.\n\nNow, we need to narrow down the remaining mutations: LEP mutation, APC gene mutation, and GJB2 mutation.\n\nNext, let's perform the **Protein Truncation Test** to check for truncated proteins, which can help rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the observation from the Protein Truncation Test, no truncated proteins were detected, which rules out the APC gene mutation.\n\nThe remaining mutations are LEP mutation and GJB2 mutation.\n\nNext, let's perform the **ELISA** to measure the concentration of leptin, which can help rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "Based on the observation from the ELISA, the concentration detected is 86.12%, which is between 75% and 100%. This means no genetic mutations are excluded, but we have already ruled out the PAH and APC gene mutations. \n\nGiven that the concentration is high, it is less likely to be the LEP mutation. However, to confirm, we can perform **Next-generation sequencing (NGS)** to check for genetic variants, which can help rule out the GJB2 mutation.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-generation sequencing (NGS), no variants were detected, which rules out the GJB2 mutation.\n\nThe only remaining mutation is the LEP mutation. Given the results from the previous assays, we can confidently identify the mutation as the LEP mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 7431, "observations": [null, {"action": "Enzyme assay", "observation": 77.5933172269576}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "ELISA", "observation": 86.11758214462493}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "Next-generation sequencing (NGS)", "Protein truncation test", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, I will perform the **Enzyme Assay** to check the activity level of specific enzymes. This can help rule out the PAH mutation if the enzyme activity is between 75% and 100%.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.59%, which is between 75% and 100%. According to the guidebook, this rules out the PAH mutation.\n\nRemaining genetic mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I will perform the **ELISA** to measure the concentration of proteins or hormones. This can help rule out the LEP mutation if the concentration is between 0 and 25.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result is 86.12%, which is between 75% and 100%. According to the guidebook, this does not rule out any genetic mutations.\n\nRemaining genetic mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I will perform **Next-Generation Sequencing (NGS)** to detect genetic variants. This can help rule out the GJB2 mutation if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The NGS result shows no variants detected, which rules out the GJB2 mutation.\n\nRemaining genetic mutations: ['LEP mutation', 'APC gene mutation']\n\nNext, I will perform the **Protein Truncation Test** to identify truncating mutations that lead to premature stop codons in proteins. This can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test result shows no truncated proteins detected, which rules out the APC gene mutation.\n\nRemaining genetic mutations: ['LEP mutation']\n\nSince only the LEP mutation remains, I will predict that the LEP mutation is the correct genetic mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 7515, "observations": [null, {"action": "Enzyme assay", "observation": 77.5933172269576}, {"action": "ELISA", "observation": 86.11758214462493}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Protein truncation test", "ELISA", "Next-generation sequencing (NGS)", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, I'll perform the **Enzyme Assay** to check the activity level of specific enzymes. This will help me rule out the PAH mutation if the enzyme activity is between 75% and 100%.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.59%, which is between 75% and 100%. This rules out the PAH mutation.\n\nRemaining genetic mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I'll perform the **Protein Truncation Test** to check for truncated proteins, which would help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, the APC gene mutation is ruled out.\n\nRemaining genetic mutations: ['LEP mutation', 'GJB2 mutation']\n\nNext, I'll perform the **ELISA** to check for the concentration of leptin, which will help rule out the LEP mutation if the concentration is between 0 and 25.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result shows a concentration of 86.12%, which is between 75 and 100. This does not rule out the LEP mutation.\n\nRemaining genetic mutations: ['LEP mutation', 'GJB2 mutation']\n\nNext, I'll perform the **Next-Generation Sequencing (NGS)** to check for genetic variants, which will help rule out the GJB2 mutation if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by NGS, the GJB2 mutation is ruled out.\n\nRemaining genetic mutation: ['LEP mutation']\n\nBased on the results, the only remaining plausible mutation is the LEP mutation.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 7403, "observations": [null, {"action": "Enzyme assay", "observation": 77.5933172269576}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "ELISA", "observation": 86.11758214462493}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "ELISA", "Protein truncation test", "Next-generation sequencing (NGS)", "LEP mutation", {"predicted_truth": "LEP mutation"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to check the activity level of specific enzymes, which can help rule out the PAH mutation if the enzyme activity is between 75% and 100%.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.59%, which is between 75% and 100%. According to the guidebook, this result rules out the PAH mutation.\n\nRemaining genetic mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I will perform an **ELISA** to measure the concentration of specific proteins or hormones, which can help rule out the LEP mutation if the concentration is between 0 and 25.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result is 86.12%, which is not between 0 and 25. According to the guidebook, this result does not rule out any of the remaining mutations.\n\nRemaining genetic mutations: ['LEP mutation', 'APC gene mutation', 'GJB2 mutation']\n\nNext, I will perform a **Protein Truncation Test** to identify truncating mutations that lead to premature stop codons in proteins, which can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test result shows no truncated proteins detected, which rules out the APC gene mutation.\n\nRemaining genetic mutations: ['LEP mutation', 'GJB2 mutation']\n\nNext, I will perform **Next-Generation Sequencing (NGS)** to detect genetic variants, which can help rule out the GJB2 mutation if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-Generation Sequencing (NGS) result shows no variants detected, which rules out the GJB2 mutation.\n\nRemaining genetic mutations: ['LEP mutation']\n\nSince the only remaining genetic mutation is the LEP mutation, I will predict that the LEP mutation is responsible for the observed trait.\n\n<ANSWER> LEP mutation </ANSWER>"], "consumed_tokens": 7547, "observations": [null, {"action": "Enzyme assay", "observation": 77.5933172269576}, {"action": "ELISA", "observation": 86.11758214462493}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}], "seed": 29, "average_actions": 6.0, "average_tokens": 7475.8, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 6.0, "average_successful_tokens": 7475.8}
{"trajectories": [{"actions": ["Sanger sequencing", "Western blot", "ELISA", "Allele-specific oligonucleotide hybridization", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will choose an assay that can potentially rule out multiple genetic mutations based on the results. The **Sanger sequencing** assay is a good choice because it can detect the presence of mutations in both BRCA1 and BRCA2, which would help narrow down the list of possible mutations more effectively.\n\n<ANSWER> Sanger sequencing </ANSWER>", "Since Sanger sequencing detected mutations, we can't rule out BRCA1 or BRCA2 mutations. However, we can now focus on assays that can help us differentiate between these two mutations and the other remaining mutations (LEP and GJB2).\n\nThe **Western blot** assay can help us rule out the BRCA1 mutation if the protein of expected size is detected. This will help us narrow down the list further.\n\n<ANSWER> Western blot </ANSWER>", "Since the Western blot detected a protein of the expected size, we can rule out the BRCA1 mutation. This leaves us with LEP mutation, GJB2 mutation, and BRCA2 mutation.\n\nNext, I will use the **ELISA** assay to measure the concentration of proteins. If the protein concentration is in the range of 0-25, it will rule out the LEP mutation, further narrowing down our options.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result is 0.19016694156173686, which falls within the range of 0-25. This means we can rule out the LEP mutation. This leaves us with GJB2 mutation and BRCA2 mutation.\n\nTo further differentiate between these two, I will use the **Allele-specific oligonucleotide hybridization** assay. If there is no hybridization with the mutant probe, we can rule out the GJB2 mutation.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Since there was no hybridization with the mutant probe in the Allele-specific oligonucleotide hybridization assay, we can rule out the GJB2 mutation. This leaves us with only the BRCA2 mutation as the remaining possibility.\n\nTherefore, I can confidently predict that the genetic mutation is the BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7264, "observations": [null, {"action": "Sanger sequencing", "observation": "Mutations detected"}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "ELISA", "observation": 0.19016694156173686}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "ELISA", "Allele-specific oligonucleotide hybridization", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["Given the initial state of the game and the information in the genetic analysis guidebook, I will start by performing a **Western blot** assay. This assay can help me rule out the BRCA1 mutation if the protein of the expected size is detected. If the protein is absent or truncated, it will not rule out any specific mutation, but it will provide valuable information.\n\n<ANSWER> Western blot </ANSWER>", "Based on the observation from the Western blot, the protein of the expected size was detected, which rules out the BRCA1 mutation. The remaining possible mutations are:\n\n- LEP mutation\n- GJB2 mutation\n- BRCA2 mutation\n\nNext, I will perform an **ELISA** assay to measure the concentration of the protein. This can help rule out the LEP mutation if the protein concentration is in the range of 0-25.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 0.19016694156173686 falls within the range of 0-25, which rules out the LEP mutation. The remaining possible mutations are:\n\n- GJB2 mutation\n- BRCA2 mutation\n\nNext, I will perform an **Allele-specific oligonucleotide hybridization** assay to see if there is hybridization with the mutant probe. This can help rule out the GJB2 mutation if there is no hybridization.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The Allele-specific oligonucleotide hybridization assay showed no hybridization with the mutant probe, which rules out the GJB2 mutation. The remaining possible mutation is:\n\n- BRCA2 mutation\n\nGiven that only the BRCA2 mutation remains, I will predict that the mutation is BRCA2.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5628, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "ELISA", "observation": 0.19016694156173686}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["ELISA", "Western blot", "TaqMan assay", "Sanger sequencing", "Allele-specific oligonucleotide hybridization", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, let's perform an assay that can potentially rule out multiple mutations. The **ELISA** assay can help us rule out the LEP mutation based on the protein concentration range. \n\n<ANSWER> ELISA </ANSWER>", "Based on the ELISA result, the protein concentration is 0.19, which falls within the range of 0-25. This rules out the LEP mutation.\n\nNow, we have the following remaining mutations:\n- GJB2 mutation\n- BRCA1 mutation\n- BRCA2 mutation\n\nNext, let's perform a **Western Blot** to see if the protein of expected size is detected, which can help rule out the BRCA1 mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western Blot result shows that the protein of expected size is detected, which rules out the BRCA1 mutation.\n\nNow, we have the following remaining mutations:\n- GJB2 mutation\n- BRCA2 mutation\n\nTo further narrow down the possibilities, let's perform a **TaqMan assay**. This assay can help us rule out the BRCA1 mutation if there is no amplification with the mutant probe.\n\n<ANSWER> TaqMan assay </ANSWER>", "The TaqMan assay result shows no amplification with the mutant probe, which rules out the BRCA1 mutation. However, since we already ruled out BRCA1 in the previous step, this confirms that BRCA1 is not the mutation.\n\nNow, we have the following remaining mutations:\n- GJB2 mutation\n- BRCA2 mutation\n\nTo further narrow it down, let's perform **Sanger sequencing**. This assay can help us detect or rule out both BRCA2 and GJB2 mutations.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing result shows that mutations are detected, which means we cannot rule out either GJB2 or BRCA2 mutations based on this result alone. \n\nTo further narrow it down, let's perform **Allele-specific oligonucleotide hybridization**. This assay can help us rule out the GJB2 mutation if there is no hybridization with the mutant probe.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The Allele-specific oligonucleotide hybridization result shows no hybridization with the mutant probe, which rules out the GJB2 mutation.\n\nNow, we have only one remaining mutation:\n- BRCA2 mutation\n\nBased on the results from the assays, the genetic mutation responsible for the trait is the **BRCA2 mutation**.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 9047, "observations": [null, {"action": "ELISA", "observation": 0.19016694156173686}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["ELISA", "Western blot", "Allele-specific oligonucleotide hybridization", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I'll use an assay that can potentially rule out multiple mutations. The **ELISA** assay can help us rule out the LEP mutation based on the protein concentration range. Let's perform the ELISA.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 0.19016694156173686 falls within the concentration range of 0-25, which rules out the LEP mutation. The remaining possible mutations are:\n\n- GJB2 mutation\n- BRCA1 mutation\n- BRCA2 mutation\n\nNext, I'll perform a **Western blot** to see if the protein of expected size is detected, which can help rule out the BRCA1 mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the protein of expected size is detected, which rules out the BRCA1 mutation. The remaining possible mutations are:\n\n- GJB2 mutation\n- BRCA2 mutation\n\nNext, I'll perform **Allele-specific oligonucleotide hybridization** to see if the GJB2 mutation can be ruled out.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The Allele-specific oligonucleotide hybridization result shows no hybridization with the mutant probe, which rules out the GJB2 mutation. The remaining possible mutation is:\n\n- BRCA2 mutation\n\nSince only one mutation remains, I can now confidently predict the BRCA2 mutation as the responsible mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5467, "observations": [null, {"action": "ELISA", "observation": 0.19016694156173686}, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["ELISA", "Allele-specific oligonucleotide hybridization", "Sanger sequencing", "TaqMan assay", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I'll use the **ELISA** assay to measure the concentration of proteins, which can help rule out the LEP mutation based on the concentration range.\n\n<ANSWER> ELISA </ANSWER>", "The protein concentration range from the ELISA assay is 0.19, which falls in the range 0-25. According to the guidebook, this rules out the LEP mutation.\n\n Remaining possible mutations: ['GJB2 mutation', 'BRCA2 mutation', 'BRCA1 mutation']\n\nNext, I will perform the **Allele-Specific Oligonucleotide Hybridization** assay to check for the presence of the GJB2 mutation.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The observation from the Allele-Specific Oligonucleotide Hybridization assay shows no hybridization with the mutant probe, which rules out the GJB2 mutation.\n\nRemaining possible mutations: ['BRCA2 mutation', 'BRCA1 mutation']\n\nNext, I will perform the **Sanger Sequencing** assay to check for mutations in the BRCA1 and BRCA2 genes.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger Sequencing assay detected mutations, which means either the BRCA1 or BRCA2 mutation is present. To further narrow it down, I will perform the **TaqMan assay** to check for the BRCA1 mutation specifically.\n\n<ANSWER> TaqMan assay </ANSWER>", "The TaqMan assay showed no amplification with the mutant probe, which rules out the BRCA1 mutation. \n\nRemaining possible mutation: ['BRCA2 mutation']\n\nSince we have ruled out all other mutations and only BRCA2 mutation remains, I will predict that the genetic mutation is the BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7067, "observations": [null, {"action": "ELISA", "observation": 0.19016694156173686}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}, {"action": "TaqMan assay", "observation": "No amplification with mutant probe"}], "successful": true, "parse_error": false}], "seed": 30, "average_actions": 5.8, "average_tokens": 6894.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.8, "average_successful_tokens": 6894.6}
{"trajectories": [{"actions": ["Southern blot", "Next-generation sequencing (NGS)", "Enzyme assay", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["Let's start by performing a test that can potentially rule out one of the mutations based on a clear outcome. The Southern blot is a good initial test because it can specifically rule out HTT gene expansion if the fragment size is normal.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot showed a normal-sized fragment, which rules out the HTT gene expansion. Now, we need to choose another assay to further narrow down the possible mutations. Next-generation sequencing (NGS) is a good choice because it can detect specific variants in genes like BRCA2 and CFTR.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-generation sequencing (NGS) did not detect any variants, which rules out BRCA2 and CFTR mutations. This leaves us with the SERPINA1 mutation as the only remaining possibility. To confirm, we can perform an enzyme assay to check for normal enzyme levels, which would help us rule out or confirm the SERPINA1 mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 3.414463108623253 is significantly below the normal range of 75 to 100, which confirms the presence of a SERPINA1 mutation. Given this result, we can confidently predict the mutation.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 4785, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Enzyme assay", "observation": 3.414463108623253}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Next-generation sequencing (NGS)", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["To start, I will perform a Southern blot to check for any abnormal fragment sizes that might indicate the HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot showed a normal-sized fragment, ruling out the HTT gene expansion. Next, I will perform a Next-generation sequencing (NGS) to check for any variants that might indicate the BRCA2 or CFTR mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-generation sequencing (NGS) showed no variants detected, ruling out the BRCA2 and CFTR mutations. This leaves us with the SERPINA1 mutation as the only remaining possibility.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 3285, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Tandem repeat PCR", "Enzyme assay", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["To start, let's perform an assay that can help us narrow down the possibilities. The 'Next-generation sequencing (NGS)' is a comprehensive assay that can rule out multiple mutations at once if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since 'Next-generation sequencing (NGS)' did not detect any variants, we can rule out the BRCA2 mutation and CFTR mutation. This leaves us with the SERPINA1 mutation and HTT gene expansion.\n\nTo further narrow it down, let's perform a 'Tandem repeat PCR' to check for the HTT gene expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of the 'Tandem repeat PCR' is 19.86, which is within the normal range of 0 to 30 repeats. This rules out the HTT gene expansion.\n\nThis leaves us with the SERPINA1 mutation as the only remaining possibility. To confirm, we can perform an 'Enzyme assay' to check the enzyme levels.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme levels are significantly below the normal range of 75 to 100, which confirms the presence of a SERPINA1 mutation. This mutation is associated with alpha-1 antitrypsin deficiency, which affects enzyme levels.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 4858, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Tandem repeat PCR", "observation": 19.864999665457898}, {"action": "Enzyme assay", "observation": 3.414463108623253}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Enzyme assay", "Tandem repeat PCR", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["Given the initial state, the most efficient first step is to perform an assay that can potentially rule out multiple mutations at once. The 'Next-generation sequencing (NGS)' is a powerful tool that can detect variants in genes, and if no variants are detected, it can rule out both BRCA2 and CFTR mutations.\n\nLet's perform the 'Next-generation sequencing (NGS)' to see if we can narrow down the list of possible mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since 'Next-generation sequencing (NGS)' did not detect any variants, we can rule out the 'BRCA2 mutation' and 'CFTR mutation'. Now we are left with 'SERPINA1 mutation' and 'HTT gene expansion'.\n\nNext, let's perform an 'Enzyme assay' to check the enzyme levels. If the enzyme levels are within the normal range (75-100), we can rule out the 'SERPINA1 mutation'.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme levels are significantly below the normal range (75-100), which suggests that the 'SERPINA1 mutation' is a strong possibility. However, to confirm, we should rule out the 'HTT gene expansion' mutation.\n\nLet's perform a 'Tandem repeat PCR' to check the repeat size. If the repeat size is within the normal range (0-30), we can rule out the 'HTT gene expansion'.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The tandem repeat size of 19.86 is within the normal range (0-30), which rules out the 'HTT gene expansion'. Therefore, the remaining mutation is 'SERPINA1 mutation'.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 5146, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Enzyme assay", "observation": 3.414463108623253}, {"action": "Tandem repeat PCR", "observation": 19.864999665457898}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Next-generation sequencing (NGS)", "Enzyme assay", "SERPINA1 mutation", {"predicted_truth": "SERPINA1 mutation"}], "generated_text": ["Let's start by performing a **Tandem Repeat PCR** to check for the HTT gene expansion. If the repeat size is between 0 and 30, we can rule out the HTT gene expansion mutation.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result of 19.865 indicates that the repeat size is within the normal range (0-30). Therefore, we can rule out the HTT gene expansion mutation.\n\nNext, let's perform a **Next-generation sequencing (NGS)** to check for BRCA2 and CFTR mutations. If no variants are detected, we can rule out these mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by Next-generation sequencing (NGS), we can rule out the BRCA2 and CFTR mutations. This leaves us with the SERPINA1 mutation as the only remaining possibility.\n\nTo confirm, let's perform an **Enzyme assay**. If the enzyme levels are between 75 and 100, we can rule out the SERPINA1 mutation. If they are outside this range, it will confirm the SERPINA1 mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme levels are significantly lower than the normal range (75-100), which confirms the presence of a SERPINA1 mutation.\n\n<ANSWER> SERPINA1 mutation </ANSWER>"], "consumed_tokens": 4932, "observations": [null, {"action": "Tandem repeat PCR", "observation": 19.864999665457898}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Enzyme assay", "observation": 3.414463108623253}], "successful": true, "parse_error": false}], "seed": 31, "average_actions": 4.8, "average_tokens": 4601.2, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.8, "average_successful_tokens": 4601.2}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Enzyme assay", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Given the initial state, the best first step is to perform an assay that can provide a broad initial ruling out of multiple mutations. The **Next-Generation Sequencing (NGS)** is a comprehensive method that can rule out multiple mutations at once, making it an efficient choice for the first step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation that no variants were detected by Next-Generation Sequencing (NGS), we can rule out the BRCA2 and CFTR mutations. This leaves us with the SERPINA1 and MTHFR mutations.\n\nNext, we can use an assay that can specifically rule out one of these remaining mutations. The **Enzyme Assay** is a good choice because it can rule out the SERPINA1 mutation if the activity is within a specific range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 87.1367370208137 falls within the range of 75 to 100, which means the SERPINA1 mutation is ruled out. This leaves us with the MTHFR mutation as the only remaining possibility.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 3852, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Enzyme assay", "observation": 87.1367370208137}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Next-generation sequencing (NGS)", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, I will perform the Enzyme assay to check the activity level and potentially rule out the SERPINA1 mutation.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 87.1367370208137 is within the range of 75 to 100, which means the SERPINA1 mutation can be ruled out.\n\nRemaining mutations: ['BRCA2 mutation', 'MTHFR mutation', 'CFTR mutation']\n\nNext, I will perform Next-Generation Sequencing (NGS) to rule out multiple mutations at once.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-Generation Sequencing (NGS) result shows no variants detected, we can rule out the BRCA2 and CFTR mutations.\n\nRemaining mutations: ['MTHFR mutation']\n\nGiven that only the MTHFR mutation remains, I will predict the truth.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 3745, "observations": [null, {"action": "Enzyme assay", "observation": 87.1367370208137}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Next-generation sequencing (NGS)", "Mass spectrometry genotyping", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to check the activity level, which can help rule out the SERPINA1 mutation if the activity is within the specified range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result is 87.1367370208137, which falls between 75 and 100. According to the guidebook, this range rules out the SERPINA1 mutation.\n\nThe remaining possible genetic mutations are:\n- BRCA2 mutation\n- MTHFR mutation\n- CFTR mutation\n\nNext, I will perform **Next-Generation Sequencing (NGS)** to check for the presence of CFTR and BRCA2 mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The NGS result shows no variants detected, which rules out the CFTR and BRCA2 mutations.\n\nThe remaining possible genetic mutation is:\n- MTHFR mutation\n\nI will now perform **Mass Spectrometry Genotyping** to confirm the absence of the MTHFR mutation.\n\n<ANSWER> Mass spectrometry genotyping </ANSWER>", "The mass spectrometry genotyping result shows mass shifts detected, which indicates the presence of the MTHFR mutation.\n\nTherefore, the genetic mutation responsible for the trait is the **MTHFR mutation**.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5299, "observations": [null, {"action": "Enzyme assay", "observation": 87.1367370208137}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Mass spectrometry genotyping", "observation": "Mass shifts detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Next-generation sequencing (NGS)", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to rule out the SERPINA1 mutation if the activity is between 75 and 100.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 87.1367370208137 falls within the range of 75 to 100, which means the SERPINA1 mutation can be ruled out.\n\nThe remaining possible genetic mutations are:\n- BRCA2 mutation\n- MTHFR mutation\n- CFTR mutation\n\nNext, I will perform **Next-Generation Sequencing (NGS)** to rule out BRCA2 and CFTR mutations if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-Generation Sequencing (NGS) did not detect any variants, the BRCA2 and CFTR mutations can be ruled out.\n\nThe remaining possible genetic mutation is:\n- MTHFR mutation\n\nGiven that only the MTHFR mutation remains, I will predict it as the responsible mutation.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 3804, "observations": [null, {"action": "Enzyme assay", "observation": 87.1367370208137}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Next-generation sequencing (NGS)", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, I'll perform an Enzyme Assay to check for the activity level, which will help me rule out the SERPINA1 mutation if the activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result shows an activity level of 87.1367370208137, which is between 75 and 100. According to the guide, this rules out the SERPINA1 mutation.\n\nNow, I will perform a Next-Generation Sequencing (NGS) to rule out the CFTR and BRCA2 mutations if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The Next-Generation Sequencing (NGS) result shows no variants detected, which rules out the CFTR and BRCA2 mutations.\n\nGiven that the SERPINA1 mutation has already been ruled out and now the CFTR and BRCA2 mutations are also ruled out, the only remaining mutation is the MTHFR mutation.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 3782, "observations": [null, {"action": "Enzyme assay", "observation": 87.1367370208137}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": true, "parse_error": false}], "seed": 32, "average_actions": 4.2, "average_tokens": 4096.4, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.2, "average_successful_tokens": 4096.4}
{"trajectories": [{"actions": ["Tandem repeat PCR", "Methylation-specific PCR", "DNA sequencing", "Protein truncation test", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, we should choose an assay that can potentially rule out multiple mutations based on its results. The **Tandem Repeat PCR** is a good initial choice because it can directly identify the FMR1 gene expansion by detecting CGG repeat sizes.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem Repeat PCR is 8.46613703896727, which is within the normal range (0 to 30). This means the FMR1 gene expansion can be ruled out.\n\nNow, we need to choose another assay to further narrow down the possible mutations. The **Methylation-specific PCR** can help rule out the UBE3A mutation by analyzing the methylation pattern.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The observation from the Methylation-specific PCR shows a normal methylation pattern, which allows us to rule out the UBE3A mutation.\n\nNow we have two remaining possible mutations: **HBB mutation** and **DMD mutation**. To further narrow it down, we can perform **DNA sequencing** to check for mutations in the HBB gene.\n\n<ANSWER> DNA sequencing </ANSWER>", "The observation from the DNA sequencing shows no mutations detected, which allows us to rule out the HBB mutation.\n\nNow, the only remaining possible mutation is the **DMD mutation**. To confirm this, we can perform the **Protein Truncation Test** to check for truncated proteins, which are indicative of DMD mutations.\n\n<ANSWER> Protein truncation test </ANSWER>", "The observation from the Protein Truncation Test shows that truncated proteins are detected, confirming the presence of a DMD mutation.\n\nSince we have ruled out all other mutations and the results are consistent with a DMD mutation, we can confidently predict the truth.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 7157, "observations": [null, {"action": "Tandem repeat PCR", "observation": 8.46613703896727}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "DNA sequencing", "observation": "No mutations detected"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Methylation-specific PCR", "DNA sequencing", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, I will use the **Tandem Repeat PCR** assay to check for the FMR1 gene expansion. This assay is specific for detecting repeat expansions, which can quickly help rule out the FMR1 gene expansion if the repeat size is normal.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem Repeat PCR assay is 8.46613703896727, which falls within the normal range (0-30 repeats). Therefore, we can rule out the FMR1 gene expansion.\n\nNext, I will perform **Methylation-specific PCR** to check for the UBE3A mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The observation from the Methylation-specific PCR assay shows a normal methylation pattern, which allows us to rule out the UBE3A mutation.\n\nNow, I will perform **DNA sequencing** to check for the HBB mutation.\n\n<ANSWER> DNA sequencing </ANSWER>", "The observation from the DNA sequencing assay shows no mutations detected, which allows us to rule out the HBB mutation.\n\nSince we have ruled out the FMR1 gene expansion, UBE3A mutation, and HBB mutation, the only remaining possibility is the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5396, "observations": [null, {"action": "Tandem repeat PCR", "observation": 8.46613703896727}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "DNA sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Methylation-specific PCR", "DNA sequencing", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial list of genetic mutations and the available assays, a strategic first step is to perform an assay that can potentially rule out multiple mutations at once. The **Tandem Repeat PCR** is a good choice because it can rule out the FMR1 gene expansion if the repeat size is normal.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of the Tandem Repeat PCR shows a repeat size of 8.47, which is well within the normal range (0-30). This allows us to rule out the FMR1 gene expansion.\n\nRemaining possible genetic mutations:\n- UBE3A mutation\n- HBB mutation\n- DMD mutation\n\nNext, we should choose an assay that can help us further narrow down the possibilities. The **Methylation-specific PCR** can help us rule out the UBE3A mutation if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The result of the Methylation-specific PCR shows a normal methylation pattern, allowing us to rule out the UBE3A mutation.\n\nRemaining possible genetic mutations:\n- HBB mutation\n- DMD mutation\n\nNext, we should perform an assay that can help us distinguish between the HBB mutation and the DMD mutation. The **DNA sequencing** assay can detect mutations in the DNA sequence, which would help us rule out the HBB mutation if no mutations are detected.\n\n<ANSWER> DNA sequencing </ANSWER>", "The result of the DNA sequencing shows no mutations detected, which allows us to rule out the HBB mutation.\n\nRemaining possible genetic mutation:\n- DMD mutation\n\nGiven that the only remaining possible genetic mutation is the DMD mutation, we can confidently predict that this is the correct mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5632, "observations": [null, {"action": "Tandem repeat PCR", "observation": 8.46613703896727}, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "DNA sequencing", "observation": "No mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "DNA sequencing", "Protein truncation test", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game, the best approach is to start with an assay that can potentially rule out multiple genetic mutations. The **Tandem Repeat PCR** is a good starting point because it can specifically rule out the **FMR1 gene expansion** if the repeat size is within the normal range (0 to 30).\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem Repeat PCR indicates a repeat size of 8.466, which falls between 0 and 30. This means we can rule out the **FMR1 gene expansion**.\n\nGiven this, the remaining possible genetic mutations are:\n- UBE3A mutation\n- HBB mutation\n- DMD mutation\n\nNext, we should perform an assay that can help us differentiate between these remaining mutations. The **DNA sequencing** is a good choice because it can directly detect mutations in the DNA sequence, which will help us rule out the **HBB mutation** if no mutations are detected.\n\n<ANSWER> DNA sequencing </ANSWER>", "The observation from the DNA sequencing indicates that no mutations were detected, allowing us to rule out the **HBB mutation**.\n\nThe remaining possible genetic mutations are:\n- UBE3A mutation\n- DMD mutation\n\nNext, we should perform an assay that can help us differentiate between these two mutations. The **Protein Truncation Test** is a good choice because it can detect truncated proteins, which would be indicative of a **DMD mutation**. If no truncated proteins are detected, we can rule out the **DMD mutation**.\n\n<ANSWER> Protein truncation test </ANSWER>", "The observation from the Protein Truncation Test indicates that truncated proteins were detected, which is consistent with the **DMD mutation**. This allows us to confidently identify the genetic mutation responsible for the observed trait.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5723, "observations": [null, {"action": "Tandem repeat PCR", "observation": 8.46613703896727}, {"action": "DNA sequencing", "observation": "No mutations detected"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "DNA sequencing", "Protein truncation test", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, let's perform an assay that can potentially rule out multiple mutations in one step. The **Tandem Repeat PCR** is a good choice because it can specifically rule out the FMR1 gene expansion if the repeat size is within a normal range.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of the Tandem Repeat PCR assay is 8.46613703896727, which indicates that the repeat size is between 0 and 30. This allows us to rule out the **FMR1 gene expansion** mutation.\n\nThe remaining possible mutations are:\n- UBE3A mutation\n- HBB mutation\n- DMD mutation\n\nNext, I will perform a **DNA sequencing** assay to check for mutations in the DNA sequence.\n\n<ANSWER> DNA sequencing </ANSWER>", "The result of the DNA sequencing assay indicates that no mutations were detected. This allows us to rule out the **HBB mutation**.\n\nThe remaining possible mutations are:\n- UBE3A mutation\n- DMD mutation\n\nNext, I will perform a **Protein Truncation Test** to check for truncated proteins, which can help us rule out the **DMD mutation**.\n\n<ANSWER> Protein truncation test </ANSWER>", "The result of the Protein Truncation Test indicates that truncated proteins were detected. This suggests the presence of a **DMD mutation**.\n\nGiven the remaining mutations and the assay results, I can confidently predict that the genetic mutation responsible for the observed trait is the **DMD mutation**.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5534, "observations": [null, {"action": "Tandem repeat PCR", "observation": 8.46613703896727}, {"action": "DNA sequencing", "observation": "No mutations detected"}, {"action": "Protein truncation test", "observation": "Truncated proteins detected"}], "successful": true, "parse_error": false}], "seed": 33, "average_actions": 5.2, "average_tokens": 5888.4, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.2, "average_successful_tokens": 5888.4}
{"trajectories": [{"actions": ["Enzyme assay", "Multiplex ligation-dependent probe amplification (MLPA)", "Fluorescence in situ hybridization (FISH)", "Next-generation sequencing (NGS)", "HBB mutation", {"predicted_truth": "HBB mutation"}], "generated_text": ["To start, I will perform an enzyme assay to check for PAH mutation, as this is a quick and non-invasive test that can rule out one of the potential mutations if the enzyme activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.41%, which is within the normal range (75-100%). This rules out the PAH mutation.\n\nRemaining genetic mutations: ['PMP22 duplication', 'BRCA2 mutation', 'HBB mutation']\n\nNext, I will perform Multiplex Ligation-Dependent Probe Amplification (MLPA) to check for PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay detected a copy number variation, which suggests the presence of a PMP22 duplication.\n\nRemaining genetic mutations: ['PMP22 duplication', 'BRCA2 mutation', 'HBB mutation']\n\nTo confirm the PMP22 duplication, I will perform Fluorescence In Situ Hybridization (FISH).\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay detected a deletion, which does not align with the expected result for a PMP22 duplication. This suggests that the PMP22 duplication is not the correct mutation.\n\nRemaining genetic mutations: ['BRCA2 mutation', 'HBB mutation']\n\nNext, I will perform Next-Generation Sequencing (NGS) to check for BRCA2 and HBB mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The NGS assay detected no variants, which rules out both BRCA2 and HBB mutations. However, since NGS did not detect any variants, the remaining mutation must be HBB mutation, as BRCA2 mutation would have been detected if present.\n\nRemaining genetic mutations: ['HBB mutation']\n\n<ANSWER> HBB mutation </ANSWER>"], "consumed_tokens": 7360, "observations": [null, {"action": "Enzyme assay", "observation": 77.41234177243516}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}], "successful": false, "parse_error": false}, {"actions": ["Enzyme assay", "Multiplex ligation-dependent probe amplification (MLPA)", "PMP22 duplication", {"predicted_truth": "PMP22 duplication"}], "generated_text": ["To start the process of elimination, let's perform an **Enzyme Assay**. This assay will help us rule out the PAH mutation if the enzyme activity is within the normal range (75-100%).\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.41, which falls within the normal range (75-100%). This rules out the PAH mutation.\n\nNow we are left with the following possible genetic mutations:\n- PMP22 duplication\n- BRCA2 mutation\n- HBB mutation\n\nNext, let's perform a **Multiplex Ligation-Dependent Probe Amplification (MLPA)** to check for the PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay detected a copy number variation, which suggests the presence of a PMP22 duplication.\n\nGiven this result, we can confidently identify the genetic mutation as **PMP22 duplication**.\n\n<ANSWER> PMP22 duplication </ANSWER>"], "consumed_tokens": 4030, "observations": [null, {"action": "Enzyme assay", "observation": 77.41234177243516}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Multiplex ligation-dependent probe amplification (MLPA)", "PMP22 duplication", {"predicted_truth": "PMP22 duplication"}], "generated_text": ["To start, I will perform an **Enzyme Assay** to rule out the PAH mutation, as it can quickly determine if the enzyme activity is normal, which would help narrow down the possible mutations.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity result of 77.41% falls within the normal range (75-100%), which rules out the PAH mutation. \n\nNext, I will perform a **Multiplex Ligation-Dependent Probe Amplification (MLPA)** to check for PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result indicates a copy number variation, which suggests the presence of a PMP22 duplication.\n\n<ANSWER> PMP22 duplication </ANSWER>"], "consumed_tokens": 3940, "observations": [null, {"action": "Enzyme assay", "observation": 77.41234177243516}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Multiplex ligation-dependent probe amplification (MLPA)", "PMP22 duplication", {"predicted_truth": "PMP22 duplication"}], "generated_text": ["To start, I will perform an enzyme assay to rule out the PAH mutation, as it is a straightforward test that can quickly eliminate one of the possibilities if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.41%, which is within the normal range of 75-100%. This rules out the PAH mutation.\n\nNext, I will perform an MLPA assay to check for PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay detected a copy number variation, which suggests a PMP22 duplication. Since this is the only remaining mutation that fits the observed results, I will predict the truth.\n\n<ANSWER> PMP22 duplication </ANSWER>"], "consumed_tokens": 3926, "observations": [null, {"action": "Enzyme assay", "observation": 77.41234177243516}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Enzyme assay", "PMP22 duplication", {"predicted_truth": "PMP22 duplication"}], "generated_text": ["To start, let's perform an assay that can help us rule out a large number of mutations. The **Next-generation sequencing (NGS)** is a high-throughput method that can detect a wide range of mutations, making it a good choice for the first step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-generation sequencing (NGS) did not detect any variants, we can rule out the HBB mutation and BRCA2 mutation. This leaves us with the PMP22 duplication and PAH mutation as the remaining possibilities.\n\nNext, let's perform an **Enzyme assay** to check for PAH enzyme activity.\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme assay result of 77.41% falls within the 75-100% range, which rules out the PAH mutation. This leaves us with the PMP22 duplication as the only remaining possibility.\n\nTherefore, the mutation responsible for the trait is likely the **PMP22 duplication**.\n\n<ANSWER> PMP22 duplication </ANSWER>"], "consumed_tokens": 4004, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Enzyme assay", "observation": 77.41234177243516}], "successful": true, "parse_error": false}], "seed": 34, "average_actions": 4.4, "average_tokens": 4652.0, "average_correct": 0.8, "average_parse_error": 0.0, "average_successful_action_num": 4.0, "average_successful_tokens": 3975.0}
{"trajectories": [{"actions": ["Southern blot", "PCR amplification", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["Let's start by performing an assay that can help us narrow down the possibilities quickly. I'll choose the `Southern blot` because it can rule out the FMR1 gene expansion, which is a common mutation and can be easily identified with this assay.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result of a normal-sized fragment indicates that the FMR1 gene expansion is not present. This rules out the FMR1 gene expansion mutation.\n\nNext, I'll perform a PCR amplification to check for the presence of the SMN1 deletion.\n\n<ANSWER> PCR amplification </ANSWER>", "The PCR amplification result of no amplification suggests that the SMN1 deletion is present, as the deletion would prevent the amplification of the fragment.\n\nGiven this information, I can confidently predict the mutation.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 3233, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "ELISA", "PCR amplification", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform an assay that can quickly rule out one of the potential mutations. The Southern blot is a good initial test because it can directly rule out the FMR1 gene expansion by checking for normal-sized fragments.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which means the FMR1 gene expansion is not present. Therefore, we can rule out the FMR1 gene expansion.\n\nNext, I will perform an ELISA to check for the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 20.135305582982394 falls within the normal range (0-25), which means the LEP mutation is not present. Therefore, we can rule out the LEP mutation.\n\nNow, we are left with two potential mutations: SMN1 deletion and COL1A1 mutation. To further narrow it down, I will perform a PCR amplification to check for the presence of the SMN1 gene.\n\n<ANSWER> PCR amplification </ANSWER>", "The PCR amplification result shows no amplification, which suggests that the SMN1 deletion is present. Therefore, we can conclude that the SMN1 deletion is the genetic mutation responsible for the observed trait.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 4604, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 20.135305582982394}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "PCR amplification", "Multiplex ligation-dependent probe amplification (MLPA)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform an assay that can help me narrow down the list of possible mutations. The Southern blot is particularly useful for detecting gene expansions, which can help me rule out the FMR1 gene expansion if a normal-sized fragment is observed.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result of a normal-sized fragment rules out the FMR1 gene expansion. Now, I need to choose another assay to further narrow down the remaining mutations.\n\nNext, I will perform a PCR amplification to check for the presence of the SMN1 deletion.\n\n<ANSWER> PCR amplification </ANSWER>", "The lack of amplification in the PCR assay suggests that the SMN1 deletion is present. However, to be thorough, I will perform an MLPA to confirm the copy number of the SMN1 gene.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result showing a copy number variation confirms the presence of the SMN1 deletion. Given this information, I can confidently identify the genetic mutation.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 4509, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "PCR amplification", "observation": "No amplification"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["Given the initial state, the most informative assay to start with would be one that can potentially rule out a large number of mutations. The **Southern blot** is a good choice because it can specifically rule out the FMR1 gene expansion, which is a common and distinctive mutation.\n\nIf the Southern blot shows a normal-sized fragment, we can immediately rule out the FMR1 gene expansion. This will help us narrow down the possibilities more efficiently.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern blot, we can rule out the FMR1 gene expansion. This leaves us with three possible mutations: LEP mutation, SMN1 deletion, and COL1A1 mutation.\n\nThe next most informative assay would be **Multiplex Ligation-dependent Probe Amplification (MLPA)**, which can specifically detect deletions or copy number variations. If the MLPA shows a normal copy number, we can rule out the SMN1 deletion.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA detected a copy number variation, which suggests that the SMN1 deletion is present. Given this observation, we can confidently predict that the genetic mutation responsible for the trait is the **SMN1 deletion**.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 3463, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "PCR amplification", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, let's perform a test that can potentially rule out one of the mutations with a high degree of confidence. The **MLPA** assay is particularly effective for detecting deletions, so it would be a good choice to rule out the **SMN1 deletion**.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The **MLPA** assay detected a copy number variation, which suggests that the **SMN1 deletion** is likely present. However, to confirm this and rule out other possibilities, we should perform another assay. The **PCR amplification** assay can further support the presence of the **SMN1 deletion** by showing if the fragment is not amplified.\n\n<ANSWER> PCR amplification </ANSWER>", "The **PCR amplification** assay did not amplify the fragment, which strongly supports the presence of the **SMN1 deletion**. Given the results from both the **MLPA** and **PCR amplification** assays, we can confidently identify the mutation.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 3346, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}], "seed": 35, "average_actions": 4.4, "average_tokens": 3831.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.4, "average_successful_tokens": 3831.0}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Fluorescence in situ hybridization (FISH)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["Given the initial state, the most informative assay to start with would be **Next-generation Sequencing (NGS)**. This assay can provide a broad overview and help rule out multiple mutations at once, which is efficient for narrowing down the possibilities.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The observation from the Next-generation Sequencing (NGS) assay indicates that no variants were detected. This result rules out the presence of both BRCA2 and GJB2 mutations, as these would have been detected by the comprehensive sequencing analysis.\n\nGiven this information, the remaining possible mutations are 'SMN1 deletion' and 'MTHFR mutation'. The next logical step is to use an assay that can specifically differentiate between these two remaining mutations. **Fluorescence in situ hybridization (FISH)** is a good choice because it can detect specific deletions, such as the SMN1 deletion.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The observation from the Fluorescence in situ hybridization (FISH) assay indicates that a deletion was detected. Given that the only remaining mutation that can cause a deletion is the 'SMN1 deletion', we can confidently identify this as the responsible mutation.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 3928, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "Fluorescence in situ hybridization (FISH)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will use an assay that can provide broad initial information to help narrow down the list of possible mutations. The Next-generation Sequencing (NGS) assay is ideal for this purpose as it can detect a wide range of genetic mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-generation Sequencing (NGS) assay, no variants were detected. This rules out both the BRCA2 mutation and the GJB2 mutation.\n\nNow, I will use an assay that can specifically help me distinguish between the remaining mutations, SMN1 deletion and MTHFR mutation. The High-resolution Melt Analysis (HRM) is a good choice for this purpose as it can detect melting curve abnormalities associated with MTHFR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the observation from the High-resolution Melt Analysis (HRM) assay, no melting curve abnormalities were detected, which rules out the MTHFR mutation. \n\nThe only remaining mutation is the SMN1 deletion. To confirm this, I will use the Fluorescence In Situ Hybridization (FISH) assay, which is specifically designed to detect deletions.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The Fluorescence In Situ Hybridization (FISH) assay detected a deletion, confirming the presence of the SMN1 deletion. Since this is the only remaining mutation and the results align with the expected outcome for an SMN1 deletion, I can confidently predict the mutation.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5446, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "Fluorescence in situ hybridization (FISH)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I'll use an assay that can help me eliminate multiple possibilities at once. Next-generation sequencing (NGS) is a comprehensive assay that can detect a broad array of genetic mutations, including BRCA2 and GJB2 mutations. If no variants are detected, I can rule out these two mutations immediately.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected with Next-generation sequencing (NGS), I can rule out the BRCA2 and GJB2 mutations. This leaves me with SMN1 deletion and MTHFR mutation as the possible candidates.\n\nTo further narrow it down, I will use an assay that can specifically detect the presence of an MTHFR mutation. High-resolution melt analysis (HRM) is suitable for this purpose as it can detect melting curve abnormalities associated with MTHFR mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since there were no melting curve abnormalities detected with High-resolution melt analysis (HRM), I can rule out the MTHFR mutation. This leaves only the SMN1 deletion as the possible mutation.\n\nTo confirm, I will use an assay that can detect the presence of an SMN1 deletion. Fluorescence in situ hybridization (FISH) is a reliable method for identifying such deletions.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The Fluorescence in situ hybridization (FISH) assay has confirmed the presence of a deletion, which aligns with the SMN1 deletion. Since this is the only remaining mutation and the assay results confirm it, I can confidently predict the truth.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5507, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will choose an assay that can potentially eliminate multiple genetic mutations in one step. Next-generation sequencing (NGS) is a comprehensive assay that can detect a broad array of genetic mutations, making it a good choice for the first round.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Given the observation from the NGS assay, no variants were detected. This rules out both BRCA2 and GJB2 mutations. The remaining possible genetic mutations are:\n\n- SMN1 deletion\n- MTHFR mutation\n\nNext, I will choose an assay that can help distinguish between these two remaining mutations. High-resolution melt analysis (HRM) is a good choice because it can detect melting curve abnormalities associated with the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The observation from the HRM assay shows no melting curve abnormalities, which rules out the MTHFR mutation. The only remaining possible genetic mutation is:\n\n- SMN1 deletion\n\nSince we have now narrowed it down to a single mutation, I can confidently predict the truth.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 3859, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "Fluorescence in situ hybridization (FISH)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["Given the initial state of the game, the most efficient first step is to perform a test that can eliminate multiple genetic mutations if possible. The `Next-generation Sequencing (NGS)` assay is the best choice for this purpose because it can detect a broad array of genetic mutations and potentially rule out several mutations in one go.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The observation from the Next-generation Sequencing (NGS) assay indicates that no variants were detected. According to the genetic analysis guidebook, this result eliminates the possibility of both BRCA2 and GJB2 mutations.\n\nRemaining possible genetic mutations:\n- SMN1 deletion\n- MTHFR mutation\n\nNext, I will use an assay that can distinguish between the remaining mutations. The `High-resolution Melt Analysis (HRM)` can rule out the MTHFR mutation if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The observation from the High-resolution Melt Analysis (HRM) indicates that no melting curve abnormalities were detected, which rules out the MTHFR mutation.\n\nGiven the remaining possible genetic mutation is SMN1 deletion, I will confirm this by using an assay that can specifically detect this deletion. The `Fluorescence in situ hybridization (FISH)` assay is suitable for this purpose.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The observation from the Fluorescence in situ hybridization (FISH) assay indicates that a deletion was detected, confirming the presence of an SMN1 deletion.\n\nGiven this result, I can confidently predict that the genetic mutation responsible for the trait is **SMN1 deletion**.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5533, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}], "seed": 36, "average_actions": 4.6, "average_tokens": 4854.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 4.6, "average_successful_tokens": 4854.6}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "Protein truncation test", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, let's use an assay that can potentially rule out one of the mutations effectively. The Multiplex Ligation-dependent Probe Amplification (MLPA) is a good choice because it can detect copy number variations, which are relevant for the PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result shows a normal copy number, which rules out the PMP22 duplication. Now, we need to choose another assay to further narrow down the list of possible mutations. The High-resolution Melt Analysis (HRM) is a good next step because it can detect sequence variations, which are relevant for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM result shows no melting curve abnormalities, which rules out the MTHFR mutation. Now, we are left with two possible mutations: 'APC gene mutation' and 'PAH mutation'. The Protein Truncation Test can help us identify if there are any truncated proteins, which would rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein Truncation Test shows no truncated proteins detected, which rules out the APC gene mutation. This leaves us with only one possible mutation: 'PAH mutation'.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5226, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "Protein truncation test", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Let's start by ruling out the PMP22 duplication, as it can be detected by the MLPA assay. This will help us narrow down the list of possible mutations.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the MLPA assay, the PMP22 duplication has been ruled out. Next, I will use the High-resolution melt analysis (HRM) to rule out the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the observations from the MLPA and HRM assays, we have ruled out the PMP22 duplication and the MTHFR mutation. The remaining possible mutations are the APC gene mutation and the PAH mutation.\n\nNext, I will use the Protein Truncation Test to rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "Based on the observations from the previous assays, we have ruled out the PMP22 duplication, MTHFR mutation, and APC gene mutation. The only remaining mutation is the PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5072, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "Protein truncation test", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["Given the initial state, we have a list of possible genetic mutations and a set of available assays. To efficiently narrow down the possible mutations, we should start with an assay that can rule out multiple mutations in one step if possible. \n\nThe **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice for the first assay because it can detect copy number variations, which would help us rule out the **PMP22 duplication** if no copy number variation is detected. This assay can significantly reduce the number of potential mutations.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA result shows a normal copy number, we can rule out **PMP22 duplication**. This leaves us with the following possible mutations: **APC gene mutation**, **MTHFR mutation**, and **PAH mutation**.\n\nNext, we should use an assay that can further narrow down the possibilities. The **High-resolution melt analysis (HRM)** is a good choice because it can detect DNA sequence variations, which would help us rule out **MTHFR mutation** if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM result shows no melting curve abnormalities, we can rule out **MTHFR mutation**. This leaves us with the following possible mutations: **APC gene mutation** and **PAH mutation**.\n\nNext, we should use an assay that can further narrow down the possibilities. The **Protein truncation test** is a good choice because it can detect truncated proteins, which would help us rule out **APC gene mutation** if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since the Protein truncation test result shows no truncated proteins detected, we can rule out **APC gene mutation**. This leaves us with only one possible mutation: **PAH mutation**.\n\nGiven the remaining mutation, we can confidently predict that the genetic mutation causing the trait is **PAH mutation**.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5642, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "Protein truncation test", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, I will use the Multiplex ligation-dependent probe amplification (MLPA) assay. This assay can detect abnormal copy numbers, which will help rule out the PMP22 duplication if no copy number variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out the PMP22 duplication. The remaining possible genetic mutations are 'APC gene mutation', 'MTHFR mutation', and 'PAH mutation'.\n\nNext, I will use the High-resolution melt analysis (HRM) to detect any sequence variations, which can help rule out the MTHFR mutation if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM assay showed no melting curve abnormalities, we can rule out the MTHFR mutation. The remaining possible genetic mutations are 'APC gene mutation' and 'PAH mutation'.\n\nNext, I will use the Protein truncation test to detect any truncated proteins, which can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since the Protein truncation test showed no truncated proteins, we can rule out the APC gene mutation. The remaining possible genetic mutation is 'PAH mutation'.\n\nI will now predict that the genetic mutation is 'PAH mutation'.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5253, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "High-resolution melt analysis (HRM)", "Protein truncation test", "PAH mutation", {"predicted_truth": "PAH mutation"}], "generated_text": ["To start, I will perform Multiplex Ligation-dependent Probe Amplification (MLPA) to check for copy number variations. This assay can help rule out PMP22 duplication if no copy number variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA result shows a normal copy number, we can rule out PMP22 duplication. The remaining possible genetic mutations are:\n\n- APC gene mutation\n- MTHFR mutation\n- PAH mutation\n\nNext, I will perform High-resolution Melt Analysis (HRM) to check for DNA sequence variations. This assay can help rule out MTHFR mutation if no melting curve abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM result shows no melting curve abnormalities, we can rule out MTHFR mutation. The remaining possible genetic mutations are:\n\n- APC gene mutation\n- PAH mutation\n\nNext, I will perform a Protein Truncation Test to check for truncated proteins, which can help rule out APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since the Protein Truncation Test shows no truncated proteins, we can rule out APC gene mutation. The remaining possible genetic mutation is:\n\n- PAH mutation\n\nGiven the remaining mutation and the results from the previous assays, I will predict that the genetic mutation is PAH mutation.\n\n<ANSWER> PAH mutation </ANSWER>"], "consumed_tokens": 5247, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}], "seed": 37, "average_actions": 5.0, "average_tokens": 5288.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 5288.0}
{"trajectories": [{"actions": ["Enzyme assay", "Southern blot", "Protein truncation test", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Given the initial state, I will start by performing an assay that can potentially rule out one of the genetic mutations. The **Enzyme assay** is a good choice because it can directly rule out the **G6PD deficiency mutation** if the enzyme activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 83.20096605773331, which falls within the range of 75 to 100%. According to the guidebook, this indicates that the G6PD deficiency mutation can be excluded.\n\nWith the G6PD deficiency mutation ruled out, the remaining possible genetic mutations are:\n- FMR1 gene expansion\n- CFTR mutation\n- APC gene mutation\n\nThe next logical step is to perform a **Southern blot** to check for the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot test revealed a normal-sized fragment, which means the FMR1 gene expansion can be ruled out.\n\nWith the FMR1 gene expansion and G6PD deficiency mutation both ruled out, the remaining possible genetic mutations are:\n- CFTR mutation\n- APC gene mutation\n\nNext, I will perform a **Protein truncation test** to check for the presence of truncated proteins, which can help rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The Protein truncation test did not detect any truncated proteins, which means the APC gene mutation can be ruled out.\n\nWith the G6PD deficiency mutation, FMR1 gene expansion, and APC gene mutation all ruled out, the only remaining possible genetic mutation is the **CFTR mutation**.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 5334, "observations": [null, {"action": "Enzyme assay", "observation": 83.20096605773331}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "Protein truncation test", "Next-generation sequencing (NGS)", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Let's start by performing a Southern blot to rule out the FMR1 gene expansion if a normal-sized fragment is detected. This will help narrow down the list of possible mutations.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot revealed a normal-sized fragment, we can rule out the FMR1 gene expansion. The remaining possible mutations are:\n\n- G6PD deficiency mutation\n- CFTR mutation\n- APC gene mutation\n\nNext, let's perform an enzyme assay to check for G6PD deficiency. If the enzyme activity is between 75 and 100%, we can exclude G6PD deficiency.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay showed an enzyme activity of 83.20096605773331%, which is between 75 and 100%. This indicates that G6PD deficiency can be excluded.\n\nThe remaining possible mutations are:\n\n- CFTR mutation\n- APC gene mutation\n\nNext, let's perform a protein truncation test to check for the APC gene mutation. If no truncated proteins are detected, we can rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, we can rule out the APC gene mutation.\n\nThe remaining possible mutation is:\n\n- CFTR mutation\n\nTo confirm this, let's perform next-generation sequencing (NGS) to check for variants in the CFTR gene. If no variants are detected, we can rule out the CFTR mutation.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since next-generation sequencing (NGS) detected variants, we can confirm that the mutation is indeed a CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 6744, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 83.20096605773331}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Next-generation sequencing (NGS)", "observation": "Variants detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "Protein truncation test", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Given the initial state and the available assays, the most logical first step is to use an assay that can potentially rule out multiple mutations at once. The **Southern blot** is a good choice because it can specifically rule out the FMR1 gene expansion if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation that a normal-sized fragment was detected in the Southern blot, the FMR1 gene expansion can be ruled out. This leaves us with the following possible genetic mutations: 'G6PD deficiency mutation', 'CFTR mutation', and 'APC gene mutation'.\n\nThe next logical step is to use an **enzyme assay** to check for G6PD enzyme activity, which can help rule out the G6PD deficiency mutation if the enzyme activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 83.20096605773331 is within the range of 75 to 100%, which indicates that G6PD deficiency can be excluded.\n\nThis leaves us with the following possible genetic mutations: 'CFTR mutation' and 'APC gene mutation'.\n\nThe next logical step is to use a **protein truncation test** to check for truncated proteins, which can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected in the protein truncation test, the APC gene mutation can be ruled out. This leaves us with only one possible genetic mutation: 'CFTR mutation'.\n\nTherefore, the remaining mutation must be the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 5295, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 83.20096605773331}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Southern blot", "Protein truncation test", "DNA sequencing", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["To start, I'll perform an enzyme assay to check for G6PD deficiency. This will help me rule out the G6PD deficiency mutation if the enzyme activity is normal.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 83.20096605773331, which falls within the range of 75 to 100%. This indicates that G6PD deficiency can be excluded.\n\nNow, I will perform a Southern blot to check for the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot revealed a normal-sized fragment, which means the FMR1 gene expansion can be ruled out.\n\nNow, I will perform a protein truncation test to check for the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The protein truncation test did not detect any truncated proteins, which means the APC gene mutation can be ruled out.\n\nThe only remaining mutation is the CFTR mutation. To confirm, I will perform a DNA sequencing test to check for CFTR mutations.\n\n<ANSWER> DNA sequencing </ANSWER>", "The DNA sequencing detected mutations, confirming the presence of a CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 6467, "observations": [null, {"action": "Enzyme assay", "observation": 83.20096605773331}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "DNA sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "Protein truncation test", "CFTR mutation", {"predicted_truth": "CFTR mutation"}], "generated_text": ["Given the initial state, the best approach is to start with an assay that can potentially rule out multiple mutations. The `Southern blot` is a good choice because it can rule out the FMR1 gene expansion if a normal-sized fragment is detected. This will help narrow down the list of possible mutations.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot revealed a normal-sized fragment, we can rule out the FMR1 gene expansion. The remaining possible mutations are:\n\n- G6PD deficiency mutation\n- CFTR mutation\n- APC gene mutation\n\nNext, we should perform an assay that can help us further narrow down the list. The `Enzyme assay` is a good choice because it can rule out the G6PD deficiency mutation if the enzyme activity is within the normal range (75-100%).\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 83.20096605773331 falls within the normal range (75-100%), which means we can rule out the G6PD deficiency mutation. The remaining possible mutations are:\n\n- CFTR mutation\n- APC gene mutation\n\nNext, we should perform an assay that can help us distinguish between these two mutations. The `Protein truncation test` can rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, we can rule out the APC gene mutation. This leaves us with the CFTR mutation as the only remaining possibility.\n\nGiven that we have ruled out all other mutations, we can confidently predict that the genetic mutation is the CFTR mutation.\n\n<ANSWER> CFTR mutation </ANSWER>"], "consumed_tokens": 5323, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 83.20096605773331}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}], "successful": true, "parse_error": false}], "seed": 38, "average_actions": 5.4, "average_tokens": 5832.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.4, "average_successful_tokens": 5832.6}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Southern blot", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game and the available assays, the most efficient first step would be to perform an assay that can potentially rule out multiple mutations in a single step. The **Next-generation sequencing (NGS)** is a comprehensive assay that can detect a wide range of genetic variants, making it a good choice for the first round.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-generation sequencing (NGS) did not detect any variants, we can rule out the BRCA1 and BRCA2 mutations. This leaves us with the DMD mutation and HTT gene expansion as potential candidates.\n\nNext, we should use an assay that can differentiate between these two remaining mutations. The **Southern blot** is a good choice because it can detect specific DNA fragments and can help us rule out the HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot detected a normal-sized fragment, which rules out the HTT gene expansion. This leaves us with the DMD mutation as the only remaining candidate.\n\nTo confirm the DMD mutation, we can use the **Fluorescence in situ hybridization (FISH)** assay, which is effective in detecting deletions associated with DMD mutations.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The Fluorescence in situ hybridization (FISH) assay detected a deletion, confirming the presence of a DMD mutation. Given this information, we can confidently identify the genetic mutation responsible for the observed trait.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5421, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Southern blot", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state and the available assays, a logical first step is to perform an assay that can potentially rule out multiple mutations at once. The **Next-generation sequencing (NGS)** is a comprehensive technique that can detect a wide range of genetic variants, making it a good choice to start with.\n\n**Reasoning:**\n- **Next-generation sequencing (NGS)** can detect variants in BRCA1, BRCA2, and other genes.\n- If no variants are detected, we can rule out BRCA1 and BRCA2 mutations, significantly narrowing down the list of possible mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Given the observation that no variants were detected by Next-generation sequencing (NGS), we can rule out BRCA1 and BRCA2 mutations. This leaves us with two possible mutations: DMD mutation and HTT gene expansion.\n\n**Reasoning:**\n- **Southern Blot** is a good next step because it can specifically detect the presence of gene expansions, which is relevant for HTT gene expansion.\n- If a normal-sized fragment is detected, it rules out HTT gene expansion, leaving DMD mutation as the only possibility.\n\n<ANSWER> Southern blot </ANSWER>", "Given the observation that a normal-sized fragment was detected by Southern blot, we can rule out HTT gene expansion. This leaves us with only one possible mutation: DMD mutation.\n\n**Reasoning:**\n- Since HTT gene expansion is ruled out and BRCA1 and BRCA2 mutations were already ruled out by the NGS result, the only remaining mutation is DMD mutation.\n- To confirm, we can use Fluorescence in situ hybridization (FISH) to check for deletions, which are typical in DMD mutations.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Given the observation that a deletion was detected by Fluorescence in situ hybridization (FISH), we can confidently identify the mutation as DMD mutation. This confirms that the remaining genetic mutation is responsible for the observed trait.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5759, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": [null], "generated_text": ["Given the initial state and the available assays, a strategic first step would be to perform a test that can potentially rule out multiple mutations based on a single result. The **Southern Blot** is a good choice for this purpose because it can specifically detect the presence or absence of an abnormal expansion in the HTT gene, which would rule out Huntington's Disease (HTT gene expansion) if no such expansion is detected.\n\n<ANSWER> Southern Blot </ANSWER>"], "consumed_tokens": 1179, "observations": [null], "successful": false, "parse_error": true}, {"actions": ["Next-generation sequencing (NGS)", "Southern blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial list of possible genetic mutations and the available assays, a good starting point would be to perform an assay that can provide broad information to rule out multiple mutations at once. The **Next-generation sequencing (NGS)** assay is particularly useful for this purpose as it can detect a wide range of genetic variants.\n\nLet's start with **Next-generation sequencing (NGS)** to see if we can rule out any of the BRCA1 or BRCA2 mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-generation sequencing (NGS) assay showed no variants detected, we can rule out BRCA1 and BRCA2 mutations. This leaves us with two possible mutations: DMD mutation and HTT gene expansion.\n\nNext, we can use the **Southern blot** assay to detect specific DNA fragments. If there is no abnormal expansion, it will help us rule out the HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot assay detected a normal-sized fragment, which rules out the HTT gene expansion. This leaves us with the DMD mutation as the only remaining possibility.\n\nSince we have ruled out all other mutations, we can confidently predict the DMD mutation as the cause of the trait.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 3938, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Southern blot", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state, the most informative assay to start with would be 'Next-generation sequencing (NGS)' because it can provide a comprehensive overview of genetic variants and help rule out multiple mutations at once.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected with Next-generation sequencing (NGS), we can rule out the BRCA1 and BRCA2 mutations. This leaves us with the DMD mutation and HTT gene expansion as possible candidates.\n\nNext, let's use the 'Southern blot' assay to check for the HTT gene expansion. If the Southern blot detects a normal-sized fragment, it would rule out the HTT gene expansion, leaving the DMD mutation as the only remaining possibility.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot detected a normal-sized fragment, we can rule out the HTT gene expansion. This leaves us with the DMD mutation as the only remaining possibility.\n\nTo confirm the DMD mutation, we can use the 'Fluorescence in situ hybridization (FISH)' assay. If no deletions are detected, it will rule out the DMD mutation. However, if deletions are detected, it will confirm the DMD mutation.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since the Fluorescence in situ hybridization (FISH) assay detected a deletion, this confirms the presence of the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5355, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}], "seed": 39, "average_actions": 4.0, "average_tokens": 4330.4, "average_correct": 0.8, "average_parse_error": 0.2, "average_successful_action_num": 4.75, "average_successful_tokens": 5118.25}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Karyotyping", "RNA sequencing", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, I will use an assay that can potentially rule out multiple mutations in one step. **Next-Generation Sequencing (NGS)** is a powerful tool that can provide detailed information about genetic variants, helping to quickly narrow down the possibilities.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected in the Next-Generation Sequencing (NGS) assay, we can rule out the **HBB mutation**. This leaves us with the following possible mutations: **MECP2 mutation**, **PMP22 duplication**, and **MTHFR mutation**.\n\nNext, I will perform **Karyotyping** to check for large genetic changes, which can help rule out **PMP22 duplication**.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, we can rule out the **PMP22 duplication**. This leaves us with **MECP2 mutation** and **MTHFR mutation**.\n\nNext, I will perform **RNA sequencing** to check for normal transcript levels, which can help rule out the **MECP2 mutation**.\n\n<ANSWER> RNA sequencing </ANSWER>", "Since the RNA sequencing showed normal transcript levels, we can rule out the **MECP2 mutation**. This leaves us with only **MTHFR mutation** as the remaining possibility.\n\nGiven the current evidence, I believe the mutation is **MTHFR mutation**.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5016, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "RNA sequencing", "observation": "Normal transcript levels"}], "successful": true, "parse_error": false}, {"actions": ["Karyotyping", "Next-generation sequencing (NGS)", "RNA sequencing", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Given the initial state and the information provided in the guidebook, the most efficient first step is to perform an assay that can potentially rule out multiple mutations. \n\n**Karyotyping** is a good choice here because it can quickly rule out **PMP22 duplication** if the karyotype is normal. This is a broad and informative assay that can help us narrow down the possibilities significantly in one step.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, we can rule out the **PMP22 duplication**. This leaves us with the following possible genetic mutations:\n\n- **MECP2 mutation**\n- **MTHFR mutation**\n- **HBB mutation**\n\nNext, we should perform an assay that can help us further narrow down these remaining mutations. **Next-generation sequencing (NGS)** is a comprehensive assay that can detect detailed sequencing information, which can help us rule out the **HBB mutation** if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected by Next-generation sequencing (NGS), we can rule out the **HBB mutation**. This leaves us with the following possible genetic mutations:\n\n- **MECP2 mutation**\n- **MTHFR mutation**\n\nNext, we should perform an assay that can help us distinguish between these two remaining mutations. **RNA sequencing** can be useful here because it measures transcript levels, and normal transcript levels would rule out the **MECP2 mutation**.\n\n<ANSWER> RNA sequencing </ANSWER>", "Since the RNA sequencing results show normal transcript levels, we can rule out the **MECP2 mutation**. This leaves us with only one possible genetic mutation:\n\n- **MTHFR mutation**\n\nTherefore, we can confidently identify the mutation as the **MTHFR mutation**.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5249, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "RNA sequencing", "observation": "Normal transcript levels"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Karyotyping", "MECP2 mutation", {"predicted_truth": "MECP2 mutation"}], "generated_text": ["To begin, let's use an assay that can rule out multiple genetic mutations in one step. Next-generation sequencing (NGS) is a good choice because it can provide detailed sequencing information and potentially rule out the presence of HBB and MTHFR mutations if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Given that no variants were detected by Next-generation sequencing (NGS), we can rule out the **HBB mutation** and **MTHFR mutation**. This leaves us with two possible mutations: **MECP2 mutation** and **PMP22 duplication**.\n\nNext, let's use Karyotyping to see if we can rule out the **PMP22 duplication**. Karyotyping can identify large genetic changes, such as duplications or deletions.\n\n<ANSWER> Karyotyping </ANSWER>", "Given that the karyotype is normal, we can rule out the **PMP22 duplication**. This leaves us with only one possible mutation: **MECP2 mutation**.\n\nSince we have eliminated all other possibilities, we can confidently predict the remaining mutation.\n\n<ANSWER> MECP2 mutation </ANSWER>"], "consumed_tokens": 3622, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Karyotyping", "observation": "Normal karyotype"}], "successful": false, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Karyotyping", "RNA sequencing", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, I will perform a broad assay that can help me rule out multiple mutations at once. Next-generation sequencing (NGS) is a good choice because it can detect a wide range of genetic variations, including those in the MECP2, PMP22, MTHFR, and HBB genes.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The observation from the Next-generation sequencing (NGS) assay indicates that no variants were detected. According to the guidebook, this result rules out the **HBB mutation**. \n\nNow, the remaining possible mutations are:\n- MECP2 mutation\n- PMP22 duplication\n- MTHFR mutation\n\nNext, I will perform Karyotyping to check for large genetic changes, which can help rule out the PMP22 duplication.\n\n<ANSWER> Karyotyping </ANSWER>", "The observation from the Karyotyping assay indicates a normal karyotype. According to the guidebook, this result rules out the **PMP22 duplication**.\n\nNow, the remaining possible mutations are:\n- MECP2 mutation\n- MTHFR mutation\n\nNext, I will perform RNA sequencing to check for normal transcript levels, which can help rule out the MECP2 mutation.\n\n<ANSWER> RNA sequencing </ANSWER>", "The observation from the RNA sequencing assay indicates normal transcript levels. According to the guidebook, this result rules out the **MECP2 mutation**.\n\nNow, the only remaining possible mutation is:\n- MTHFR mutation\n\nTherefore, I will predict that the genetic mutation responsible for the trait is the **MTHFR mutation**.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5113, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "RNA sequencing", "observation": "Normal transcript levels"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Karyotyping", "RNA sequencing", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Given the initial state, I will start by performing an assay that can potentially eliminate multiple options. The **Next-Generation Sequencing (NGS)** is a comprehensive assay that can detect various types of mutations, making it a good initial choice to rule out multiple options if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS assay did not detect any variants, we can rule out the **HBB mutation**. Next, I will perform **Karyotyping** to check for large genetic changes that could indicate a **PMP22 duplication**.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, we can rule out the **PMP22 duplication**. This leaves us with **MECP2 mutation** and **MTHFR mutation**. Next, I will perform **RNA sequencing** to check for normal transcript levels, which would help rule out the **MECP2 mutation**.\n\n<ANSWER> RNA sequencing </ANSWER>", "Since the RNA sequencing showed normal transcript levels, we can rule out the **MECP2 mutation**. This leaves us with the **MTHFR mutation**. \n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 4915, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "RNA sequencing", "observation": "Normal transcript levels"}], "successful": true, "parse_error": false}], "seed": 40, "average_actions": 4.8, "average_tokens": 4783.0, "average_correct": 0.8, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 5073.25}
{"trajectories": [{"actions": ["Tandem repeat PCR", "Fluorescence in situ hybridization (FISH)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform an assay that can potentially rule out multiple mutations or provide a clear indication of the type of mutation we are dealing with. The **Tandem Repeat PCR** assay is a good choice because it can directly identify the HTT gene expansion, which is a specific and distinct mutation.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result of 19.84742917072265 is well within the range of (0, 30) repeats, which rules out the HTT gene expansion.\n\nNow, we need to determine which of the remaining mutations (SMN1 deletion, HBB mutation, UBE3A mutation) is the correct one. The **Fluorescence in situ hybridization (FISH)** assay can help rule out the SMN1 deletion, which is a specific and detectable deletion.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay detected a deletion, which strongly suggests that the mutation is the **SMN1 deletion**. Given this result, we can confidently predict that the genetic mutation is the SMN1 deletion.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 4116, "observations": [null, {"action": "Tandem repeat PCR", "observation": 19.84742917072265}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": false, "parse_error": false}, {"actions": ["Karyotyping", "RFLP analysis", "Tandem repeat PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the initial state, it's best to start with an assay that can potentially rule out a significant number of mutations. Karyotyping is a good initial test because it can easily rule out the SMN1 deletion if the karyotype is normal.\n\n<ANSWER> Karyotyping </ANSWER>", "The karyotype is normal, which rules out the SMN1 deletion. Now, we have the following mutations left to consider: 'HTT gene expansion', 'HBB mutation', and 'UBE3A mutation'.\n\nNext, let's perform an RFLP analysis to check for the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The normal restriction pattern from the RFLP analysis rules out the HBB mutation. Now, we have the following mutations left to consider: 'HTT gene expansion' and 'UBE3A mutation'.\n\nNext, let's perform a Tandem repeat PCR to check for the HTT gene expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem repeat PCR result of 19.84742917072265 falls within the normal range (0, 30) repeats, which rules out the HTT gene expansion. \n\nNow, the only remaining mutation is 'UBE3A mutation'.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 5486, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Tandem repeat PCR", "observation": 19.84742917072265}], "successful": true, "parse_error": false}, {"actions": ["Karyotyping", "RFLP analysis", "Tandem repeat PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, I will perform an assay that can potentially rule out a common genetic mutation. Karyotyping is a good initial test as it can quickly rule out SMN1 deletion, which is a structural change that would be visible in the karyotype.\n\n<ANSWER> Karyotyping </ANSWER>", "Given the normal karyotype, we can rule out the SMN1 deletion. The remaining possible mutations are HTT gene expansion, HBB mutation, and UBE3A mutation. Next, I will perform an assay that can help rule out another mutation. RFLP analysis is a good choice as it can detect the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "Given the normal restriction pattern, we can rule out the HBB mutation. The remaining possible mutations are HTT gene expansion and UBE3A mutation. Next, I will perform an assay that can help distinguish between these two. Tandem repeat PCR is a good choice as it can detect the CAG trinucleotide repeats associated with the HTT gene expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem repeat PCR shows 19.84742917072265 repeats, which falls within the (0, 30) range. This range indicates that the HTT gene expansion is ruled out. Therefore, the only remaining possible mutation is UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 5546, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Tandem repeat PCR", "observation": 19.84742917072265}], "successful": true, "parse_error": false}, {"actions": ["Karyotyping", "RFLP analysis", "Tandem repeat PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, I will choose an assay that can help rule out one or more mutations based on the initial state. Karyotyping is a good first step because it can help rule out the SMN1 deletion if the results are normal.\n\n<ANSWER> Karyotyping </ANSWER>", "Since the karyotype is normal, the SMN1 deletion has been ruled out. Next, I will perform RFLP analysis to check for the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The normal karyotype has ruled out the SMN1 deletion, and the normal restriction pattern has ruled out the HBB mutation. This leaves us with the HTT gene expansion and the UBE3A mutation. \n\nTo distinguish between these two, I will perform Tandem repeat PCR to check for the HTT gene expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The result of 19.84742917072265 repeats from the Tandem repeat PCR is within the (0, 30) range, which rules out the HTT gene expansion. This leaves us with the UBE3A mutation as the only remaining possibility.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 5407, "observations": [null, {"action": "Karyotyping", "observation": "Normal karyotype"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Tandem repeat PCR", "observation": 19.84742917072265}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "Tandem repeat PCR", "RFLP analysis", "Karyotyping", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the initial state of the game, we have four possible genetic mutations: 'HTT gene expansion', 'SMN1 deletion', 'HBB mutation', and 'UBE3A mutation'. To make an informed decision, we should start with an assay that can potentially rule out the most mutations in one step. \n\nKaryotyping and FISH are both useful for detecting large structural changes or deletions, which can help us rule out the SMN1 deletion. However, Karyotyping is more general and might not detect smaller deletions, while FISH is more specific for deletions and can provide a clear result.\n\nLet's start with FISH to see if we can rule out the SMN1 deletion.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since the FISH assay detected a deletion, we cannot rule out the SMN1 deletion. This leaves us with the following possible mutations: 'HTT gene expansion', 'SMN1 deletion', 'HBB mutation', and 'UBE3A mutation'.\n\nTo narrow it down further, we can use Tandem Repeat PCR, which is specific for detecting expansions like those in the HTT gene. If the assay shows a normal number of repeats, we can rule out the HTT gene expansion.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result of 19.84742917072265 repeats is within the normal range (0 to 30 repeats). Therefore, we can rule out the HTT gene expansion.\n\nThis leaves us with the following possible mutations: 'SMN1 deletion', 'HBB mutation', and 'UBE3A mutation'.\n\nNext, we can use RFLP analysis to check for the HBB mutation. If the restriction pattern is normal, we can rule out the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis result shows a normal restriction pattern, which allows us to rule out the HBB mutation.\n\nThis leaves us with the following possible mutations: 'SMN1 deletion' and 'UBE3A mutation'.\n\nSince FISH already detected a deletion, which is consistent with the SMN1 deletion, we can perform a final assay to confirm this. Karyotyping can help us rule out or confirm the SMN1 deletion more definitively.\n\n<ANSWER> Karyotyping </ANSWER>", "The normal karyotype result rules out the SMN1 deletion. This leaves us with the UBE3A mutation as the only remaining possible mutation.\n\nSince we have ruled out all other mutations, we can confidently predict the UBE3A mutation as the responsible genetic mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 8047, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "Tandem repeat PCR", "observation": 19.84742917072265}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Karyotyping", "observation": "Normal karyotype"}], "successful": true, "parse_error": false}], "seed": 41, "average_actions": 5.0, "average_tokens": 5720.4, "average_correct": 0.8, "average_parse_error": 0.0, "average_successful_action_num": 5.25, "average_successful_tokens": 6121.5}
{"trajectories": [{"actions": ["Western blot", "RFLP analysis", "High-resolution melt analysis (HRM)", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["Given the initial state, the best initial action is to perform an assay that can potentially rule out multiple mutations. The **Western blot** is a good choice because it can provide information about protein size and presence, which can help us eliminate the DMD mutation if the protein is of expected size, or prompt further investigation if it is absent or truncated.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the protein is of expected size, ruling out the DMD mutation. The remaining possible mutations are CFTR, BRCA2, and HBB.\n\nNext, we can use **RFLP analysis** to check for the HBB mutation. If the restriction pattern is normal, it will rule out the HBB mutation, leaving us with CFTR and BRCA2 mutations to investigate.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis result shows a normal restriction pattern, ruling out the HBB mutation. The remaining possible mutations are CFTR and BRCA2.\n\nNext, we can use **High-resolution melt analysis (HRM)** to check for the CFTR mutation. If no melting curve abnormalities are detected, it will rule out the CFTR mutation, leaving us with the BRCA2 mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) result shows no melting curve abnormalities, ruling out the CFTR mutation. The only remaining possible mutation is BRCA2.\n\nSince we have ruled out all other mutations, the only plausible mutation is BRCA2.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5702, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "High-resolution melt analysis (HRM)", "RFLP analysis", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To begin, I will choose an assay that can potentially rule out a significant number of mutations in one step. The Western blot is a good initial choice because it can provide information about the presence or absence of proteins, which can help rule out at least one mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the protein of expected size is detected. This rules out the DMD mutation, as it suggests that the dystrophin protein is present and of normal size.\n\nNext, I will perform a High-resolution melt analysis (HRM) to further narrow down the possibilities.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) result shows no melting curve abnormalities, which rules out the CFTR mutation, as it suggests there are no significant nucleotide changes in the region of interest.\n\nWith the DMD and CFTR mutations ruled out, we are left with the BRCA2 and HBB mutations. The next logical step is to perform RFLP analysis to further narrow down the possibilities.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis result shows a normal restriction pattern, which rules out the HBB mutation, as it indicates the absence of beta-globin related abnormalities.\n\nGiven that the DMD, CFTR, and HBB mutations have been ruled out, the only remaining mutation is the BRCA2 mutation. Therefore, I will predict the BRCA2 mutation as the answer.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5598, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "High-resolution melt analysis (HRM)", "RFLP analysis", "Sanger sequencing", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I will perform a **Western blot** to determine if the protein of interest is present and of the expected size. This can help rule out the DMD mutation, which is associated with the absence or truncation of the dystrophin protein.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result shows that the protein of expected size is detected, which rules out the DMD mutation. Now, I will perform a **High-resolution melt analysis (HRM)** to check for any melting curve abnormalities that could indicate the presence of the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM result shows no melting curve abnormalities, which rules out the CFTR mutation. Now, I will perform a **RFLP analysis** to check for any abnormalities in the restriction pattern that could indicate the presence of the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis shows a normal restriction pattern, which rules out the HBB mutation. At this point, the only remaining mutation is the BRCA2 mutation. I will confirm this by performing a **Sanger sequencing** to check for any mutations at the single-nucleotide level.\n\n<ANSWER> Sanger sequencing </ANSWER>", "The Sanger sequencing detected mutations, which confirms the presence of a genetic mutation. Given that the only remaining mutation is the BRCA2 mutation, I can confidently predict that this is the responsible mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 7113, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "Sanger sequencing", "observation": "Mutations detected"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "RFLP analysis", "High-resolution melt analysis (HRM)", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To begin, I will choose the Western blot assay. This assay can provide information about the presence or absence of specific proteins, which can help rule out the DMD mutation if the dystrophin protein is present and of normal size.\n\n<ANSWER> Western blot </ANSWER>", "Based on the Western blot result, the protein of expected size was detected, which rules out the DMD mutation. The remaining possible mutations are CFTR mutation, BRCA2 mutation, and HBB mutation.\n\nNext, I will perform the RFLP analysis to further narrow down the possible mutations.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis showed a normal restriction pattern, which rules out the HBB mutation. The remaining possible mutations are CFTR mutation and BRCA2 mutation.\n\nNext, I will perform the High-resolution melt analysis (HRM) to further narrow down the possible mutations.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) showed no melting curve abnormalities, which rules out the CFTR mutation. The only remaining possible mutation is the BRCA2 mutation.\n\nI will predict that the mutation is BRCA2 mutation.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5486, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Western blot", "RFLP analysis", "High-resolution melt analysis (HRM)", "BRCA2 mutation", {"predicted_truth": "BRCA2 mutation"}], "generated_text": ["To start, I'll perform a Western blot to get an initial indication of protein expression levels. This will help me rule out the DMD mutation if the protein of expected size is detected.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result indicates that the protein of expected size was detected, ruling out the DMD mutation. Next, I'll perform an RFLP analysis to check for the HBB mutation.\n\n<ANSWER> RFLP analysis </ANSWER>", "The RFLP analysis result shows a normal restriction pattern, ruling out the HBB mutation. Next, I'll perform a High-resolution melt analysis (HRM) to check for the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) result shows no melting curve abnormalities, ruling out the CFTR mutation. This leaves us with the BRCA2 mutation as the only remaining possibility.\n\n<ANSWER> BRCA2 mutation </ANSWER>"], "consumed_tokens": 5350, "observations": [null, {"action": "Western blot", "observation": "Protein of expected size detected"}, {"action": "RFLP analysis", "observation": "Normal restriction pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}], "seed": 42, "average_actions": 5.2, "average_tokens": 5849.8, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.2, "average_successful_tokens": 5849.8}
{"trajectories": [{"actions": ["Methylation-specific PCR", "High-resolution melt analysis (HRM)", "Allele-specific oligonucleotide hybridization", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, I will perform an assay that can potentially rule out multiple mutations. The **Methylation-specific PCR** is a good initial choice because it can rule out the MECP2 mutation, which is associated with specific methylation patterns.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The normal methylation pattern from the Methylation-specific PCR rules out the MECP2 mutation. Next, I will perform a **High-resolution melt analysis (HRM)** to check for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The absence of melting curve abnormalities in the High-resolution melt analysis (HRM) rules out the MTHFR mutation. Now, I will perform **Allele-specific oligonucleotide hybridization** to check for the GJB2 mutation.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "The lack of hybridization with the mutant probe in the Allele-specific oligonucleotide hybridization rules out the GJB2 mutation. Given the results so far, the only remaining mutation is the COL1A1 mutation.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 4880, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "High-resolution melt analysis (HRM)", "Allele-specific oligonucleotide hybridization", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, I will perform an assay that can help narrow down the list of possible mutations. The **Methylation-specific PCR** is a good initial test because it can rule out the MECP2 mutation, which is associated with DNA methylation patterns.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Given the observation of a normal methylation pattern, the MECP2 mutation can be ruled out. The remaining possible mutations are MTHFR, GJB2, and COL1A1.\n\nNext, I will perform **High-resolution melt analysis (HRM)** to check for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Given the observation of no melting curve abnormalities, the MTHFR mutation can be ruled out. The remaining possible mutations are GJB2 and COL1A1.\n\nNext, I will perform **Allele-specific oligonucleotide hybridization** to check for the GJB2 mutation.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Given the observation of no hybridization with the mutant probe, the GJB2 mutation can be ruled out. The only remaining possible mutation is COL1A1.\n\nTherefore, the mutation responsible for the trait is the **COL1A1 mutation**.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 4972, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "High-resolution melt analysis (HRM)", "Western blot", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["Given the initial state and the available assays, I will start by performing a **Methylation-specific PCR** to quickly rule out the **MECP2 mutation** if the methylation pattern is normal.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Since the methylation pattern is normal, we can rule out the **MECP2 mutation**. Next, I will perform a **High-resolution melt analysis (HRM)** to check for the **MTHFR mutation**.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since there are no melting curve abnormalities, we can rule out the **MTHFR mutation**. Next, I will perform a **Western blot** to check for the **COL1A1 mutation**.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot observation shows that the protein is absent or truncated, which strongly suggests the presence of a **COL1A1 mutation**. Therefore, I will predict that the genetic mutation is **COL1A1 mutation**.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 4821, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["DNA sequencing", "Western blot", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["Given the initial state, I will start by using an assay that can potentially rule out multiple mutations. The `DNA sequencing` assay is comprehensive and can detect mutations in both the MTHFR and GJB2 genes. If no mutations are detected, it will significantly narrow down the list of possible mutations.\n\n<ANSWER> DNA sequencing </ANSWER>", "Since DNA sequencing did not detect any mutations in the MTHFR and GJB2 genes, we can rule out both of these mutations. This leaves us with the COL1A1 and MECP2 mutations. To further narrow it down, I will perform a `Western blot` to check for the presence of the COL1A1 protein. If the protein is detected, we can rule out the COL1A1 mutation.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot showed that the COL1A1 protein is absent or truncated, which strongly suggests a mutation in the COL1A1 gene. Given this result, the most plausible mutation is the COL1A1 mutation. I will predict this as the truth.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 3603, "observations": [null, {"action": "DNA sequencing", "observation": "No mutations detected"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Methylation-specific PCR", "High-resolution melt analysis (HRM)", "Allele-specific oligonucleotide hybridization", "Western blot", "COL1A1 mutation", {"predicted_truth": "COL1A1 mutation"}], "generated_text": ["To start, I will perform an assay that can help me rule out a significant number of mutations. The **Methylation-specific PCR** is a good choice because it can rule out the MECP2 mutation, which is a strong candidate given its association with DNA methylation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "Based on the observation of a normal methylation pattern, the MECP2 mutation has been ruled out. The remaining possible mutations are MTHFR, GJB2, and COL1A1. \n\nNext, I will perform **High-resolution melt analysis (HRM)** to check for the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Based on the observation of no melting curve abnormalities, the MTHFR mutation has been ruled out. The remaining possible mutations are GJB2 and COL1A1.\n\nNext, I will perform **Allele-specific oligonucleotide hybridization** to check for the GJB2 mutation.\n\n<ANSWER> Allele-specific oligonucleotide hybridization </ANSWER>", "Based on the observation of no hybridization with the mutant probe, the GJB2 mutation has been ruled out. The only remaining possible mutation is COL1A1.\n\nI will now perform **Western blot** to confirm the presence of the COL1A1 mutation.\n\n<ANSWER> Western blot </ANSWER>", "Based on the observation that the protein is absent or truncated, it confirms the presence of a COL1A1 mutation.\n\n<ANSWER> COL1A1 mutation </ANSWER>"], "consumed_tokens": 6480, "observations": [null, {"action": "Methylation-specific PCR", "observation": "Normal methylation pattern"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Allele-specific oligonucleotide hybridization", "observation": "No hybridization with mutant probe"}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}], "seed": 43, "average_actions": 5.0, "average_tokens": 4951.2, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 4951.2}
{"trajectories": [{"actions": ["Enzyme assay", "Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the initial list of genetic mutations and the available assays, the most strategic first step is to perform an assay that can potentially rule out multiple mutations. The **Enzyme assay** is a good choice because it can immediately rule out the G6PD deficiency mutation if the results are within the normal range. This will help narrow down the list of possible mutations more efficiently.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 77.504502638558 falls within the normal range (75-100), which rules out the G6PD deficiency mutation. This leaves us with the following possible mutations: PMP22 duplication, CFTR mutation, and UBE3A mutation.\n\nNext, we should choose an assay that can help us rule out another mutation. The **Fluorescence in situ hybridization (FISH)** is a good choice because it can detect deletions or duplications, which would help rule out the PMP22 duplication if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay results show no deletions detected, which rules out the PMP22 duplication. This leaves us with the CFTR mutation and the UBE3A mutation.\n\nNext, we should choose an assay that can help us distinguish between these two remaining mutations. The **High-resolution melt analysis (HRM)** is a good choice because it can detect abnormalities in the melting curves, which would help rule out the CFTR mutation if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-resolution melt analysis (HRM) results show no melting curve abnormalities, which rules out the CFTR mutation. This leaves us with only one possible mutation: the UBE3A mutation.\n\nSince we have ruled out all other mutations, the remaining mutation is the UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 5988, "observations": [null, {"action": "Enzyme assay", "observation": 77.504502638558}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "Methylation-specific PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the initial state, the most logical first step is to perform an assay that can potentially rule out a significant number of mutations. The **Enzyme assay** is a good choice because it can immediately rule out the **G6PD deficiency mutation** if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 77.504502638558 falls within the normal range (75-100), which rules out the **G6PD deficiency mutation**. \n\nNow, the remaining possible mutations are:\n- PMP22 duplication\n- CFTR mutation\n- UBE3A mutation\n\nThe next logical step is to perform a **Fluorescence in situ hybridization (FISH)** to check for chromosomal deletions or duplications, which can rule out the **PMP22 duplication** if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay result shows no deletions detected, which rules out the **PMP22 duplication**.\n\nNow, the remaining possible mutations are:\n- CFTR mutation\n- UBE3A mutation\n\nThe next logical step is to perform a **High-Resolution Melt Analysis (HRM)** to check for variations in the DNA sequence, which can rule out the **CFTR mutation** if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM assay result shows no melting curve abnormalities, which rules out the **CFTR mutation**.\n\nNow, the only remaining possible mutation is:\n- UBE3A mutation\n\nTo confirm the UBE3A mutation, we can perform a **Methylation-specific PCR** to check for abnormal methylation patterns, which are indicative of the UBE3A mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The Methylation-specific PCR assay result shows an abnormal methylation pattern, which confirms the **UBE3A mutation**.\n\nGiven the results from the previous assays and the final confirmation from the Methylation-specific PCR, the only remaining and confirmed mutation is the **UBE3A mutation**.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 7710, "observations": [null, {"action": "Enzyme assay", "observation": 77.504502638558}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Methylation-specific PCR", "observation": "Abnormal methylation pattern"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "Methylation-specific PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, I will use the **Enzyme Assay** to check for the activity of the G6PD enzyme. This will help me rule out the G6PD deficiency mutation if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is 77.504502638558, which is within the normal range (75-100). This rules out the G6PD deficiency mutation.\n\nNext, I will use **Fluorescence in situ hybridization (FISH)** to check for the presence or absence of specific DNA sequences on chromosomes, which can help rule out PMP22 duplication.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay did not detect any deletions, which rules out the PMP22 duplication.\n\nNow, I will use **High-Resolution Melt Analysis (HRM)** to check for variations in DNA that can help rule out the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The HRM assay did not detect any melting curve abnormalities, which rules out the CFTR mutation.\n\nThe remaining mutation is the UBE3A mutation. To confirm this, I will use **Methylation-Specific PCR** to check for normal methylation patterns, which can rule out the UBE3A mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The Methylation-Specific PCR assay detected an abnormal methylation pattern, which is consistent with the UBE3A mutation. Given that all other mutations have been ruled out, the remaining plausible mutation is the UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 7363, "observations": [null, {"action": "Enzyme assay", "observation": 77.504502638558}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Methylation-specific PCR", "observation": "Abnormal methylation pattern"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "Methylation-specific PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["Given the initial state, the best first step is to perform an assay that can rule out one or more genetic mutations effectively. The \"Enzyme assay\" is a good choice because it can directly rule out the G6PD deficiency mutation if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme assay result of 77.504502638558 is within the normal range (75-100), which rules out the G6PD deficiency mutation. Now, the remaining possible genetic mutations are:\n\n- PMP22 duplication\n- CFTR mutation\n- UBE3A mutation\n\nNext, I will perform a Fluorescence in situ hybridization (FISH) to check for the presence or absence of specific DNA sequences on chromosomes, which can help rule out the PMP22 duplication.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay result shows \"No deletions detected,\" which rules out the PMP22 duplication. Now, the remaining possible genetic mutations are:\n\n- CFTR mutation\n- UBE3A mutation\n\nNext, I will perform a High-Resolution Melt Analysis (HRM) to check for variations in DNA, which can help rule out the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) result shows \"No melting curve abnormalities,\" which rules out the CFTR mutation. Now, the only remaining possible genetic mutation is:\n\n- UBE3A mutation\n\nTo confirm this, I will perform a Methylation-Specific PCR to check for the methylation pattern, which can help rule out or confirm the UBE3A mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The Methylation-Specific PCR result shows an \"Abnormal methylation pattern,\" which confirms the UBE3A mutation. Given that all other mutations have been ruled out, the remaining and confirmed genetic mutation is the UBE3A mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 7620, "observations": [null, {"action": "Enzyme assay", "observation": 77.504502638558}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Methylation-specific PCR", "observation": "Abnormal methylation pattern"}], "successful": true, "parse_error": false}, {"actions": ["Enzyme assay", "Fluorescence in situ hybridization (FISH)", "High-resolution melt analysis (HRM)", "Methylation-specific PCR", "UBE3A mutation", {"predicted_truth": "UBE3A mutation"}], "generated_text": ["To start, let's use the Enzyme assay. This assay can help us rule out the G6PD deficiency mutation if the enzyme activity is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity is within the normal range (77.504502638558), which rules out the G6PD deficiency mutation. \n\nNext, let's use the Fluorescence in situ hybridization (FISH) to check for the PMP22 duplication.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay shows no deletions detected, which rules out the PMP22 duplication.\n\nNow, we are left with the CFTR mutation and the UBE3A mutation. Let's use the High-Resolution Melt Analysis (HRM) to check for the CFTR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The High-Resolution Melt Analysis (HRM) shows no melting curve abnormalities, which rules out the CFTR mutation.\n\nWe are now left with the UBE3A mutation. To confirm, let's use the Methylation-Specific PCR to check for the methylation pattern associated with the UBE3A mutation.\n\n<ANSWER> Methylation-specific PCR </ANSWER>", "The Methylation-Specific PCR shows an abnormal methylation pattern, which is consistent with the UBE3A mutation. Based on the results from all the assays, we can confidently identify the UBE3A mutation as the responsible genetic mutation.\n\n<ANSWER> UBE3A mutation </ANSWER>"], "consumed_tokens": 7221, "observations": [null, {"action": "Enzyme assay", "observation": 77.504502638558}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "No deletions detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Methylation-specific PCR", "observation": "Abnormal methylation pattern"}], "successful": true, "parse_error": false}], "seed": 44, "average_actions": 5.8, "average_tokens": 7180.4, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.8, "average_successful_tokens": 7180.4}
{"trajectories": [{"actions": ["Enzyme assay", "Tandem repeat PCR", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, I will use an assay that can potentially rule out multiple mutations. The **Enzyme Assay** is a good choice because it can help rule out both the **SERPINA1 mutation** and the **G6PD deficiency mutation** if the enzyme activity is within a specific range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level is 95.19, which falls within the range of 75 to 100. According to the guidebook, this range allows us to exclude the **SERPINA1 mutation** and the **G6PD deficiency mutation**. This leaves us with the **DMD mutation** and the **FMR1 gene expansion**.\n\nNext, I will use the **Tandem Repeat PCR** to check for the number of repeats, which can help rule out the **FMR1 gene expansion**.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The tandem repeat count is 28.69, which falls within the range of 0 to 30. According to the guidebook, this range allows us to rule out the **FMR1 gene expansion** mutation. This leaves us with the **DMD mutation**.\n\nGiven the remaining possibilities, the most plausible mutation is the **DMD mutation**.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 4385, "observations": [null, {"action": "Enzyme assay", "observation": 95.19151134746268}, {"action": "Tandem repeat PCR", "observation": 28.690079371118145}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Enzyme assay", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Given the initial state of the game, the most strategic first step is to perform an assay that can potentially rule out a significant number of mutations. The **Tandem Repeat PCR** assay is particularly useful here because it can directly rule out the *FMR1 gene expansion* if the repeat count is normal. This will help narrow down the list of possible mutations more effectively.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem Repeat PCR assay indicates a repeat count of approximately 28.69, which falls within the normal range (0-30). This allows us to rule out the *FMR1 gene expansion* mutation.\n\nThe remaining possible mutations are:\n- DMD mutation\n- G6PD deficiency mutation\n- SERPINA1 mutation\n\nNext, we should perform an assay that can further narrow down these options. The **Enzyme assay** can help us rule out the *SERPINA1 mutation* and *G6PD deficiency mutation* if the enzyme activity is within a normal range (75-100).\n\n<ANSWER> Enzyme assay </ANSWER>", "The observation from the Enzyme assay indicates an activity level of approximately 95.19, which falls within the normal range (75-100). This allows us to rule out the *SERPINA1 mutation* and *G6PD deficiency mutation*.\n\nThe remaining possible mutation is:\n- DMD mutation\n\nTo confirm the DMD mutation, we can perform a **Western Blot** assay. If the protein of expected size is detected, it will rule out the DMD mutation. If the protein is absent or truncated, it will confirm the DMD mutation.\n\n<ANSWER> Western blot </ANSWER>", "The observation from the Western Blot assay indicates that the protein is absent or truncated. This confirms the presence of the *DMD mutation*.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6288, "observations": [null, {"action": "Tandem repeat PCR", "observation": 28.690079371118145}, {"action": "Enzyme assay", "observation": 95.19151134746268}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Southern blot", "Enzyme assay", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["Based on the initial state and the information provided in the guidebook, I will start by performing a **Tandem Repeat PCR** assay. This assay is particularly useful for detecting FMR1 gene expansions, which can help me quickly rule out the *FMR1 gene expansion* if the repeat count is normal.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The Tandem Repeat PCR result of 28.69 is within the range of 0 to 30 repeats, which indicates a normal number of repeats. Therefore, we can rule out the *FMR1 gene expansion* mutation.\n\nNext, I will perform a **Southern Blot** assay to further narrow down the possibilities. This assay can help detect DNA fragments of varying sizes, which can be useful in ruling out the *FMR1 gene expansion* mutation if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot result of a normal-sized fragment further confirms that the *FMR1 gene expansion* mutation can be ruled out. Now, we have narrowed down the possible mutations to:\n\n- DMD mutation\n- G6PD deficiency mutation\n- SERPINA1 mutation\n\nNext, I will perform an **Enzyme Assay** to measure enzyme activity levels. This assay can help us rule out the *SERPINA1 mutation* and *G6PD deficiency mutation* if the activity level is within the normal range (75-100).\n\n<ANSWER> Enzyme assay </ANSWER>", "The Enzyme Assay result of 95.19 is within the normal range (75-100), which allows us to rule out the *SERPINA1 mutation* and *G6PD deficiency mutation*.\n\nNow, the only remaining possible mutation is the *DMD mutation*.\n\nTo confirm this, I will perform a **Western Blot** to detect the presence of the protein related to the DMD gene. If the protein is of the expected size, we can rule out the *DMD mutation*.\n\n<ANSWER> Western blot </ANSWER>", "The Western Blot result indicates that the protein is either absent or truncated, which is consistent with the *DMD mutation*. This confirms that the remaining mutation is indeed the *DMD mutation*.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 8081, "observations": [null, {"action": "Tandem repeat PCR", "observation": 28.690079371118145}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 95.19151134746268}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Enzyme assay", "Western blot", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, I will perform a **Southern blot** to check for any expanded fragments, which can help rule out the *FMR1 gene expansion* mutation if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result of a normal-sized fragment allows us to rule out the *FMR1 gene expansion* mutation. The remaining possible mutations are:\n\n- DMD mutation\n- G6PD deficiency mutation\n- SERPINA1 mutation\n\nNext, I will perform an **Enzyme assay** to check the enzyme activity levels. This can help rule out the *SERPINA1 mutation* and *G6PD deficiency mutation* if the activity level is within the normal range.\n\n<ANSWER> Enzyme assay </ANSWER>", "The enzyme activity level of 95.19 is within the normal range (75, 100). This allows us to rule out the *SERPINA1 mutation* and *G6PD deficiency mutation*.\n\nThe remaining possible mutation is:\n\n- DMD mutation\n\nTo confirm, I will perform a **Western blot** to check for the presence of the protein of the expected size, which can help rule out the *DMD mutation* if the protein is detected.\n\n<ANSWER> Western blot </ANSWER>", "The Western blot result showing the protein is absent or truncated confirms that the *DMD mutation* is present, as this indicates a problem with the protein related to the DMD gene.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5933, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Enzyme assay", "observation": 95.19151134746268}, {"action": "Western blot", "observation": "Protein absent or truncated"}], "successful": true, "parse_error": false}, {"actions": ["Tandem repeat PCR", "Western blot", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, I will perform a **Tandem Repeat PCR** to check for the number of repeats in the FMR1 gene. This assay is particularly useful for ruling out the *FMR1 gene expansion* mutation, which is a key indicator of Fragile X Syndrome.\n\n<ANSWER> Tandem repeat PCR </ANSWER>", "The observation from the Tandem Repeat PCR indicates a repeat count of 28.69, which falls within the normal range (0, 30). This allows us to rule out the *FMR1 gene expansion* mutation.\n\nNext, I will perform a **Western Blot** to check for the presence and size of the protein associated with the DMD gene. This will help us determine if the *DMD mutation* can be ruled out.\n\n<ANSWER> Western blot </ANSWER>", "The observation from the Western Blot indicates that the protein is absent or truncated. This does not allow us to rule out the *DMD mutation*, but it suggests that the *DMD mutation* is still a possibility.\n\nNext, I will perform a **Fluorescence in situ Hybridization (FISH)** to check for deletions in the chromosome region associated with the DMD gene. This will help us further investigate the *DMD mutation*.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The observation from the Fluorescence in situ Hybridization (FISH) indicates a deletion detected, which strongly suggests the presence of the *DMD mutation*.\n\nGiven the results from the Tandem Repeat PCR (normal repeat count, ruling out *FMR1 gene expansion*), Western Blot (protein absent or truncated, suggesting *DMD mutation*), and FISH (deletion detected, confirming *DMD mutation*), I can confidently predict the mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6091, "observations": [null, {"action": "Tandem repeat PCR", "observation": 28.690079371118145}, {"action": "Western blot", "observation": "Protein absent or truncated"}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}], "seed": 45, "average_actions": 5.0, "average_tokens": 6155.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.0, "average_successful_tokens": 6155.6}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "Protein truncation test", "Southern blot", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will use the `Next-generation sequencing (NGS)` assay. This assay can comprehensively sequence DNA and help identify a wide range of genetic variants, which will allow me to rule out the presence of an HBB mutation if no variants are detected.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected in the Next-generation sequencing (NGS) assay, we can rule out the presence of an HBB mutation. The remaining possible genetic mutations are:\n\n- APC gene mutation\n- HTT gene expansion\n- MTHFR mutation\n\nNext, I will use the `High-resolution melt analysis (HRM)` assay to check for any melting curve abnormalities, which can help rule out an MTHFR mutation if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since no melting curve abnormalities were detected in the High-resolution melt analysis (HRM) assay, we can rule out the presence of an MTHFR mutation. The remaining possible genetic mutations are:\n\n- APC gene mutation\n- HTT gene expansion\n\nNext, I will use the `Protein truncation test` to check for the presence of truncated proteins, which can help rule out an APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected in the Protein truncation test, we can rule out the presence of an APC gene mutation. The remaining possible genetic mutation is:\n\n- HTT gene expansion\n\nTo confirm the presence of HTT gene expansion, I will use the `Southern blot` assay, which is effective in identifying large-scale variations such as gene expansions.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot assay detected an expanded fragment, this confirms the presence of an HTT gene expansion.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 7510, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Protein truncation test", "High-resolution melt analysis (HRM)", "Southern blot", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will use the **Protein Truncation Test** to check for the presence of truncated proteins, which can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since no truncated proteins were detected, we can rule out the APC gene mutation. Next, I will use **High-Resolution Melt Analysis (HRM)** to check for any melting curve abnormalities, which can help rule out the MTHFR mutation if no abnormalities are detected.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since no melting curve abnormalities were detected, we can rule out the MTHFR mutation. Now, we are left with the HTT gene expansion and HBB mutation. To differentiate between these, I will use **Southern Blot** to check for the presence of a gene expansion, which can help rule out the HTT gene expansion if a normal-sized fragment is detected.\n\n<ANSWER> Southern blot </ANSWER>", "Since an expanded fragment was detected by the Southern Blot, this strongly indicates the presence of a HTT gene expansion. Therefore, I can confidently predict that the genetic mutation is the HTT gene expansion.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 5565, "observations": [null, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "Protein truncation test", "Southern blot", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will perform a test that can provide broad information and help rule out multiple mutations efficiently. The Next-Generation Sequencing (NGS) is a comprehensive technique that can identify a wide range of genetic variants, making it a good initial choice.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "The observation from the Next-Generation Sequencing (NGS) indicates that no variants were detected. This rules out the HBB mutation. \n\nNext, I will perform a High-Resolution Melt Analysis (HRM) to rule out the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "The observation from the High-Resolution Melt Analysis (HRM) indicates that there are no melting curve abnormalities, ruling out the MTHFR mutation.\n\nNow, I will perform a Protein Truncation Test to rule out the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "The observation from the Protein Truncation Test indicates that no truncated proteins were detected, ruling out the APC gene mutation.\n\nThe only remaining mutation is the HTT gene expansion. To confirm this, I will perform a Southern Blot to check for the presence of a gene expansion in the HTT gene.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot has detected an expanded fragment, confirming the presence of an HTT gene expansion.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 7213, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "High-resolution melt analysis (HRM)", "Protein truncation test", "Southern blot", "HTT gene expansion", {"predicted_truth": "HTT gene expansion"}], "generated_text": ["To start, I will use the **Next-Generation Sequencing (NGS)** assay to rule out the presence of the HBB mutation. This is a comprehensive approach that can detect a wide range of genetic variants, making it a good first step in narrowing down the possibilities.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the NGS assay did not detect any variants, we can rule out the HBB mutation. The remaining possible mutations are 'APC gene mutation', 'HTT gene expansion', and 'MTHFR mutation'. \n\nNext, I will use the **High-Resolution Melt Analysis (HRM)** assay to rule out the presence of the MTHFR mutation.\n\n<ANSWER> High-resolution melt analysis (HRM) </ANSWER>", "Since the HRM assay did not detect any melting curve abnormalities, we can rule out the MTHFR mutation. The remaining possible mutations are 'APC gene mutation' and 'HTT gene expansion'.\n\nNext, I will use the **Protein Truncation Test** to rule out the presence of the APC gene mutation.\n\n<ANSWER> Protein truncation test </ANSWER>", "Since the Protein Truncation Test did not detect any truncated proteins, we can rule out the APC gene mutation. The only remaining possible mutation is 'HTT gene expansion'.\n\nI will use the **Southern Blot** assay to confirm the presence of the HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern Blot assay detected an expanded fragment, confirming the presence of the HTT gene expansion.\n\n<ANSWER> HTT gene expansion </ANSWER>"], "consumed_tokens": 7355, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "High-resolution melt analysis (HRM)", "observation": "No melting curve abnormalities"}, {"action": "Protein truncation test", "observation": "No truncated proteins detected"}, {"action": "Southern blot", "observation": "Expanded fragment detected"}], "successful": true, "parse_error": false}, {"actions": [null], "generated_text": ["To start, I will use the **Protein Truncation Test** to check for the presence of truncated proteins, which can help rule out the APC gene mutation if no truncated proteins are detected.\n\n<ANSWER> Protein Truncation Test </ANSWER>"], "consumed_tokens": 1227, "observations": [null], "successful": false, "parse_error": true}], "seed": 46, "average_actions": 4.8, "average_tokens": 5774.0, "average_correct": 0.8, "average_parse_error": 0.2, "average_successful_action_num": 5.75, "average_successful_tokens": 6910.75}
{"trajectories": [{"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Southern blot", "ELISA", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, I will perform an assay that can help me narrow down the list of potential mutations. The **Multiplex Ligation-dependent Probe Amplification (MLPA)** is a good initial test because it can rule out PMP22 duplication, which is one of the more specific mutations.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the MLPA assay shows a normal copy number, which rules out PMP22 duplication. This leaves us with the following potential mutations: 'DMD mutation', 'HTT gene expansion', and 'LEP mutation'.\n\nNext, I will perform a **Southern Blot** to rule out the HTT gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "The observation from the Southern Blot shows a normal-sized fragment, which rules out HTT gene expansion. This leaves us with the following potential mutations: 'DMD mutation' and 'LEP mutation'.\n\nNext, I will perform an **ELISA** to rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 18.096438897156673 is within the normal range, which rules out the LEP mutation. This leaves us with only one potential mutation: 'DMD mutation'.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5039, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 18.096438897156673}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "PCR amplification", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To begin, we should choose an assay that can potentially rule out multiple mutations in one step. The **Fluorescence in Situ Hybridization (FISH)** assay can rule out both **PMP22 duplication** and **DMD mutation** if no deletions are detected. This is a strategic choice to quickly narrow down the list of possible mutations.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since a deletion was detected by the FISH assay, we can rule out **PMP22 duplication** and **HTT gene expansion** because these mutations do not typically involve deletions. This leaves us with **DMD mutation** and **LEP mutation**.\n\nNext, we should use an assay that can distinguish between these two remaining mutations. The **PCR amplification** assay can rule out **DMD mutation** if a fragment is successfully amplified, which would indicate that the DMD gene is intact.\n\n<ANSWER> PCR amplification </ANSWER>", "Since there was no amplification during the PCR amplification assay, this indicates that the DMD gene is disrupted, suggesting a **DMD mutation**. \n\nGiven the results so far, the only remaining plausible mutation is **DMD mutation**.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 3726, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "Fluorescence in situ hybridization (FISH)", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, I will perform a **Southern blot** assay. This assay can help rule out the HTT gene expansion if it shows a normal-sized fragment.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot assay showed a normal-sized fragment, which rules out the HTT gene expansion. The remaining possible mutations are: 'DMD mutation', 'PMP22 duplication', and 'LEP mutation'.\n\nNext, I will perform a **Multiplex ligation-dependent probe amplification (MLPA)** assay to check for a normal copy number, which can rule out PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA assay showed a normal copy number, which rules out PMP22 duplication. The remaining possible mutations are: 'DMD mutation' and 'LEP mutation'.\n\nNext, I will perform an **ELISA** assay to check for normal leptin levels, which can rule out LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA assay showed an ELISA value of 18.096438897156673, which is within the range of normal leptin levels. This rules out the LEP mutation. The remaining possible mutation is 'DMD mutation'.\n\nI will now perform a **Fluorescence in situ hybridization (FISH)** assay to check for deletions, which can rule out DMD mutation if no deletions are detected.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "The FISH assay detected a deletion, which confirms the presence of a DMD mutation. Since this is the only remaining mutation and the FISH assay has provided a positive result, I can confidently identify the mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6573, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "ELISA", "observation": 18.096438897156673}, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}], "successful": true, "parse_error": false}, {"actions": ["Fluorescence in situ hybridization (FISH)", "Multiplex ligation-dependent probe amplification (MLPA)", "Southern blot", "ELISA", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, let's use an assay that can potentially rule out multiple mutations at once. The **Fluorescence in Situ Hybridization (FISH)** can help us rule out both PMP22 duplication and DMD mutation if no deletions are detected. This will allow us to narrow down our list more efficiently.\n\n<ANSWER> Fluorescence in situ hybridization (FISH) </ANSWER>", "Since the FISH assay detected a deletion, we can rule out PMP22 duplication, as FISH would not detect a deletion in this case. However, a deletion detected by FISH could indicate a DMD mutation. To further confirm, we should perform an assay that can specifically rule out DMD mutation if the result is normal.\n\nLet's use **Multiplex Ligation-dependent Probe Amplification (MLPA)** to check for copy number variations.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out PMP22 duplication. The FISH assay detected a deletion, which suggests a DMD mutation, but the MLPA result is normal, so we need to consider the remaining possibilities.\n\nThe next step is to use an assay that can specifically rule out HTT gene expansion. The **Southern Blot** assay can help us exclude HTT gene expansion if the fragment size is normal.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern Blot showed a normal-sized fragment, we can rule out HTT gene expansion. This leaves us with the LEP mutation as the only remaining possibility.\n\nTo confirm, we can use the **ELISA** assay to check for normal leptin levels. If the ELISA values are low, we can rule out the LEP mutation, but if they are normal, the LEP mutation is the only remaining candidate.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 18.096438897156673 is not in the range of 0 to 25, which rules out the LEP mutation. This means that the only remaining mutation, and the one we have not yet ruled out, is the DMD mutation.\n\nGiven the results of the assays performed, the mutation is most likely the DMD mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 6943, "observations": [null, {"action": "Fluorescence in situ hybridization (FISH)", "observation": "Deletion detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 18.096438897156673}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "DMD mutation", {"predicted_truth": "DMD mutation"}], "generated_text": ["To start, we should select an assay that can help us rule out one or more mutations with a single test. The **Southern blot** is a good initial choice because it can rule out the **HTT gene expansion** if the fragment size is normal. This will help us narrow down the possibilities early on.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result of a normal-sized fragment rules out the **HTT gene expansion**. This leaves us with the following possible mutations: **DMD mutation**, **PMP22 duplication**, and **LEP mutation**.\n\nNext, we should perform an assay that can help us rule out another mutation. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can rule out **PMP22 duplication** if the copy number is normal.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result of a normal copy number rules out the **PMP22 duplication**. This leaves us with the following possible mutations: **DMD mutation** and **LEP mutation**.\n\nNext, we should perform an assay that can help us rule out one of these remaining mutations. The **ELISA** is a good choice because it can rule out **LEP mutation** if the ELISA values are within the normal range.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 18.096438897156673 is within the normal range, which rules out the **LEP mutation**. This leaves us with only one possible mutation: **DMD mutation**.\n\nSince we have ruled out all other mutations, we can confidently predict the remaining mutation.\n\n<ANSWER> DMD mutation </ANSWER>"], "consumed_tokens": 5214, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "ELISA", "observation": 18.096438897156673}], "successful": true, "parse_error": false}], "seed": 47, "average_actions": 5.2, "average_tokens": 5499.0, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.2, "average_successful_tokens": 5499.0}
{"trajectories": [{"actions": ["Next-generation sequencing (NGS)", "Multiplex ligation-dependent probe amplification (MLPA)", "PCR amplification", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform a broad assay to gather as much information as possible. Next-generation sequencing (NGS) is a suitable choice because it can identify a wide range of genetic variants, helping to narrow down the possible mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Given that no variants were detected using Next-generation sequencing (NGS), we can rule out mutations in the COL1A1 and GJB2 genes. This leaves us with the LEP mutation and SMN1 deletion as the remaining possibilities.\n\nNext, I will perform an assay that can help distinguish between these two remaining mutations. Multiplex ligation-dependent probe amplification (MLPA) is a good choice because it can detect deletions or duplications, which would be relevant for the SMN1 deletion.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the MLPA assay indicates a copy number variation, which suggests that the SMN1 deletion is likely the mutation responsible for the trait. However, to confirm this and rule out any false positives, I will perform a confirmatory assay. PCR amplification is a good choice because it can specifically amplify the SMN1 gene and confirm the deletion.\n\n<ANSWER> PCR amplification </ANSWER>", "The lack of amplification in the PCR assay confirms that there is a deletion in the SMN1 gene, which aligns with the previous MLPA results. Based on these observations, I can confidently predict that the mutation responsible for the trait is the SMN1 deletion.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5601, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}, {"action": "PCR amplification", "observation": "No amplification"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["Given the initial state and the genetic analysis guidebook, the most informative assay to start with is **Next-generation sequencing (NGS)**. This assay can help us identify a wide range of genetic variants and potentially rule out multiple mutations in one step.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Based on the observation from the Next-generation sequencing (NGS) assay, no variants were detected. This means we can rule out the COL1A1 and GJB2 mutations. \n\nThe remaining possible mutations are:\n- LEP mutation\n- SMN1 deletion\n\nNext, to further narrow down the possibilities, we can use the **Multiplex ligation-dependent probe amplification (MLPA)** assay. This assay can help us detect deletions or duplications, which would be relevant for ruling out the SMN1 deletion.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the Multiplex ligation-dependent probe amplification (MLPA) assay indicates that a copy number variation was detected. This suggests that the SMN1 deletion is a likely candidate. However, to confirm this, we should perform another assay to rule out the LEP mutation.\n\nThe **ELISA** assay can help us quantify the expression effect of the LEP gene. If the results are within the normal range, we can rule out the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 19.05656857632108 is within the normal range (0, 25). This allows us to rule out the LEP mutation.\n\nGiven the observations:\n- No variants detected by Next-generation sequencing (NGS), ruling out COL1A1 and GJB2 mutations.\n- Copy number variation detected by MLPA, suggesting SMN1 deletion.\n- ELISA result within the normal range, ruling out LEP mutation.\n\nThe remaining mutation is the **SMN1 deletion**.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5746, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}, {"action": "ELISA", "observation": 19.05656857632108}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Multiplex ligation-dependent probe amplification (MLPA)", null], "generated_text": ["To start, I'll use the assay that can provide the most comprehensive information about the presence of genetic variants. This will help me narrow down the list of possible mutations more effectively.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-generation sequencing (NGS) did not detect any variants, we can rule out the COL1A1 and GJB2 mutations. This leaves us with LEP mutation and SMN1 deletion as the possible candidates.\n\nNext, I'll use an assay that can help distinguish between these two remaining mutations. The MLPA assay is suitable for detecting deletions, which would be relevant for SMN1 deletion.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the MLPA assay indicates a copy number variation, which suggests that the SMN1 deletion is likely the mutation we are looking for. However, to confirm this, I will perform a PCR amplification to ensure that the SMN1 deletion is indeed present.\n\n<ANSWER> PCR Amplification </ANSWER>"], "consumed_tokens": 3938, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": false, "parse_error": true}, {"actions": ["Next-generation sequencing (NGS)", "ELISA", "Multiplex ligation-dependent probe amplification (MLPA)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will perform a broad assay that can help rule out multiple mutations at once. Next-generation sequencing (NGS) is a good choice because it can identify potential variants in the genes of interest, allowing me to narrow down the list of possible mutations.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since no variants were detected in the NGS assay, we can rule out the COL1A1 and GJB2 mutations. This leaves us with LEP mutation and SMN1 deletion as possible candidates.\n\nNext, I will perform an ELISA to check for the expression of the LEP gene.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 19.05656857632108 falls within the range of 0 to 25, which allows us to exclude the LEP mutation.\n\nThis leaves us with the SMN1 deletion as the only possible candidate. To confirm, I will perform a Multiplex ligation-dependent probe amplification (MLPA) to check for the copy number of the SMN1 gene.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result indicates a copy number variation, which confirms the presence of a deletion in the SMN1 gene. Therefore, the genetic mutation responsible for the observed trait is the SMN1 deletion.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 5530, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "ELISA", "observation": 19.05656857632108}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}, {"actions": ["Next-generation sequencing (NGS)", "Multiplex ligation-dependent probe amplification (MLPA)", "SMN1 deletion", {"predicted_truth": "SMN1 deletion"}], "generated_text": ["To start, I will use an assay that can potentially rule out multiple mutations in one step. The **Next-generation sequencing (NGS)** is a powerful tool that can identify variants in multiple genes at once, which can help me narrow down the list of possible mutations quickly.\n\n<ANSWER> Next-generation sequencing (NGS) </ANSWER>", "Since the Next-generation sequencing (NGS) did not detect any variants, we can rule out the **COL1A1 mutation** and **GJB2 mutation** because these mutations would typically be detected by NGS.\n\nThe remaining possible mutations are:\n- **LEP mutation**\n- **SMN1 deletion**\n\nNext, I will use an assay that can help me distinguish between these two remaining mutations. The **Multiplex ligation-dependent probe amplification (MLPA)** is a good choice because it can detect deletions, which would help me identify whether the SMN1 deletion is present.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The observation from the MLPA assay indicates a copy number variation, which suggests the presence of a deletion. Given that the only remaining mutation is the **SMN1 deletion**, this result strongly points to that mutation.\n\n<ANSWER> SMN1 deletion </ANSWER>"], "consumed_tokens": 4056, "observations": [null, {"action": "Next-generation sequencing (NGS)", "observation": "No variants detected"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Copy number variation detected"}], "successful": true, "parse_error": false}], "seed": 48, "average_actions": 4.4, "average_tokens": 4974.2, "average_correct": 0.8, "average_parse_error": 0.2, "average_successful_action_num": 4.75, "average_successful_tokens": 5233.25}
{"trajectories": [{"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Given the initial state of the game, we have four possible genetic mutations and six available assays. To efficiently narrow down the possibilities, we should start with an assay that can potentially rule out one or more mutations based on a specific outcome.\n\n### Initial Analysis:\n- **Southern blot**: Can rule out FMR1 gene expansion if a normal-sized fragment is observed.\n- **Multiplex ligation-dependent probe amplification (MLPA)**: Can rule out PMP22 duplication if a normal copy number is detected.\n- **ELISA**: Can rule out LEP mutation if the results are in the range (0, 25).\n- **Mass spectrometry genotyping**: Can rule out MTHFR mutation if no mass shifts are detected.\n- **DNA sequencing**: Can rule out MTHFR mutation if no mutations are detected.\n- **RNA sequencing**: Can rule out FMR1 gene expansion if normal transcript levels are observed.\n\n### Strategy:\n- **Southern blot** and **RNA sequencing** can both rule out FMR1 gene expansion, which is a significant reduction in the list of possible mutations.\n- **Multiplex ligation-dependent probe amplification (MLPA)** can rule out PMP22 duplication, which is also a useful reduction.\n- **ELISA**, **Mass spectrometry genotyping**, and **DNA sequencing** can each rule out one specific mutation.\n\n### Decision:\nTo maximize the reduction in the number of possible mutations, I will start with the **Southern blot** assay. If a normal-sized fragment is observed, we can immediately rule out the FMR1 gene expansion, reducing the list to three possible mutations.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern blot, we have ruled out the FMR1 gene expansion. The remaining possible genetic mutations are:\n\n- LEP mutation\n- PMP22 duplication\n- MTHFR mutation\n\nNext, I will use the **Multiplex ligation-dependent probe amplification (MLPA)** assay to check for copy number variations. If a normal copy number is detected, we can rule out the PMP22 duplication, further narrowing down the list.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the MLPA, we have ruled out the PMP22 duplication. The remaining possible genetic mutations are:\n\n- LEP mutation\n- MTHFR mutation\n\nNext, I will use the **ELISA** assay to check for hormone levels. If the results are in the range (0, 25), we can rule out the LEP mutation, leaving us with only the MTHFR mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 10.001982567918777 falls within the range (0, 25), which allows us to rule out the LEP mutation. The remaining possible genetic mutation is:\n\n- MTHFR mutation\n\nSince we have only one remaining mutation, we can confidently predict that the genetic mutation responsible for the trait is the MTHFR mutation.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 6492, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "ELISA", "observation": 10.001982567918777}], "successful": true, "parse_error": false}, {"actions": ["Multiplex ligation-dependent probe amplification (MLPA)", "Southern blot", "ELISA", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Given the initial state, the most efficient first step would be to perform an assay that can potentially rule out multiple mutations based on the results. The `Multiplex ligation-dependent probe amplification (MLPA)` is a good choice because it can detect copy number variations, which would help us rule out the PMP22 duplication if no variation is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the observation from the MLPA assay was a normal copy number, we can rule out the PMP22 duplication. This leaves us with the following possible mutations: LEP mutation, MTHFR mutation, and FMR1 gene expansion.\n\nNext, we should perform an assay that can help us distinguish between these remaining mutations. The `Southern blot` assay can detect specific DNA sequences and is particularly useful for identifying the FMR1 gene expansion.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot assay showed a normal-sized fragment, we can rule out the FMR1 gene expansion. This leaves us with the following possible mutations: LEP mutation and MTHFR mutation.\n\nNext, we should perform an assay that can help us distinguish between these two remaining mutations. The `ELISA` assay can measure hormone levels and is particularly useful for detecting the LEP mutation, which is associated with changes in leptin levels.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA assay result of 10.001982567918777 falls within the range (0, 25), which suggests that the LEP mutation can be excluded.\n\nThis leaves us with the MTHFR mutation as the only remaining possibility. We can confidently predict that the mutation is MTHFR mutation.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5440, "observations": [null, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "ELISA", "observation": 10.001982567918777}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "Mass spectrometry genotyping", "ELISA", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["To start, let's perform an assay that can potentially rule out a significant number of mutations. The **Southern blot** is a good initial choice because it can specifically rule out the FMR1 gene expansion if a normal-sized fragment is observed.\n\n<ANSWER> Southern blot </ANSWER>", "Based on the observation from the Southern blot, we can rule out the FMR1 gene expansion. Now, we have three remaining possible mutations: LEP mutation, PMP22 duplication, and MTHFR mutation.\n\nNext, let's use the **Multiplex ligation-dependent probe amplification (MLPA)** to check for copy number variations. This assay can help us rule out the PMP22 duplication if a normal copy number is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Based on the observation from the MLPA, we can rule out the PMP22 duplication. This leaves us with two remaining possible mutations: LEP mutation and MTHFR mutation.\n\nNext, let's use **Mass spectrometry genotyping** to check for specific mass shifts. This assay can help us rule out the MTHFR mutation if no mass shifts are detected.\n\n<ANSWER> Mass spectrometry genotyping </ANSWER>", "Based on the observation from the Mass spectrometry genotyping, mass shifts were detected, which means we cannot rule out the MTHFR mutation. Since we have already ruled out FMR1 gene expansion and PMP22 duplication, the remaining possible mutation is LEP mutation.\n\nTo confirm, let's perform an **ELISA** to measure hormone levels. If the results are in the range (0, 25), we can rule out the LEP mutation, leaving MTHFR mutation as the only possibility.\n\n<ANSWER> ELISA </ANSWER>", "Based on the ELISA result of 10.001982567918777, which falls in the range (0, 25), we can rule out the LEP mutation. This leaves the MTHFR mutation as the only remaining possibility.\n\nTherefore, the mutation responsible for the trait is the MTHFR mutation.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 7017, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "Mass spectrometry genotyping", "observation": "Mass shifts detected"}, {"action": "ELISA", "observation": 10.001982567918777}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Let's start by ruling out the mutations that can be identified with a single assay. The Southern blot can help us rule out the FMR1 gene expansion if we see a normal-sized fragment. If we detect an expanded fragment, we can't rule out any mutations, so this is a good first step.\n\n<ANSWER> Southern blot </ANSWER>", "Since the Southern blot showed a normal-sized fragment, we can rule out the FMR1 gene expansion. Now we are left with the following mutations: LEP mutation, PMP22 duplication, and MTHFR mutation.\n\nNext, let's use the MLPA assay to check for copy number variations, which will help us rule out the PMP22 duplication if a normal copy number is detected.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "Since the MLPA assay showed a normal copy number, we can rule out the PMP22 duplication. Now we are left with the LEP mutation and MTHFR mutation.\n\nNext, let's use the ELISA assay to measure hormone levels, which will help us rule out the LEP mutation if the results are in the range (0, 25).\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result of 10.001982567918777 falls within the range (0, 25), which allows us to rule out the LEP mutation. Now we are left with the MTHFR mutation as the only remaining possibility.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5313, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "ELISA", "observation": 10.001982567918777}], "successful": true, "parse_error": false}, {"actions": ["Southern blot", "Multiplex ligation-dependent probe amplification (MLPA)", "ELISA", "MTHFR mutation", {"predicted_truth": "MTHFR mutation"}], "generated_text": ["Let's start by performing a **Southern blot** to check for the FMR1 gene expansion. This assay will help us rule out the FMR1 gene expansion if a normal-sized fragment is observed.\n\n<ANSWER> Southern blot </ANSWER>", "The Southern blot result shows a normal-sized fragment, which means the FMR1 gene expansion can be ruled out. Now, let's use **Multiplex ligation-dependent probe amplification (MLPA)** to check for the PMP22 duplication.\n\n<ANSWER> Multiplex ligation-dependent probe amplification (MLPA) </ANSWER>", "The MLPA result shows a normal copy number, which means the PMP22 duplication can be ruled out. Now, we are left with the LEP mutation and the MTHFR mutation. Let's perform an **ELISA** to check for the LEP mutation.\n\n<ANSWER> ELISA </ANSWER>", "The ELISA result is 10.001982567918777, which falls in the range (0, 25). This means the LEP mutation can be ruled out. Now, we are left with the MTHFR mutation.\n\n<ANSWER> MTHFR mutation </ANSWER>"], "consumed_tokens": 5096, "observations": [null, {"action": "Southern blot", "observation": "Normal-sized fragment"}, {"action": "Multiplex ligation-dependent probe amplification (MLPA)", "observation": "Normal copy number"}, {"action": "ELISA", "observation": 10.001982567918777}], "successful": true, "parse_error": false}], "seed": 49, "average_actions": 5.2, "average_tokens": 5871.6, "average_correct": 1.0, "average_parse_error": 0.0, "average_successful_action_num": 5.2, "average_successful_tokens": 5871.6}
